,,,,,,,,,,,,,,,index,trial_id,registry,registration_date,start_date,retrospective_registration,sponsor,recruitment_status,phase,study_type,countries,title,acronym,study_category,intervention,intervention_list,enrollment,primary_completion_date,full_completion_date,registy_url,results_type,results_published_date,results_url,last_updated,cross_registration
0,NCT04255940,ClinicalTrials.gov,3.02.2020,20.01.2020,TRUE,Qilu,Hospital,of,Shandong,University,Recruiting,Not,Applicable,Observational,China,2019-nCoV,Outbreak,and,Cardiovascular,Diseases,,Clinical,Presentation,No,Intervention,No,Intervention,12000,30.04.2020,30.04.2020,https://clinicaltrials.gov/show/NCT04255940,No,Results,No,Results,No,Results,17.02.2020,None
45,ChiCTR2000029763,ChiCTR,12.02.2020,13.02.2020,FALSE,China,Academy,of,Chinese,Medical,Sciences,,,,,,,,,,,,,,,,,,,,,,,,,,,,
74,ChiCTR2000029559,ChiCTR,4.02.2020,31.01.2020,TRUE,Renmin,Hospital,of,Wuhan,University,Recruiting,Phase,4,Interventional,China,Therapeutic,effect,of,hydroxychloroquine,on,novel,coronavirus,pneumonia,(COVID-19),,Drug,Hydroxychloroquine,Hydroxychloroquine,300,Not,Available,29.02.2020,http://www.chictr.org.cn/showproj.aspx?proj=48880,Pre-Print,Article,31.03.2020,https://doi.org/10.1101/2020.03.22.20040758,17.02.2020,None
83,ChiCTR2000029495,ChiCTR,2.02.2020,3.02.2020,FALSE,Xinhua,Affiliated,Hospital,,Hubei,University,of,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,
84,ChiCTR2000029493,ChiCTR,2.02.2020,3.02.2020,FALSE,Xinhua,Affiliated,Hospital,,Hubei,University,of,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,
88,ChiCTR2000029461,ChiCTR,2.02.2020,3.02.2020,FALSE,Xinhua,Affiliated,Hospital,,Hubei,University,of,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,
89,ChiCTR2000029460,ChiCTR,2.02.2020,2.02.2020,FALSE,Xinhua,Affiliated,Hospital,,Hubei,University,of,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,
90,ChiCTR2000029459,ChiCTR,2.02.2020,3.02.2020,FALSE,Xinhua,Affiliated,Hospital,,Hubei,University,of,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,
91,ChiCTR2000029439,ChiCTR,1.02.2020,2.02.2020,FALSE,Beijing,Hospital,of,Traditional,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
92,ChiCTR2000029438,ChiCTR,1.02.2020,4.02.2020,FALSE,Beijing,Hospital,of,Traditional,Chinese,Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
102,NCT04268537,ClinicalTrials.gov,8.02.2020,10.02.2020,FALSE,Southeast,University,,China,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Immunoregulatory,Therapy,for,2019-nCoV,,Drug,PD1,vs.,thymosin,PD1,,,,,,,,,,,,
191,NCT04280588,ClinicalTrials.gov,20.02.2020,22.02.2020,FALSE,The,First,Affiliated,Hospital,of,Fujian,Medical,University,Recruiting,Phase,2,Interventional,China,Fingolimod,in,COVID-19,,Drug,Fingolimod,Fingolimod,30,1.07.2020,1.07.2020,https://clinicaltrials.gov/show/NCT04280588,No,Results,No,Results,No,Results,2.03.2020,None,,
307,NCT04296643,ClinicalTrials.gov,3.03.2020,1.04.2020,FALSE,McMaster,University,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Medical,Masks,vs,N95,Respirators,for,COVID-19,,Other,(device),Masks,Masks,576,1.02.2021,1.04.2021,https://clinicaltrials.gov/show/NCT04296643,No,Results,No,Results,No,Results,16.03.2020,None
368,ChiCTR2000030773,ChiCTR,14.03.2020,12.02.2020,TRUE,Huashan,Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
377,ChiCTR2000030757,ChiCTR,13.03.2020,13.03.2020,FALSE,Shenzhen-Peking,University,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
425,NCT04299724,ClinicalTrials.gov,5.03.2020,15.02.2020,TRUE,Shenzhen,Geno-Immune,Medical,Institute,Recruiting,Phase,1,Interventional,China,Safety,and,Immunity,of,Covid-19,aAPC,Vaccine,,ATMP,Plasma,Plasma,100,31.07.2023,31.12.2024,https://clinicaltrials.gov/show/NCT04299724,No,Results,No,Results,No,Results,23.03.2020,None,,
478,ChiCTR2000029496,ChiCTR,3.02.2020,29.01.2020,TRUE,The,First,Hospital,of,Changsha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
486,NCT04276896,ClinicalTrials.gov,17.02.2020,24.03.2020,FALSE,Shenzhen,Geno-Immune,Medical,Institute,Recruiting,Phase,1/Phase,2,Interventional,China,Immunity,and,Safety,of,Covid-19,Synthetic,Minigene,Vaccine,,ATMP,Vaccine,Vaccine,100,31.07.2023,31.12.2024,https://clinicaltrials.gov/show/NCT04276896,No,Results,No,Results,No,Results,30.03.2020,None
489,NCT04292964,ClinicalTrials.gov,1.03.2020,1.03.2020,FALSE,Chongqing,Medical,University,Not,Recruiting,Not,Applicable,Observational,China,Prognostic,Factors,of,Patients,With,COVID-19,,Prognosis,No,Intervention,No,Intervention,201,13.03.2020,13.03.2020,https://clinicaltrials.gov/show/NCT04292964,Journal,Article,15.04.2020,http://dx.doi.org/10.1186/s12931-020-01352-w,30.03.2020,None,,,
492,NCT04308317,ClinicalTrials.gov,4.03.2020,5.03.2020,FALSE,Henan,Provincial,People's,Hospital,Recruiting,Phase,4,Interventional,China,Tetrandrine,Tablets,Used,in,the,Treatment,of,COVID-19,TT-NPC,Drug,Tetrandrine,Tetrandrine,60,1.03.2021,1.05.2021,https://clinicaltrials.gov/show/NCT04308317,No,Results,No,Results,No,Results,30.03.2020,None,
493,NCT04312100,ClinicalTrials.gov,13.03.2020,1.02.2020,TRUE,Henan,Provincial,People's,Hospital,Recruiting,Not,Applicable,Observational,China,Sequential,Oxygen,Therapy,Strategy,for,Patients,With,COVID-19,SOTSPC,Drug,Oxygen,Oxygen,30,20.10.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04312100,No,Results,No,Results,No,Results,30.03.2020,None,
494,NCT04312464,ClinicalTrials.gov,4.03.2020,1.01.2020,TRUE,Wuhan,Union,Hospital,,China,Recruiting,Not,Applicable,Observational,China,Myocardial,Damage,in,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,500,15.03.2020,18.03.2020,https://clinicaltrials.gov/show/NCT04312464,No,Results,No,Results,No,Results,30.03.2020,None,
500,NCT04316884,ClinicalTrials.gov,13.03.2020,12.03.2020,TRUE,Uppsala,University,Recruiting,Not,Applicable,Observational,Sweden,Mechanisms,for,Organ,Dysfunction,in,Covid-19,UMODCOVID19,Clinical,Presentation,No,Intervention,No,Intervention,100,31.12.2020,31.12.2021,https://clinicaltrials.gov/show/NCT04316884,No,Results,No,Results,No,Results,30.03.2020,None,,
528,ChiCTR2000031187,ChiCTR,23.03.2020,23.03.2020,FALSE,Wuhan,Third,Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
548,NCT04319211,ClinicalTrials.gov,20.03.2020,25.03.2020,FALSE,Istanbul,University-Cerrahpasa,Not,Recruiting,Not,Applicable,Observational,Turkey,Effects,of,Social,Isolation,From,Coronavirus,,,,,,,,,,,,,,,,,,,,
584,NCT04321811,ClinicalTrials.gov,23.03.2020,21.03.2020,TRUE,xCures,Recruiting,Not,Applicable,Observational,United,States,Behavior,,Environment,And,Treatments,for,Covid-19,BEAT19,Clinical,Presentation,No,Intervention,No,Intervention,100000,20.03.2021,20.03.2022,https://clinicaltrials.gov/show/NCT04321811,No,Results,No,Results,No,Results,14.04.2020,None,
586,NCT04324528,ClinicalTrials.gov,25.03.2020,27.03.2020,TRUE,Dr.,Alexander,Supady,Recruiting,Not,Applicable,Interventional,Germany,Cytokine,Adsorption,in,Severe,COVID-19,Pneumonia,Requiring,Extracorporeal,Membrane,Oxygenation,CYCOV,Drug,Oxygen,Oxygen,30,26.09.2020,26.11.2020,https://clinicaltrials.gov/show/NCT04324528,No,Results,No,Results,No,Results,14.04.2020,DRKS00021300
591,NCT04328272,ClinicalTrials.gov,25.03.2020,28.03.2020,FALSE,Dr.,Umar,Farooq,Not,Recruiting,Phase,3,Interventional,Pakistan,Effectiveness,of,Hydroxychloroquine,in,Covid-19,Patients,Covid,Drug,Hydroxychloroquine,vs.,Hydroxychloroquine,+,Azithromycin,Hydroxychloroquine,,,,,,,,,,,
595,NCT04330261,ClinicalTrials.gov,30.03.2020,18.03.2020,TRUE,University,of,Calgary,Recruiting,Not,Applicable,Observational,Canada,Clinical,Characteristics,and,Outcomes,of,Pediatric,COVID-19,PERN-COVID-19,Clinical,Presentation,No,Intervention,No,Intervention,12500,17.03.2021,17.03.2022,https://clinicaltrials.gov/show/NCT04330261,No,Results,No,Results,No,Results,14.04.2020,None
596,NCT04331574,ClinicalTrials.gov,30.03.2020,10.03.2020,TRUE,Società,Italiana,dell'Ipertensione,Arteriosa-Lega,Italiana,Recruiting,Not,Applicable,Observational,Italy,Renin-Angiotensin,System,Inhibitors,and,COVID-19,SARS-RAS,Drug,ACE,Inhibitors,or,ARBs,ACE,Inhibitors,,,,,,,,,,,
598,NCT04332016,ClinicalTrials.gov,30.03.2020,2.04.2020,FALSE,University,Hospital,,Bordeaux,Recruiting,Not,Applicable,Observational,France,COVID-19,Biological,Samples,Collection,COLCOV19-BX,Clinical,Presentation,No,Intervention,No,Intervention,2000,23.03.2020,23.03.2020,https://clinicaltrials.gov/show/NCT04332016,No,Results,No,Results,No,Results,14.04.2020,None,,
602,NCT04335201,ClinicalTrials.gov,31.03.2020,6.04.2020,TRUE,IRCCS,Ospedale,San,Raffaele,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Defibrotide,in,COVID-19,Pneumonia,DEFI-VID19,Drug,Defibrotide,Defibrotide,50,30.09.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04335201,No,Results,No,Results,No,Results,14.04.2020,EUCTR2020-001513-20,,
635,EUCTR2020-001565-37-ES,EU,Clinical,Trials,Register,7.04.2020,3.04.2020,TRUE,ISGlobal,Authorised,Phase,3,Interventional,Spain,Prevention,of,novel,Coronavirus,infection,with,hydroxychloroquine,,Drug,Hydroxychloroquine,Hydroxychloroquine,440,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,No,Results,No,Results,No,Results,14.04.2020,None
641,NCT04261517,ClinicalTrials.gov,6.02.2020,6.02.2020,FALSE,Shanghai,Public,Health,Clinical,Center,Not,Recruiting,Phase,3,Interventional,China,Efficacy,and,Safety,of,Hydroxychloroquine,for,Treatment,of,COVID-19,,Drug,Hydroxychloroquine,Hydroxychloroquine,30,25.02.2020,25.02.2020,https://clinicaltrials.gov/show/NCT04261517,Journal,Article,6.03.2020,https://doi.org/10.3785/j.issn.1008-9292.2020.03.03,20.04.2020,None
644,NCT04302766,ClinicalTrials.gov,2.03.2020,1.04.2020,FALSE,U.S.,Army,Medical,Research,and,Development,Command,Not,Recruiting,Phase,1,Expanded,Access,No,Country,Given,Expanded,Access,Remdesivir,(RDV,,,,,,,,,,,,,,
645,NCT04306055,ClinicalTrials.gov,8.03.2020,13.03.2020,FALSE,Guangzhou,Blood,Center,Not,Recruiting,Not,Applicable,Interventional,China,Blood,Donor,Recruitment,During,Epidemic,of,COVID-19,,Other,No,Intervention,No,Intervention,19491,13.03.2020,3.04.2020,https://clinicaltrials.gov/show/NCT04306055,No,Results,No,Results,No,Results,20.04.2020,None
647,NCT04315480,ClinicalTrials.gov,14.03.2020,12.03.2020,TRUE,Universit,Politecnica,delle,Marche,Not,Recruiting,Phase,2,Interventional,Italy,Tocilizumab,for,SARS-CoV2,(COVID-19),Severe,Pneumonitis,,Drug,Tocilizumab,Tocilizumab,38,9.04.2020,20.05.2020,https://clinicaltrials.gov/show/NCT04315480,Pre-Print,Article,11.07.2020,https://doi.org/10.1101/2020.07.11.20151365,20.04.2020,None,,,,
648,NCT04319315,ClinicalTrials.gov,16.03.2020,11.03.2020,TRUE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Social,Media,Effect,on,Knowledge,Dissemination,During,COVID-19,Virus,Outbreak,,Other,No,Intervention,No,Intervention,400,1.04.2020,16.04.2020,https://clinicaltrials.gov/show/NCT04319315,Pre-Print,Article,3.06.2020,https://doi.org/10.1101/2020.05.31.20118232,20.04.2020,None,
650,NCT04329546,ClinicalTrials.gov,29.03.2020,27.03.2020,TRUE,University,Hospital,,Geneva,Recruiting,Not,Applicable,Observational,Switzerland,Understanding,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,250,31.01.2022,31.03.2022,https://clinicaltrials.gov/show/NCT04329546,No,Results,No,Results,No,Results,20.04.2020,None,,,,
653,NCT04331509,ClinicalTrials.gov,31.03.2020,23.03.2020,TRUE,King's,College,London,Recruiting,Not,Applicable,Observational,United,States,,United,Kingdom,COVID-19,Symptom,Tracker,,Clinical,Presentation,No,Intervention,No,Intervention,10000000,23.03.2022,23.03.2022,https://clinicaltrials.gov/show/NCT04331509,Pre-Print,Article,12.05.2020,https://doi.org/10.1101/2020.04.29.20084111,20.04.2020,None,,
658,NCT04333953,ClinicalTrials.gov,31.03.2020,1.04.2020,FALSE,University,of,Missouri-Columbia,Recruiting,Not,Applicable,Observational,United,States,COVID-19,in,Patients,With,HIV,,Clinical,Presentation,No,Intervention,No,Intervention,500,1.10.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04333953,No,Results,No,Results,No,Results,20.04.2020,None,
661,NCT04335188,ClinicalTrials.gov,31.03.2020,6.04.2020,FALSE,IHF,GmbH,-,Institut,for,Herzinfarktforschung,Recruiting,Not,Applicable,Observational,Germany,COVID-19,Registry,Rhineland-Palatinate,(Germany),,Clinical,Presentation,No,Intervention,No,Intervention,4000,31.07.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04335188,No,Results,No,Results,No,Results,20.04.2020,None
662,NCT04335630,ClinicalTrials.gov,2.04.2020,30.03.2020,TRUE,Memorial,Hermann,Health,System,Recruiting,Not,Applicable,Observational,United,States,Cardiovascular,Manifestations,of,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,500,21.03.2020,22.03.2020,https://clinicaltrials.gov/show/NCT04335630,No,Results,No,Results,No,Results,20.04.2020,None,
671,NCT04337502,ClinicalTrials.gov,6.04.2020,23.12.2019,TRUE,Maastricht,University,Not,Recruiting,Not,Applicable,Observational,China,Clinical,and,Radiomic,Model,of,COVID-19,,Other,(software),Other,Other,300,20.01.2020,3.03.2020,https://clinicaltrials.gov/show/NCT04337502,No,Results,No,Results,No,Results,20.04.2020,None,,,
672,NCT04337762,ClinicalTrials.gov,6.04.2020,6.04.2020,FALSE,Beat,COVID,LLC,Recruiting,Not,Applicable,Observational,United,States,Beat,COVID-19,-,Observational,Trial,JUPITER,Clinical,Presentation,No,Intervention,No,Intervention,100000,20.12.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04337762,No,Results,No,Results,No,Results,20.04.2020,None,
677,NCT04339387,ClinicalTrials.gov,6.04.2020,1.03.2020,TRUE,Brigham,and,Women's,Hospital,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Risk,Stratification,,Prognosis,No,Intervention,No,Intervention,1500,15.04.2020,15.04.2020,https://clinicaltrials.gov/show/NCT04339387,No,Results,No,Results,No,Results,20.04.2020,None,,,
678,NCT04339608,ClinicalTrials.gov,7.04.2020,2.04.2020,TRUE,Max,Healthcare,Insititute,Limited,Recruiting,Not,Applicable,Observational,India,Max,COVID19-,Study,,Clinical,Presentation,No,Intervention,No,Intervention,10000,30.05.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04339608,No,Results,No,Results,No,Results,20.04.2020,None,,,
707,ChiCTR2000029434,ChiCTR,1.02.2020,1.02.2020,FALSE,Hebei,Yiling,Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
708,ChiCTR2000029433,ChiCTR,1.02.2020,1.02.2020,FALSE,Hebei,Yiling,Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
710,EUCTR2020-001160-28-ES,EU,Clinical,Trials,Register,13.04.2020,9.04.2020,TRUE,Medica,Scientia,Innovation,Research,S.L.,(MEDSIR),Authorised,Phase,2,Interventional,Spain,Tocilizumab,plus,Pembrolizumab,in,COVID-19,,Drug,Tocilizumab,+,Pembrolizumab,Tocilizumab,,,,,,,,,
746,IRCT20200325046860N1,IRCT,30.03.2020,15.03.2020,TRUE,Darmanara,Co.,Recruiting,Not,Applicable,Interventional,Iran,Convalescent,Plasma,therapy,for,COVID-19,Patients,,ATMP,Plasma,Plasma,200,Not,Available,Not,Available,http://en.irct.ir/trial/46759,No,Results,No,Results,No,Results,21.04.2020,None,,,
760,NCT04257656,ClinicalTrials.gov,31.01.2020,6.02.2020,FALSE,Capital,Medical,University,Not,Recruiting,Phase,3,Interventional,China,A,Trial,of,Remdesivir,in,Adults,With,Severe,COVID-19,,Drug,Remdesivir,Remdesivir,237,30.03.2020,10.04.2020,https://clinicaltrials.gov/show/NCT04257656,Journal,Article,29.04.2020,https://doi.org/10.1016/S0140-6736(20)31022-9,27.04.2020,None,,
763,NCT04280224,ClinicalTrials.gov,13.02.2020,15.02.2020,FALSE,Xinxiang,Medical,University,Recruiting,Phase,1,Interventional,China,NK,Cells,Treatment,for,COVID-19,,ATMP,Cells,(NK),Cells,(NK),30,30.09.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04280224,No,Results,No,Results,No,Results,27.04.2020,None,,,
768,NCT04320953,ClinicalTrials.gov,21.03.2020,16.03.2020,TRUE,Changhai,Hospital,Not,Recruiting,Not,Applicable,Interventional,China,Non-contact,Endoscopy,at,Covid-19,Outbreak,,Other,(device),Non-contact,Endoscopy,Non-contact,Endoscopy,5,26.03.2020,9.04.2020,https://clinicaltrials.gov/show/NCT04320953,No,Results,No,Results,No,Results,27.04.2020,None,,
769,NCT04321174,ClinicalTrials.gov,18.03.2020,17.04.2020,FALSE,Darrell,Tan,Recruiting,Phase,3,Interventional,Canada,COVID-19,Ring-based,Prevention,Trial,With,Lopinavir/Ritonavir,CORIPREV-LR,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,1220,31.03.2021,31.03.2022,https://clinicaltrials.gov/show/NCT04321174,No,Results,No,Results,No,Results,27.04.2020,None,,,,,
773,NCT04324190,ClinicalTrials.gov,26.03.2020,8.04.2020,FALSE,Gunther,Meinlschmidt,Recruiting,Not,Applicable,Interventional,Germany,DIgital,Online,SuPport,for,COVID-19,StrEss,DISPOSE,Other,(psych),Psychological,Psychological,600,20.06.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04324190,No,Results,No,Results,No,Results,27.04.2020,None,,,,
779,NCT04334044,ClinicalTrials.gov,1.04.2020,15.04.2020,FALSE,Grupo,Cooperativo,Hemopatías,Malignas,Recruiting,Phase,1/Phase,2,Interventional,Mexico,Treatment,of,SARS,Caused,by,COVID-19,With,Ruxolitinib,,Drug,Ruxolitinib,Ruxolitinib,20,1.06.2020,1.06.2020,https://clinicaltrials.gov/show/NCT04334044,No,Results,No,Results,No,Results,27.04.2020,None
781,NCT04336215,ClinicalTrials.gov,2.04.2020,7.04.2020,FALSE,Rutgers,University,Recruiting,Not,Applicable,Observational,United,States,Rutgers,COVID-19,Cohort,Study,,Clinical,Presentation,No,Intervention,No,Intervention,750,1.09.2020,21.10.2021,https://clinicaltrials.gov/show/NCT04336215,Pre-Print,Article,24.04.2020,https://doi.org/10.1101/2020.04.20.20072470,27.04.2020,None,,,,,
791,NCT04344106,ClinicalTrials.gov,8.04.2020,1.04.2020,TRUE,ELHARRAR,Xavier,Recruiting,Not,Applicable,Interventional,France,Prone,Positioning,in,Spontaneously,Breathing,Nonintubated,Covid-19,Patient:,a,Pilot,Study,ProCov,Procedure,Positioning,Positioning,25,15.04.2020,1.05.2020,https://clinicaltrials.gov/show/NCT04344106,No,Results,No,Results,No,Results,27.04.2020,None
792,NCT04344171,ClinicalTrials.gov,10.04.2020,30.03.2020,TRUE,ClarData,Recruiting,Not,Applicable,Observational,Germany,,Romania,CovidDB:,The,Covid-19,Inpatient,Database,,Clinical,Presentation,No,Intervention,No,Intervention,5000,31.12.2022,30.06.2023,https://clinicaltrials.gov/show/NCT04344171,No,Results,No,Results,No,Results,27.04.2020,None,,
794,NCT04344535,ClinicalTrials.gov,10.04.2020,8.04.2020,TRUE,Stony,Brook,University,Recruiting,Phase,1/Phase,2,Interventional,United,States,Convalescent,Plasma,vs.,Standard,Plasma,for,COVID-19,,ATMP,Plasma,Plasma,500,30.04.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04344535,No,Results,No,Results,No,Results,27.04.2020,None,
805,NCT04345523,ClinicalTrials.gov,2.04.2020,3.04.2020,FALSE,Cristina,Avendaño-Solá,Recruiting,Phase,2,Interventional,Spain,Convalescent,Plasma,Therapy,vs.,SOC,for,the,Treatment,of,COVID19,in,Hospitalized,Patients,ConPlas-19,ATMP,Plasma,Plasma,278,20.07.2020,20.07.2020,https://clinicaltrials.gov/show/NCT04345523,Pre-Print,Article,1.09.2020,https://doi.org/10.1101/2020.08.26.20182444,27.04.2020,None
808,NCT04345887,ClinicalTrials.gov,10.04.2020,21.04.2020,FALSE,Istanbul,University-Cerrahpasa,Not,Recruiting,Phase,4,Interventional,Turkey,Spironolactone,in,Covid-19,Induced,ARDS,,Drug,Spironolactone,Spironolactone,60,21.07.2020,21.10.2020,https://clinicaltrials.gov/show/NCT04345887,No,Results,No,Results,No,Results,27.04.2020,None,,,,,
825,NCT04348877,ClinicalTrials.gov,13.04.2020,20.04.2020,FALSE,Ain,Shams,University,Not,Recruiting,Not,Applicable,Interventional,Egypt,Plasma,Rich,Antibodies,From,Recovered,Patients,From,COVID19,PRA-001,ATMP,Plasma,Plasma,20,20.10.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04348877,No,Results,No,Results,No,Results,27.04.2020,None,
826,NCT04349371,ClinicalTrials.gov,12.04.2020,1.04.2020,TRUE,Columbia,University,Recruiting,Phase,2,Interventional,United,States,Saved,From,COVID-19,,Drug,(Chemoprophylaxis),Chloroquine,Chloroquine,350,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04349371,No,Results,No,Results,No,Results,27.04.2020,None,,,,,,
834,NCT04351529,ClinicalTrials.gov,16.04.2020,1.04.2020,TRUE,Arbeitsgemeinschaft,medikamentoese,Tumortherapie,(AGMT),Recruiting,Not,Applicable,Observational,Austria,Austrian,COVID-19,Registry,,Clinical,Presentation,No,Intervention,No,Intervention,1000,21.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04351529,No,Results,No,Results,No,Results,27.04.2020,None,,,
838,NCT04351763,ClinicalTrials.gov,14.04.2020,27.04.2020,FALSE,Nicolaus,Copernicus,University,Recruiting,Phase,2/Phase,3,Interventional,Poland,Amiodarone,or,Verapamil,in,COVID-19,Hospitalized,Patients,With,Symptoms,ReCOVery-SIRIO,Drug,Amiodarone,or,Verapamil,Amiodarone,,,,,,,,,,
842,NCT04352582,ClinicalTrials.gov,13.04.2020,14.04.2020,FALSE,University,Hospital,,Geneva,Recruiting,Not,Applicable,Observational,United,Kingdom,COVID-19,and,Vaccination,Attitudes,VACAT,Other,No,Intervention,No,Intervention,1000,30.04.2020,30.04.2020,https://clinicaltrials.gov/show/NCT04352582,No,Results,No,Results,No,Results,27.04.2020,None,,
851,NCT04355247,ClinicalTrials.gov,17.04.2020,14.04.2020,TRUE,Auxilio,Mutuo,Cancer,Center,Recruiting,Phase,2,Interventional,Puerto,Rico,Prophylactic,Corticosteroid,to,Prevent,COVID-19,Cytokine,Storm,,Drug,(Chemoprophylaxis),Corticosteroids,Methylprednisolone,20,31.07.2020,30.04.2021,https://clinicaltrials.gov/show/NCT04355247,No,Results,No,Results,No,Results,27.04.2020,None
885,EUCTR2020-001527-14-NL,EU,Clinical,Trials,Register,6.04.2020,21.04.2020,FALSE,Erasmus,MC,Authorised,Phase,4,Interventional,Netherlands,COVID-19:,addition,of,azithromycin,to,chloroquine,treatment,,Drug,Chloroquine,+,Azithromycin,Chloroquine,,,,,,,,,,,
892,NCT04318444,ClinicalTrials.gov,20.03.2020,29.03.2020,FALSE,Columbia,University,Recruiting,Phase,2/Phase,3,Interventional,United,States,Hydroxychloroquine,Post,Exposure,Prophylaxis,for,Coronavirus,Disease,(COVID-19),,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,21.03.2020,22.03.2020,https://clinicaltrials.gov/show/NCT04318444,No,Results,No,Results,No,Results,4.05.2020,None
894,NCT04319445,ClinicalTrials.gov,20.03.2020,22.03.2020,FALSE,Wake,Forest,University,Recruiting,Not,Applicable,Interventional,United,States,Mindfulness,During,COVID-19,,Other,(psych),Psychological,Psychological,200,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04319445,No,Results,No,Results,No,Results,4.05.2020,None,,,,,
897,NCT04320862,ClinicalTrials.gov,23.03.2020,3.04.2020,FALSE,Duke,University,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Pandemic,Response,Network,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,200000,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04320862,No,Results,No,Results,No,Results,4.05.2020,None,,
901,NCT04331808,ClinicalTrials.gov,31.03.2020,30.03.2020,TRUE,Assistance,Publique,–,Hôpitaux,de,Paris,Not,Recruiting,Phase,2,Interventional,France,CORIMUNO-19,-,Tocilizumab,Trial,-,TOCI,(CORIMUNO-TOCI),CORIMUNO-TOC,Drug,Tocilizumab,Tocilizumab,228,31.03.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04331808,Journal,Article,20.10.2020,https://doi.org/10.1001/jamainternmed.2020.6820,4.05.2020,None,
908,NCT04341493,ClinicalTrials.gov,7.04.2020,6.04.2020,TRUE,Hugo,Mendieta,Zeron,Recruiting,Phase,4,Interventional,Mexico,Hydroxychloroquine,vs,Nitazoxanide,in,Patients,With,COVID-19,,Drug,Hydroxychloroquine,vs.,Nitazoxanide,Hydroxychloroquine,,,,,,,,,,,,,
911,NCT04345679,ClinicalTrials.gov,11.04.2020,14.04.2020,FALSE,Orthosera,Kft.,Not,Recruiting,Phase,1,Interventional,No,Country,Given,Anti,COVID-19,Convalescent,Plasma,Therapy,,ATMP,Plasma,Plasma,20,1.06.2020,1.04.2021,https://clinicaltrials.gov/show/NCT04345679,No,Results,No,Results,No,Results,4.05.2020,None,,,
934,NCT04357496,ClinicalTrials.gov,20.04.2020,20.04.2020,FALSE,Centogene,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,COVID-19,Epidemic,Response,Study,COVeR,Clinical,Presentation,No,Intervention,No,Intervention,400,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04357496,No,Results,No,Results,No,Results,4.05.2020,None,,
939,NCT04358510,ClinicalTrials.gov,20.04.2020,1.04.2020,TRUE,Dascena,Not,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Mortality,Prediction,Model,,Prognosis,No,Intervention,No,Intervention,114,17.04.2020,17.04.2020,https://clinicaltrials.gov/show/NCT04358510,No,Results,No,Results,No,Results,4.05.2020,None,,,,
941,NCT04358614,ClinicalTrials.gov,19.04.2020,16.03.2020,TRUE,Fabrizio,Cantini,Not,Recruiting,Phase,2/Phase,3,Interventional,Italy,Baricitinib,Therapy,in,COVID-19,,Drug,Baricitinib,Baricitinib,12,5.04.2020,7.04.2020,https://clinicaltrials.gov/show/NCT04358614,No,Results,No,Results,No,Results,4.05.2020,None,,,,,
947,NCT04359316,ClinicalTrials.gov,18.04.2020,20.04.2020,FALSE,Shahid,Beheshti,University,of,Medical,Sciences,Not,Recruiting,Phase,4,Interventional,Iran,Azithromycin,in,Hospitalized,COVID-19,Patients,AIC,Drug,Azithromycin,vs.,Hydroxychloroquine,Azithromycin,,,,,,,,,,,
948,NCT04359329,ClinicalTrials.gov,21.04.2020,20.04.2020,TRUE,Sharon,Nachman,Recruiting,Phase,2,Interventional,United,States,Estrogen,Patch,for,COVID-19,Symptoms,,Drug,Estradiol,Estradiol,110,15.11.2020,15.11.2020,https://clinicaltrials.gov/show/NCT04359329,No,Results,No,Results,No,Results,4.05.2020,None,,,,,
950,NCT04359615,ClinicalTrials.gov,18.04.2020,20.04.2020,FALSE,Shahid,Beheshti,University,of,Medical,Sciences,Not,Recruiting,Phase,4,Interventional,Iran,Favipiravir,in,Hospitalized,COVID-19,Patients,FIC,Drug,Favipiravir,+,Hydroxychloroquine,vs.,Hydroxychloroquine,Favipiravir,,,,,,,,,
953,NCT04359914,ClinicalTrials.gov,19.04.2020,15.04.2020,TRUE,University,of,Rostock,Recruiting,Not,Applicable,Observational,Germany,Neurocognitive,Impairment,in,Patients,With,COVID-19,NCoV,Clinical,Presentation,No,Intervention,No,Intervention,80,31.12.2020,1.04.2021,https://clinicaltrials.gov/show/NCT04359914,No,Results,No,Results,No,Results,4.05.2020,None,
955,NCT04360356,ClinicalTrials.gov,19.04.2020,1.05.2020,FALSE,Tanta,University,Not,Recruiting,Phase,2/Phase,3,Interventional,No,Country,Given,Ivermectin,and,Nitazoxanide,Combination,Therapy,for,COVID-19,,Drug,Ivermectin,+,Nitazoxanide,Ivermectin,,,,,,,,,,
961,NCT04361318,ClinicalTrials.gov,18.04.2020,1.05.2020,FALSE,Tanta,University,Not,Recruiting,Phase,2/Phase,3,Interventional,No,Country,Given,Hydroxychloroquine,and,Nitazoxanide,Combination,Therapy,for,COVID-19,,Drug,Hydroxychloroquine,+,Nitazoxanide,Hydroxychloroquine,,,,,,,,,,
965,NCT04361526,ClinicalTrials.gov,21.04.2020,17.04.2020,TRUE,Manuel,Castella,Recruiting,Not,Applicable,Interventional,Spain,Pilot,Study,on,Cytokine,Filtration,in,COVID-19,ARDS,CytokCOVID19,Other,(device),Cytokine,Adsorber,Cytokine,Adsorber,40,20.07.2020,20.07.2020,https://clinicaltrials.gov/show/NCT04361526,No,Results,No,Results,No,Results,4.05.2020,None
966,NCT04361591,ClinicalTrials.gov,22.04.2020,1.03.2020,TRUE,Hospital,Clinic,of,Barcelona,Recruiting,Not,Applicable,Observational,Spain,COVID-19,in,Liver,Transplant,Recipients,COVID19-SETH,Clinical,Presentation,No,Intervention,No,Intervention,200,1.03.2021,21.03.2020,https://clinicaltrials.gov/show/NCT04361591,No,Results,No,Results,No,Results,4.05.2020,None,
972,NCT04362943,ClinicalTrials.gov,22.04.2020,20.04.2020,TRUE,Complejo,Hospitalario,Universitario,de,Albacete,Recruiting,Not,Applicable,Observational,Spain,Clinical-epidemiological,Characterization,of,COVID-19,Disease,in,Hospitalized,Older,Adults,COVID-AGE,Drug,Baricitinib,or,Anakinra,Baricitinib,,,,,,,,,
977,NCT04363788,ClinicalTrials.gov,23.04.2020,28.02.2020,TRUE,Lazarski,University,Not,Recruiting,Not,Applicable,Observational,Poland,Needle,Stick,Injuries,in,Emergency,Medical,Service,Practice,,Procedure,Double,Gloves,Double,Gloves,300,24.04.2020,24.04.2020,https://clinicaltrials.gov/show/NCT04363788,No,Results,No,Results,No,Results,4.05.2020,None
981,NCT04365439,ClinicalTrials.gov,18.04.2020,27.04.2020,FALSE,Enos,Bernasconi,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Convalescent,Plasma,for,COVID-19,,ATMP,Plasma,Plasma,10,30.05.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04365439,No,Results,No,Results,No,Results,4.05.2020,None,,,,
983,NCT04365699,ClinicalTrials.gov,25.04.2020,8.04.2020,TRUE,NYU,Langone,Health,Recruiting,Phase,2,Interventional,United,States,Cardiovascular,Effects,of,COVID-19,,Drug,AT-001,AT-001,500,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04365699,No,Results,No,Results,No,Results,4.05.2020,None,,,,,
986,NCT04365959,ClinicalTrials.gov,21.04.2020,20.03.2020,TRUE,University,of,Milano,Bicocca,Not,Recruiting,Not,Applicable,Observational,Italy,The,Prone,Position,in,Covid-19,Affected,Patients,PRON-COVID,Procedure,Positioning,Positioning,56,9.04.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04365959,No,Results,No,Results,No,Results,4.05.2020,None,
1017,NCT04318301,ClinicalTrials.gov,20.03.2020,21.03.2020,FALSE,Zhenhua,Zen,Not,Recruiting,Not,Applicable,Observational,China,Hypertension,in,Patients,Hospitalized,With,COVID-19,HT-COVID19,Clinical,Presentation,No,Intervention,No,Intervention,275,28.03.2020,30.03.2020,https://clinicaltrials.gov/show/NCT04318301,No,Results,No,Results,No,Results,11.05.2020,None,
1018,NCT04321096,ClinicalTrials.gov,23.03.2020,4.04.2020,TRUE,Aarhus,University,Recruiting,Phase,1/Phase,2,Interventional,Denmark,The,Impact,of,Camostat,Mesilate,on,COVID-19,Infection,CamoCO-19,Drug,Camostat,Mesilate,Camostat,Mesilate,580,31.12.2020,1.05.2021,https://clinicaltrials.gov/show/NCT04321096,No,Results,No,Results,No,Results,11.05.2020,EUCTR2020-001200-42
1020,NCT04329923,ClinicalTrials.gov,30.03.2020,9.04.2020,FALSE,Ravi,Amaravadi,,MD,Recruiting,Phase,2,Interventional,United,States,The,PATCH,Trial,(Prevention,And,Treatment,of,COVID-19,With,Hydroxychloroquine),PATCH,Drug,Hydroxychloroquine,Hydroxychloroquine,400,1.04.2021,1.12.2021,https://clinicaltrials.gov/show/NCT04329923,Journal,Article,30.09.2020,https://doi.org/10.1001/jamainternmed.2020.6319,11.05.2020,None
1031,NCT04365231,ClinicalTrials.gov,23.04.2020,1.04.2020,TRUE,Hospital,St.,Joseph,,Marseille,Not,Recruiting,Phase,3,Interventional,France,Hydroxychloroquine,Azithromycin,COVID-19,Pregnancy,Trial,HASCOPT,Drug,Hydroxychloroquine,+,Azithromycin,Hydroxychloroquine,,,,,,,,,,,,
1032,NCT04365309,ClinicalTrials.gov,24.04.2020,10.02.2020,TRUE,Xijing,Hospital,Recruiting,Phase,2/Phase,3,Interventional,China,Protective,Effect,of,Aspirin,on,COVID-19,Patients,PEAC,Drug,Aspirin,Aspirin,128,20.04.2020,20.06.2020,https://clinicaltrials.gov/show/NCT04365309,No,Results,No,Results,No,Results,11.05.2020,None,,,
1042,NCT04366739,ClinicalTrials.gov,24.04.2020,29.04.2020,FALSE,Centre,Hospitalier,St.,Anne,Not,Recruiting,Phase,3,Interventional,France,Repurposing,of,Chlorpromazine,in,Covid-19,Treatment,reCoVery,Drug,Chlorpromazine,Chlorpromazine,40,30.08.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04366739,No,Results,No,Results,No,Results,11.05.2020,None,,
1049,NCT04367129,ClinicalTrials.gov,16.04.2020,14.04.2020,TRUE,University,Hospital,,Ferrara,Recruiting,Not,Applicable,Observational,Italy,Electrocardiogram,Analysis,in,COVID-19,Patients,ELCOVID,Clinical,Presentation,No,Intervention,No,Intervention,1000,1.12.2020,1.12.2021,https://clinicaltrials.gov/show/NCT04367129,No,Results,No,Results,No,Results,11.05.2020,None,
1051,NCT04367363,ClinicalTrials.gov,17.04.2020,8.03.2020,TRUE,Jean,Liu,Recruiting,Not,Applicable,Observational,Singapore,Social,Media,and,COVID-19,,Other,No,Intervention,No,Intervention,150,7.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04367363,No,Results,No,Results,No,Results,11.05.2020,None,,,,,
1066,NCT04368390,ClinicalTrials.gov,28.04.2020,3.04.2020,TRUE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,Neuroradiolological,Analysis,of,COVID-19,Patients,COVID-19BRAIN,Clinical,Presentation,No,Intervention,No,Intervention,100,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04368390,No,Results,No,Results,No,Results,11.05.2020,None,
1067,NCT04368975,ClinicalTrials.gov,27.04.2020,12.03.2020,TRUE,Hospital,Clinic,of,Barcelona,Recruiting,Not,Applicable,Observational,Spain,ARDS,Caused,by,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,500,21.04.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04368975,No,Results,No,Results,No,Results,11.05.2020,None,,
1072,NCT04369989,ClinicalTrials.gov,28.04.2020,14.04.2020,TRUE,OSF,Healthcare,System,Recruiting,Not,Applicable,Observational,United,States,Observational,Study,of,COVID-19,Treatment,Efficacy,,Clinical,Presentation,No,Intervention,No,Intervention,1000,14.04.2021,14.04.2021,https://clinicaltrials.gov/show/NCT04369989,No,Results,No,Results,No,Results,11.05.2020,None
1073,NCT04370197,ClinicalTrials.gov,29.04.2020,3.03.2020,TRUE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,Covid-19,Epidemic,on,Acute,Stroke,Management,Stroke-Covid19,Clinical,Presentation,No,Intervention,No,Intervention,300,30.04.2020,30.04.2020,https://clinicaltrials.gov/show/NCT04370197,No,Results,No,Results,No,Results,11.05.2020,None
1076,NCT04370938,ClinicalTrials.gov,29.04.2020,29.04.2020,FALSE,University,of,Pittsburgh,Recruiting,Not,Applicable,Interventional,United,States,Provider,Burnout,During,COVID-19,,Other,(psych),Psychological,Psychological,250,29.10.2020,29.10.2020,https://clinicaltrials.gov/show/NCT04370938,No,Results,No,Results,No,Results,11.05.2020,None,,,,
1088,ChiCTR2000032737,ChiCTR,8.05.2020,8.05.2020,FALSE,The,First,Affiliated,Hospital,of,Guangdong,Pharmaceutical,University,,,,,,,,,,,,,,,,,,,,,,,,,,
1112,NCT04324489,ClinicalTrials.gov,25.03.2020,6.03.2020,TRUE,Renmin,Hospital,of,Wuhan,University,Not,Recruiting,Not,Applicable,Interventional,China,DAS181,for,Severe,COVID-19:,Compassionate,Use,,Drug,DAS181,DAS181,4,16.04.2020,30.04.2020,https://clinicaltrials.gov/show/NCT04324489,No,Results,No,Results,No,Results,14.05.2020,None,
1113,NCT04333550,ClinicalTrials.gov,1.04.2020,1.04.2020,FALSE,Kermanshah,University,of,Medical,Sciences,Recruiting,Phase,1/Phase,2,Interventional,Iran,Application,of,Desferal,to,Treat,COVID-19,,Drug,Deferoxamine,Deferoxamine,50,20.09.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04333550,No,Results,No,Results,No,Results,14.05.2020,None,
1114,NCT04337047,ClinicalTrials.gov,3.04.2020,31.03.2020,TRUE,Wefight,Not,Recruiting,Not,Applicable,Observational,France,Distress,in,Crisis,Situations,During,COVID-19,,Other,(psych),No,Intervention,No,Intervention,2000,30.04.2020,3.05.2020,https://clinicaltrials.gov/show/NCT04337047,Pre-Print,Article,15.05.2020,https://doi.org/10.1101/2020.05.10.20093161,14.05.2020,None,,,,
1122,NCT04354766,ClinicalTrials.gov,17.04.2020,29.04.2020,FALSE,Hospices,Civils,de,Lyon,Recruiting,Not,Applicable,Observational,France,COVID-19,:,Neutralizing,Human,Monoclonal,Antibodies,Against,SARS-Cov-2,ANTI-COV-2,ATMP,Plasma,Plasma,10,20.07.2020,20.07.2020,https://clinicaltrials.gov/show/NCT04354766,No,Results,No,Results,No,Results,14.05.2020,None,
1143,NCT04373213,ClinicalTrials.gov,30.04.2020,5.05.2020,FALSE,Erzincan,University,Not,Recruiting,Not,Applicable,Observational,Turkey,Evaluation,of,the,Fluid,Response,of,SARS-CoV-2,(COVID-19),Patients,in,Intensive,Care,,,,,,,,,,,,,,
1146,NCT04374058,ClinicalTrials.gov,1.05.2020,20.03.2020,TRUE,Dialisis,Madariaga,Not,Recruiting,Not,Applicable,Observational,Argentina,Less,Frequency,Hemodialysis,and,COVID-19,,Other,Other,Other,50,21.03.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04374058,No,Results,No,Results,No,Results,14.05.2020,None,,,,,
1147,NCT04374071,ClinicalTrials.gov,30.04.2020,12.03.2020,TRUE,Henry,Ford,Health,System,Not,Recruiting,Not,Applicable,Observational,United,States,Early,Short,Course,Corticosteroids,in,COVID-19,,Drug,Corticosteroids,Methylprednisolone,250,27.03.2020,30.04.2020,https://clinicaltrials.gov/show/NCT04374071,Pre-Print,Article,No,Results,https://doi.org/10.1101/2020.05.04.20074609,,https://doi.org/10.1101/2020.05.06.20076687,14.05.2020,None
1148,NCT04374422,ClinicalTrials.gov,29.04.2020,10.04.2020,TRUE,Acibadem,University,Not,Recruiting,Not,Applicable,Observational,Turkey,COVID-19,Pandemic,and,Female,Sexual,Behavior,,Other,No,Intervention,No,Intervention,58,12.04.2020,12.04.2020,https://clinicaltrials.gov/show/NCT04374422,No,Results,No,Results,No,Results,14.05.2020,None,,
1153,NCT04376034,ClinicalTrials.gov,19.04.2020,16.04.2020,TRUE,West,Virginia,University,Recruiting,Phase,3,Interventional,United,States,Convalescent,Plasma,Collection,and,Treatment,in,Pediatrics,and,Adults,,ATMP,Plasma,Plasma,240,30.03.2021,30.03.2021,https://clinicaltrials.gov/show/NCT04376034,No,Results,No,Results,No,Results,14.05.2020,None
1158,NCT04341441,ClinicalTrials.gov,7.04.2020,7.04.2020,FALSE,Henry,Ford,Health,System,Recruiting,Phase,3,Interventional,United,States,Will,Hydroxychloroquine,Impede,or,Prevent,COVID-19,WHIP,COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,30.06.2020,30.04.2021,https://clinicaltrials.gov/show/NCT04341441,No,Results,No,Results,No,Results,18.05.2020,None,
1165,NCT04356885,ClinicalTrials.gov,19.04.2020,1.04.2020,TRUE,University,Hospital,,Montpellier,Recruiting,Not,Applicable,Observational,France,COVID-19,and,Psychotic,Symptoms,in,France,SCHIZOVID-19,Clinical,Presentation,No,Intervention,No,Intervention,600,30.07.2020,1.08.2020,https://clinicaltrials.gov/show/NCT04356885,No,Results,No,Results,No,Results,18.05.2020,None
1169,NCT04363008,ClinicalTrials.gov,21.04.2020,30.03.2020,TRUE,University,of,British,Columbia,Recruiting,Not,Applicable,Observational,Canada,COVID,19,Biomarkers,,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,150,30.04.2020,30.09.2021,https://clinicaltrials.gov/show/NCT04363008,No,Results,No,Results,No,Results,18.05.2020,None
1178,NCT04371107,ClinicalTrials.gov,27.04.2020,29.04.2020,FALSE,CHU,de,Amiens,Not,Recruiting,Phase,3,Interventional,France,Proactive,Care,of,Ambulatory,COVID19,Patients,AMBU-COVID,Drug,Azithromycin,Azithromycin,64,20.06.2020,20.07.2020,https://clinicaltrials.gov/show/NCT04371107,No,Results,No,Results,No,Results,18.05.2020,None,,,
1179,NCT04371640,ClinicalTrials.gov,28.04.2020,1.05.2020,FALSE,Walter,K.,Kraft,Recruiting,Phase,1,Interventional,United,States,Sirolimus,in,COVID-19,Phase,1,SirCO-1,Drug,Sirolimus,Sirolimus,40,20.07.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04371640,No,Results,No,Results,No,Results,18.05.2020,None,,,,
1180,NCT04373161,ClinicalTrials.gov,30.04.2020,20.03.2020,TRUE,Swedish,Hospital,Not,Recruiting,Not,Applicable,Interventional,United,States,Home,Pulse,Oximeter,Use,in,Patients,With,COVID-19,,Other,(device),Biosensors,Biosensors,209,22.04.2020,22.04.2020,https://clinicaltrials.gov/show/NCT04373161,No,Results,No,Results,No,Results,18.05.2020,None
1192,NCT04376996,ClinicalTrials.gov,4.05.2020,20.04.2020,TRUE,University,of,Ljubljana,Recruiting,Not,Applicable,Observational,Slovenia,Slovenian,National,COVID-19,Prevalence,Study,SLO-COVID-19,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,3000,20.10.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04376996,No,Results,No,Results,No,Results,18.05.2020,None,
1195,NCT04377308,ClinicalTrials.gov,18.04.2020,1.05.2020,FALSE,University,of,Toledo,Recruiting,Phase,4,Interventional,United,States,Fluoxetine,to,Reduce,Intubation,and,Death,After,COVID19,Infection,,Drug,Fluoxetine,Fluoxetine,2000,20.04.2021,20.10.2021,https://clinicaltrials.gov/show/NCT04377308,No,Results,No,Results,No,Results,18.05.2020,None
1207,NCT04378738,ClinicalTrials.gov,1.05.2020,1.05.2020,FALSE,Acibadem,University,Recruiting,Not,Applicable,Interventional,Turkey,Social,Media,and,Covid19,Pandemic,,Other,No,Intervention,No,Intervention,212,7.05.2020,8.05.2020,https://clinicaltrials.gov/show/NCT04378738,No,Results,No,Results,No,Results,18.05.2020,None,,,,
1212,NCT04379336,ClinicalTrials.gov,4.05.2020,4.05.2020,FALSE,TASK,Applied,Science,Recruiting,Phase,3,Interventional,South,Africa,BCG,Vaccination,for,Healthcare,Workers,in,COVID-19,Pandemic,,ATMP,Vaccine,Vaccine,500,28.04.2021,28.04.2021,https://clinicaltrials.gov/show/NCT04379336,No,Results,No,Results,No,Results,18.05.2020,None,
1213,NCT04379440,ClinicalTrials.gov,3.05.2020,25.04.2020,TRUE,Raffaele,Antonelli,Incalzi,Recruiting,Not,Applicable,Observational,Italy,Geriatric,Population,COVID-19,Observational,Study,(GEROCOVIDobs),GEROCOVIDobs,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1500,30.09.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04379440,No,Results,No,Results,No,Results,18.05.2020,None
1215,NCT04379661,ClinicalTrials.gov,5.05.2020,3.04.2020,TRUE,Columbia,University,Recruiting,Not,Applicable,Interventional,United,States,SUNLIGHT,Study:,Online,Support,Groups,for,MS,to,Address,COVID-19,,Other,Other,Other,52,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04379661,No,Results,No,Results,No,Results,18.05.2020,None
1231,IRCT20150303021315N17,IRCT,12.04.2020,15.03.2020,TRUE,Aryogen,Pharmed,Recruiting,Phase,3,Interventional,Iran,Tocilizumab,in,severe,COVID-19,,Drug,Tocilizumab,Tocilizumab,85,Not,Available,Not,Available,http://en.irct.ir/trial/46550,No,Results,No,Results,No,Results,18.05.2020,None,,,,,
1233,IRCT20190727044343N2,IRCT,19.04.2020,5.04.2020,TRUE,Mazandaran,University,of,Medical,Sciences,Not,Recruiting,Phase,2/Phase,3,Interventional,Iran,Atorvastatin,effect,on,COVID-19,,Drug,Atorvastatin,Atorvastatin,100,Not,Available,Not,Available,http://en.irct.ir/trial/46639,No,Results,No,Results,No,Results,18.05.2020,None
1250,IRCT20200328046886N1,IRCT,12.04.2020,5.03.2020,TRUE,Mazandaran,University,of,Medical,Sciences,Not,Recruiting,Phase,3,Interventional,Iran,The,effectiveness,of,Sovodak,(sofosbuvir+daclatasvir),in,Covid-19,patients,,Drug,Daclatasvir/sofosbuvir,Daclatasvir/sofosbuvir,48,Not,Available,4.05.2020,http://en.irct.ir/trial/46885,Journal,Article,19.08.2020,https://doi.org/10.1093/jac/dkaa332,18.05.2020,None
1261,IRCT20151227025726N14,IRCT,10.04.2020,5.04.2020,TRUE,Shahid,Beheshti,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Evaluation,the,effects,of,Favipiravir,in,COVID-19,patients,,Drug,Favipiravir,vs.,Lopinavir/ritonavir,Favipiravir,,,,,,,,,
1269,IRCT20081019001369N4,IRCT,11.04.2020,20.04.2020,FALSE,Mashhad,University,of,Medical,Sciences,Recruiting,Phase,2,Interventional,Iran,Effect,of,minocycline,on,COVID-19,,Drug,Minocycline,Minocycline,40,Not,Available,Not,Available,http://en.irct.ir/trial/46977,No,Results,No,Results,No,Results,18.05.2020,None,
1271,IRCT20200408046992N1,IRCT,14.04.2020,16.04.2020,FALSE,Birjand,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Effect,of,Trifluoperazine,in,treatment,of,COVID-19,,Drug,Trifluoprazine,+,Hydroxychloroquine,vs.,Hydroxychloroquine,Trifluoprazine,,,,,,,,,
1272,IRCT20180129038542N1,IRCT,13.04.2020,6.04.2020,TRUE,University,of,Baqiyatallah,Not,Recruiting,Not,Applicable,Interventional,Iran,Early,tracheostomy,in,COVID-19,,Other,(physical),Mechanical,ventilation,Mechanical,ventilation,30,Not,Available,13.04.2020,http://en.irct.ir/trial/47013,No,Results,No,Results,No,Results,18.05.2020,None,
1305,IRCT20200419047128N1,IRCT,22.04.2020,4.05.2020,FALSE,Ahvaz,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Tranilast,in,COVID19,,Drug,Tranilast,Tranilast,60,Not,Available,Not,Available,http://en.irct.ir/trial/47265,No,Results,No,Results,No,Results,18.05.2020,None,,,
1313,IRCT20190618043923N4,IRCT,4.05.2020,25.04.2020,TRUE,Tabriz,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,Ozone,Autohemotherapy,in,Covid19,,Drug,Ozone,Ozone,20,Not,Available,Not,Available,http://en.irct.ir/trial/47363,No,Results,No,Results,No,Results,18.05.2020,None,
1338,KCT0005005,CRIS,11.05.2020,11.05.2020,FALSE,Daegu,Catholic,University,Medical,Center,Not,Recruiting,Not,Applicable,Observational,South,Korea,Psychiatric,Consultation,for,COVID-19,Patients,,Other,(psych),Psychological,Psychological,54,31.07.2020,31.12.2020,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16339,No,Results,No,Results,No,Results,18.05.2020,None
1354,NCT04344015,ClinicalTrials.gov,9.04.2020,13.04.2020,FALSE,Thomas,Jefferson,University,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,Plasma,Collection,,ATMP,Plasma,Plasma,2000,12.04.2021,12.04.2021,https://clinicaltrials.gov/show/NCT04344015,No,Results,No,Results,No,Results,21.05.2020,None,,,,,,
1356,NCT04353323,ClinicalTrials.gov,15.04.2020,25.05.2020,FALSE,University,Hospital,,Limoges,Not,Recruiting,Not,Applicable,Observational,France,COVID,19-Caregivers,IGg,Seroconversion,CoSigS,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,130,25.06.2020,25.12.2020,https://clinicaltrials.gov/show/NCT04353323,No,Results,No,Results,No,Results,21.05.2020,None
1359,NCT04375709,ClinicalTrials.gov,4.05.2020,15.03.2020,TRUE,Kantonsspital,Winterthur,(KSW),Recruiting,Not,Applicable,Observational,Switzerland,Quality,of,Life,and,Physical,Performance,After,Novel,Coronavirus,Infection,(COVID-19),,,,,,,,,,,,,,,
1360,NCT04376476,ClinicalTrials.gov,28.04.2020,5.05.2020,FALSE,Hospices,Civils,de,Lyon,Recruiting,Not,Applicable,Interventional,France,Host-pathogen,Interactions,During,SARS-CoV-2,Infection,HPI-COVID-19,Clinical,Presentation,No,Intervention,No,Intervention,450,5.06.2021,5.06.2021,https://clinicaltrials.gov/show/NCT04376476,No,Results,No,Results,No,Results,21.05.2020,None,
1362,NCT04378686,ClinicalTrials.gov,5.05.2020,23.04.2020,TRUE,UZ,Leuven,Recruiting,Not,Applicable,Observational,Belgium,Serological,Testing,for,COVID-19,(SARS-CoV-2),in,ESKD,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,500,1.05.2021,1.05.2022,https://clinicaltrials.gov/show/NCT04378686,No,Results,No,Results,No,Results,21.05.2020,None
1377,NCT04381858,ClinicalTrials.gov,6.05.2020,6.05.2020,FALSE,Centenario,Hospital,Miguel,Hidalgo,Recruiting,Phase,3,Interventional,Mexico,Convalescent,Plasma,vs,Human,Immunoglobulin,to,Treat,COVID-19,Pneumonia,,ATMP,Plasma,vs.,Immunoglobulin,Plasma,,,,,,,,,,
1385,NCT04382781,ClinicalTrials.gov,6.05.2020,1.05.2020,TRUE,Spanish,Network,for,Research,in,Infectious,Diseases,Recruiting,Not,Applicable,Observational,Spain,Immunosupressive,Treatment,in,COVID-19,Patients,SAM-COVID,Drug,Immunosupressives,Immunosupressives,500,20.05.2020,20.05.2020,https://clinicaltrials.gov/show/NCT04382781,No,Results,No,Results,No,Results,21.05.2020,None,
1388,NCT04383626,ClinicalTrials.gov,10.05.2020,2.03.2020,TRUE,Cairo,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Fear,Among,Dentists,During,COVID-19,Pandemic,,Other,(psych),No,Intervention,No,Intervention,216,5.04.2020,5.05.2020,https://clinicaltrials.gov/show/NCT04383626,No,Results,No,Results,No,Results,21.05.2020,None,
1391,NCT04384029,ClinicalTrials.gov,20.04.2020,24.03.2020,TRUE,Francois,Mach,Not,Recruiting,Not,Applicable,Observational,Switzerland,The,Geneva,Covid-19,CVD,Study,,Clinical,Presentation,No,Intervention,No,Intervention,7000,31.03.2021,31.03.2022,https://clinicaltrials.gov/show/NCT04384029,No,Results,No,Results,No,Results,21.05.2020,None,,
1392,NCT04384250,ClinicalTrials.gov,10.05.2020,10.05.2020,FALSE,Mansoura,University,Recruiting,Not,Applicable,Observational,Egypt,Genetic,Basis,of,COVID-19,Infection,,Genomics,No,Intervention,No,Intervention,50,31.08.2020,1.05.2021,https://clinicaltrials.gov/show/NCT04384250,No,Results,No,Results,No,Results,21.05.2020,None,,,,
1393,NCT04384471,ClinicalTrials.gov,1.05.2020,29.04.2020,TRUE,McGill,University,Recruiting,Not,Applicable,Observational,Canada,Covid-19,Pandemic:,Patients',Experience,in,T1D,,Other,No,Intervention,No,Intervention,384,1.07.2020,1.01.2021,https://clinicaltrials.gov/show/NCT04384471,No,Results,No,Results,No,Results,21.05.2020,None,,,
1396,NCT04385576,ClinicalTrials.gov,28.04.2020,15.05.2020,FALSE,University,of,Malaya,Recruiting,Not,Applicable,Interventional,Malaysia,"""Taiwan","""""Aerosol","Box""""",Versus,UMMC,"""""Intubation","Box""""""",,Other,(physical),Mechanical,ventilation,Mechanical,ventilation,30,15.09.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04385576,No,Results,No,Results,No,Results,21.05.2020,None
1403,NCT04335162,ClinicalTrials.gov,3.04.2020,28.02.2020,TRUE,CHU,de,Nice,Recruiting,Not,Applicable,Observational,France,Cardiovascular,Complications,and,COVID-19,(CovCardioVasc),CovCardioVasc,Clinical,Presentation,No,Intervention,No,Intervention,100,28.08.2021,28.08.2021,https://clinicaltrials.gov/show/NCT04335162,No,Results,No,Results,No,Results,25.05.2020,None,,
1404,NCT04340050,ClinicalTrials.gov,7.04.2020,10.04.2020,FALSE,University,of,Chicago,Not,Recruiting,Phase,1,Interventional,United,States,COVID-19,Convalescent,Plasma,,ATMP,Plasma,Plasma,10,31.12.2020,31.12.2021,https://clinicaltrials.gov/show/NCT04340050,No,Results,No,Results,No,Results,25.05.2020,None,,,,,
1406,NCT04344119,ClinicalTrials.gov,9.04.2020,9.04.2020,FALSE,CHU,de,Nice,Recruiting,Not,Applicable,Observational,France,Assessment,of,Chilbains,Occuring,During,Covid-19,Infection,ChilblainCOVID,Clinical,Presentation,No,Intervention,No,Intervention,30,30.06.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04344119,No,Results,No,Results,No,Results,25.05.2020,None
1407,NCT04352933,ClinicalTrials.gov,7.04.2020,11.05.2020,TRUE,Cambridge,University,Hospitals,NHS,Foundation,Trust,Recruiting,Phase,3,Interventional,United,Kingdom,PROLIFIC,ChemoprophylaxisTrial,(COVID-19),,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,31.10.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04352933,No,Results,No,Results,No,Results,25.05.2020,EUCTR2020-001331-26,,
1410,NCT04355624,ClinicalTrials.gov,17.04.2020,15.04.2020,TRUE,CHU,de,Nice,Recruiting,Not,Applicable,Observational,France,Kidney,Involvement,in,COVID-19,Disease,(COVKID),COVKID,Clinical,Presentation,No,Intervention,No,Intervention,80,30.04.2020,30.07.2020,https://clinicaltrials.gov/show/NCT04355624,No,Results,No,Results,No,Results,25.05.2020,None,
1417,NCT04365257,ClinicalTrials.gov,24.04.2020,13.05.2020,FALSE,Johns,Hopkins,University,Recruiting,Phase,2,Interventional,United,States,Prazosin,to,Prevent,COVID-19,(PREVENT-COVID,Trial),PREVENT,Drug,Prazosin,Prazosin,220,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04365257,No,Results,No,Results,No,Results,25.05.2020,None,,,
1429,NCT04385017,ClinicalTrials.gov,10.05.2020,11.05.2020,FALSE,CHU,de,Nice,Recruiting,Not,Applicable,Interventional,France,Role,of,Inflammasomes,in,COVID-19,Disease,CoVInnate,Clinical,Presentation,No,Intervention,No,Intervention,40,12.06.2021,12.06.2021,https://clinicaltrials.gov/show/NCT04385017,No,Results,No,Results,No,Results,25.05.2020,None,
1430,NCT04385043,ClinicalTrials.gov,4.05.2020,1.05.2020,TRUE,University,of,Catanzaro,Recruiting,Phase,2/Phase,3,Interventional,Italy,Hyperimmune,Plasma,in,Patients,With,COVID-19,Severe,Infection,COV2-CP,ATMP,Plasma,Plasma,400,15.10.2020,15.05.2021,https://clinicaltrials.gov/show/NCT04385043,No,Results,No,Results,No,Results,25.05.2020,None,
1432,NCT04385199,ClinicalTrials.gov,9.05.2020,4.05.2020,TRUE,Henry,Ford,Health,System,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,for,Patients,With,COVID-19,,ATMP,Plasma,Plasma,30,1.08.2020,1.08.2020,https://clinicaltrials.gov/show/NCT04385199,No,Results,No,Results,No,Results,25.05.2020,None,,
1438,NCT04386109,ClinicalTrials.gov,15.04.2020,1.04.2020,TRUE,University,of,Oxford,Recruiting,Not,Applicable,Observational,United,Kingdom,Neonatal,Complications,of,Coronavirus,Disease,(COVID-19),,Clinical,Presentation,No,Intervention,No,Intervention,500,31.03.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04386109,No,Results,No,Results,No,Results,25.05.2020,None
1451,NCT04388657,ClinicalTrials.gov,13.05.2020,1.05.2020,TRUE,Ramsay,Générale,de,Santé,Recruiting,Not,Applicable,Observational,France,COVID-19,,bLOod,Coagulation,and,Thrombosis,CLOT,Clinical,Presentation,No,Intervention,No,Intervention,100,1.09.2020,1.09.2020,https://clinicaltrials.gov/show/NCT04388657,No,Results,No,Results,No,Results,25.05.2020,None
1454,NCT04389320,ClinicalTrials.gov,11.05.2020,15.03.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Antimalarial,and,Covid,19,in,Rheumatoid,Arthritis,,Drug,Hydroxychloroquine,Hydroxychloroquine,60,1.05.2020,1.05.2020,https://clinicaltrials.gov/show/NCT04389320,No,Results,No,Results,No,Results,25.05.2020,None,,,
1457,NCT04390178,ClinicalTrials.gov,10.04.2020,10.04.2020,FALSE,Joakim,Dillner,Not,Recruiting,Phase,1/Phase,2,Interventional,Sweden,Convalescent,Plasma,as,Treatment,for,Acute,Coronavirus,Disease,(COVID-19),,ATMP,Plasma,Plasma,10,20.06.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04390178,No,Results,No,Results,No,Results,25.05.2020,None
1474,ChiCTR2000033056,ChiCTR,19.05.2020,29.01.2020,TRUE,Guizhou,Provincial,Jiangjunshan,Hospital,Not,Recruiting,Not,Applicable,Interventional,China,Convalescent,Plasma,in,the,treatment,of,6,COVID-19,Patients,,ATMP,Plasma,Plasma,6,Not,Available,30.04.2020,http://www.chictr.org.cn/showproj.aspx?proj=53859,Pre-Print,Article,26.05.2020,https://doi.org/10.1101/2020.05.21.201095122,25.05.2020,None
1490,NCT04338932,ClinicalTrials.gov,7.04.2020,17.04.2020,FALSE,Jessa,Hospital,Not,Recruiting,Not,Applicable,Observational,Belgium,COVID-19,and,Deep,Venous,Thrombosis,,Clinical,Presentation,No,Intervention,No,Intervention,12,15.05.2020,15.05.2020,https://clinicaltrials.gov/show/NCT04338932,No,Results,No,Results,No,Results,28.05.2020,None,,
1493,NCT04342182,ClinicalTrials.gov,31.03.2020,8.04.2020,FALSE,Erasmus,Medical,Center,Recruiting,Phase,2/Phase,3,Interventional,Netherlands,Convalescent,Plasma,as,Therapy,for,Covid-19,Severe,SARS-CoV-2,Disease,(CONCOVID,Study),ConCoVid-19,ATMP,Plasma,Plasma,426,1.07.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04342182,Pre-Print,Article,3.07.2020,https://doi.org/10.1101/2020.07.01.20139857,28.05.2020,None
1495,NCT04352842,ClinicalTrials.gov,16.04.2020,21.01.2020,TRUE,RenJi,Hospital,Not,Recruiting,Not,Applicable,Observational,China,Echocardiographic,Manifestation,in,Patient,With,COVID-19,(EARLY-MYO,COVID-19),,Clinical,Presentation,No,Intervention,No,Intervention,51,8.04.2020,8.04.2020,https://clinicaltrials.gov/show/NCT04352842,Pre-Print,Article,18.05.2020,https://doi.org/10.1101/2020.05.12.20095885,28.05.2020,None,
1498,NCT04361253,ClinicalTrials.gov,23.04.2020,30.04.2020,FALSE,Brigham,and,Women's,Hospital,Recruiting,Phase,3,Interventional,United,States,Evaluation,of,SARS-CoV-2,(COVID-19),Antibody-containing,Plasma,thErapy,(ESCAPE),ATMP,Plasma,Plasma,220,21.06.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04361253,No,Results,No,Results,No,Results,28.05.2020,None,
1504,NCT04371952,ClinicalTrials.gov,27.04.2020,1.06.2020,FALSE,Nantes,University,Hospital,Not,Recruiting,Phase,3,Interventional,France,DYNAMIC,Study,(DoxycYcliNe,AMbulatoIre,COVID-19),DYNAMIC,Drug,Doxycycline,Doxycycline,330,1.12.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04371952,No,Results,No,Results,No,Results,28.05.2020,None,,,,
1505,NCT04374513,ClinicalTrials.gov,2.05.2020,2.05.2020,FALSE,Damanhour,University,Recruiting,Not,Applicable,Observational,Egypt,Community,Pharmacists,Behaviour,During,Covid-19,,Health,System,No,Intervention,No,Intervention,50,1.10.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04374513,No,Results,No,Results,No,Results,28.05.2020,None,,,
1507,NCT04377685,ClinicalTrials.gov,5.05.2020,1.03.2020,TRUE,CHU,de,Saint,Etienne,Recruiting,Not,Applicable,Observational,France,Prediction,of,Clinical,Course,in,COVID19,Patients,COVID-CTPRED,Prognosis,No,Intervention,No,Intervention,800,30.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04377685,No,Results,No,Results,No,Results,28.05.2020,None
1509,NCT04388436,ClinicalTrials.gov,11.05.2020,11.05.2020,FALSE,Mansoura,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Post,Covid-19,Cardiopulmonary,and,Immunological,Changes,covid-19,Clinical,Presentation,No,Intervention,No,Intervention,100,10.07.2021,10.10.2021,https://clinicaltrials.gov/show/NCT04388436,No,Results,No,Results,No,Results,28.05.2020,None,
1513,NCT04389385,ClinicalTrials.gov,12.05.2020,1.05.2020,TRUE,TC,Erciyes,University,Not,Recruiting,Phase,1,Interventional,Turkey,COVID-19,Specific,T,Cell,Derived,Exosomes,(CSTC-Exo),,ATMP,Exosomes,Exosomes,60,30.09.2020,31.05.2021,https://clinicaltrials.gov/show/NCT04389385,No,Results,No,Results,No,Results,28.05.2020,None,,
1519,NCT04390477,ClinicalTrials.gov,7.05.2020,4.05.2020,TRUE,Bioithas,SL,Recruiting,Not,Applicable,Interventional,Spain,Study,to,Evaluate,the,Effect,of,a,Probiotic,in,COVID-19,,Supplement,Probiotics,Probiotics,40,20.07.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04390477,No,Results,No,Results,No,Results,28.05.2020,None,
1520,NCT04390503,ClinicalTrials.gov,14.05.2020,1.05.2020,TRUE,Columbia,University,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,for,COVID-19,Close,Contacts,,ATMP,Plasma,Plasma,200,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04390503,No,Results,No,Results,No,Results,28.05.2020,None,,,,
1521,NCT04390555,ClinicalTrials.gov,6.05.2020,30.04.2020,TRUE,University,of,Zurich,Recruiting,Not,Applicable,Observational,Switzerland,The,Global,PCHF-COVICAV,Registry,PCHF-COVICAV,Clinical,Presentation,No,Intervention,No,Intervention,1500,20.12.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04390555,No,Results,No,Results,No,Results,28.05.2020,None,,,
1524,NCT04392245,ClinicalTrials.gov,15.05.2020,15.04.2020,TRUE,Società,Italiana,di,Chirurgia,Colo-Rettale,Not,Recruiting,Not,Applicable,Observational,Italy,Proctologic,Practice,and,Covid-19,PROCTOLOCK,Health,System,No,Intervention,No,Intervention,1050,26.04.2020,26.04.2020,https://clinicaltrials.gov/show/NCT04392245,No,Results,No,Results,No,Results,28.05.2020,None
1528,NCT04392713,ClinicalTrials.gov,5.05.2020,15.04.2020,TRUE,Combined,Military,Hospital,,Pakistan,Recruiting,Not,Applicable,Interventional,Pakistan,Efficacy,of,Ivermectin,in,COVID-19,,Drug,Ivermectin,Ivermectin,100,20.07.2020,20.07.2020,https://clinicaltrials.gov/show/NCT04392713,No,Results,No,Results,No,Results,28.05.2020,None,,,
1531,NCT04394000,ClinicalTrials.gov,16.05.2020,4.05.2020,TRUE,Jessa,Hospital,Not,Recruiting,Not,Applicable,Observational,Belgium,Impact,of,an,Intensified,Thromboprofylaxis,Protocol,in,COVID-19,,Drug,Heparin,Heparin,72,15.05.2020,15.05.2020,https://clinicaltrials.gov/show/NCT04394000,No,Results,No,Results,No,Results,28.05.2020,None,,
1532,NCT04394026,ClinicalTrials.gov,15.05.2020,16.04.2020,TRUE,Francesco,De,Cobelli,Recruiting,Not,Applicable,Observational,Italy,Imaging,Feature,of,SARS-CoV2,Infection,COVID19IF,Clinical,Presentation,No,Intervention,No,Intervention,500,31.08.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04394026,No,Results,No,Results,No,Results,28.05.2020,None,,
1541,NCT04341675,ClinicalTrials.gov,5.04.2020,24.04.2020,FALSE,University,of,Cincinnati,Recruiting,Phase,2,Interventional,United,States,Sirolimus,Treatment,in,Hospitalized,Patients,With,COVID-19,Pneumonia,SCOPE,Drug,Sirolimus,Sirolimus,30,20.07.2020,20.09.2020,https://clinicaltrials.gov/show/NCT04341675,No,Results,No,Results,No,Results,1.06.2020,None,
1542,NCT04342637,ClinicalTrials.gov,7.04.2020,10.04.2020,FALSE,Al-Azhar,University,Not,Recruiting,Not,Applicable,Observational,United,States,,Egypt,,Iran,COVID-19,Endoscopy,Survey,COVID-19,Endo,Other,Other,Other,163,25.04.2020,1.05.2020,https://clinicaltrials.gov/show/NCT04342637,No,Results,No,Results,No,Results,1.06.2020,None,
1548,NCT04355897,ClinicalTrials.gov,15.04.2020,28.04.2020,FALSE,The,Christ,Hospital,Recruiting,Phase,1,Interventional,United,States,CoVID-19,Plasma,in,Treatment,of,COVID-19,Patients,,ATMP,Plasma,Plasma,100,20.07.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04355897,No,Results,No,Results,No,Results,1.06.2020,None,,
1557,NCT04375670,ClinicalTrials.gov,28.04.2020,11.05.2020,FALSE,Assistance,Publique,–,Hôpitaux,de,Paris,Recruiting,Not,Applicable,Observational,France,COVID19-FOIE,National,Observatory,,Clinical,Presentation,No,Intervention,No,Intervention,1000,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04375670,No,Results,No,Results,No,Results,1.06.2020,None,
1558,NCT04380402,ClinicalTrials.gov,1.05.2020,20.05.2020,FALSE,Mount,Auburn,Hospital,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Atorvastatin,as,Adjunctive,Therapy,in,COVID-19,STATCO19,Drug,Atorvastatin,Atorvastatin,300,31.12.2021,8.05.2022,https://clinicaltrials.gov/show/NCT04380402,No,Results,No,Results,No,Results,1.06.2020,None,
1563,NCT04393051,ClinicalTrials.gov,16.05.2020,20.05.2020,FALSE,AOU,Pisana,Not,Recruiting,Phase,2,Interventional,Italy,Baricitinib,Compared,to,Standard,Therapy,in,Patients,With,COVID-19,BARICIVID-19,Drug,Baricitinib,Baricitinib,126,30.06.2020,30.07.2020,https://clinicaltrials.gov/show/NCT04393051,No,Results,No,Results,No,Results,1.06.2020,None,
1564,NCT04393155,ClinicalTrials.gov,6.05.2020,16.04.2020,TRUE,University,of,Vermont,Recruiting,Not,Applicable,Observational,United,States,Longitudinal,COVID-19,Cohort,Study,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,225,30.09.2022,31.05.2023,https://clinicaltrials.gov/show/NCT04393155,No,Results,No,Results,No,Results,1.06.2020,None,
1569,NCT04393974,ClinicalTrials.gov,18.05.2020,24.03.2020,TRUE,Imperial,College,London,Recruiting,Not,Applicable,Observational,United,Kingdom,COVID-19,and,Cancer,Patients,OnCovid,Clinical,Presentation,No,Intervention,No,Intervention,1000,24.03.2022,24.03.2022,https://clinicaltrials.gov/show/NCT04393974,No,Results,No,Results,No,Results,1.06.2020,None,,
1572,NCT04394442,ClinicalTrials.gov,17.05.2020,21.03.2020,TRUE,Samah,Lutfy,Recruiting,Phase,2,Interventional,Saudi,Arabia,Hydroxychloroquine,in,COVID-19,Patients,,Drug,Hydroxychloroquine,Hydroxychloroquine,200,20.08.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04394442,No,Results,No,Results,No,Results,1.06.2020,None,,,,,,
1604,ChiCTR2000033323,ChiCTR,28.05.2020,11.05.2020,TRUE,No,Sponsor,Name,Given,Not,Recruiting,Not,Applicable,Interventional,Iraq,Severe,Reluctant,COVID-19,Patients,Responding,to,Convalescent,,Plasma,,,,,,,,,,,,,,,
1623,EUCTR2020-001536-98-ES,EU,Clinical,Trials,Register,20.04.2020,18.04.2020,TRUE,Mútua,Terrassa,University,Hospital,Not,Recruiting,Phase,3,Interventional,Spain,Prophylaxis,of,COVID-19,infection,with,hydroxychloroquine,in,healthcare,,,,,,,,,,,,,
"""",personnel,with,high,risk,of,"infection.""""""",,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,300,Not,Available,27.04.2020,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,No,Results,No,Results,No,Results,2.06.2020,None,,,,,,,,,,,,,,,
1633,EUCTR2020-001671-32-ES,EU,Clinical,Trials,Register,31.05.2020,28.05.2020,TRUE,Staidson,(Beijing),Biopharmaceuticals,Co.,,Ltd,,,,,,,,,,,,,,,,,,,,,,,,,
1634,NCT04331600,ClinicalTrials.gov,30.03.2020,16.04.2020,TRUE,Wroclaw,Medical,University,Recruiting,Phase,4,Interventional,Poland,Chloroquine,as,Antiviral,Treatment,in,Coronavirus,Infection,2020,,Drug,Chloroquine,Chloroquine,400,30.09.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04331600,No,Results,No,Results,No,Results,4.06.2020,EUCTR2020-001469-35,,
1641,NCT04380532,ClinicalTrials.gov,29.04.2020,15.05.2020,FALSE,Immunitor,LLC,Not,Recruiting,Phase,1/Phase,2,Interventional,Mongolia,,Canada,Tableted,COVID-19,Therapeutic,Vaccine,COVID-19,ATMP,Vaccine,Vaccine,20,15.05.2021,15.06.2021,https://clinicaltrials.gov/show/NCT04380532,No,Results,No,Results,No,Results,4.06.2020,None,,,
1645,NCT04397497,ClinicalTrials.gov,20.05.2020,22.05.2020,FALSE,IRCCS,Ospedale,San,Raffaele,Not,Recruiting,Phase,2,Interventional,Italy,Mavrilimumab,in,Severe,COVID-19,Pneumonia,and,Hyper-inflammation,(COMBAT-19),COMBAT-19,Drug,Mavrilimumab,Mavrilimumab,50,22.09.2020,22.11.2020,https://clinicaltrials.gov/show/NCT04397497,No,Results,No,Results,No,Results,4.06.2020,None
1650,NCT04400006,ClinicalTrials.gov,21.05.2020,6.05.2020,TRUE,Marmara,University,Not,Recruiting,Not,Applicable,Observational,Turkey,Ozone,Therapy,in,the,Prevention,of,COVID-19,Infection,,Drug,Ozone,Ozone,71,16.05.2020,17.05.2020,https://clinicaltrials.gov/show/NCT04400006,No,Results,No,Results,No,Results,4.06.2020,None,,
1653,NCT04401072,ClinicalTrials.gov,22.05.2020,24.04.2020,TRUE,Damanhour,University,Recruiting,Not,Applicable,Observational,Egypt,Attitude,of,Egyptian,Population,Toward,COVID,19,in,Ramadan,,Other,No,Intervention,No,Intervention,500,22.05.2020,20.10.2020,https://clinicaltrials.gov/show/NCT04401072,No,Results,No,Results,No,Results,4.06.2020,None
1654,NCT04401098,ClinicalTrials.gov,22.05.2020,2.05.2020,TRUE,Damanhour,University,Recruiting,Not,Applicable,Observational,Egypt,Changing,Of,Egyptian,Population,Behaviour,Towards,COVID,19,Outbreak,,Other,No,Intervention,No,Intervention,700,1.10.2020,1.04.2021,https://clinicaltrials.gov/show/NCT04401098,No,Results,No,Results,No,Results,4.06.2020,None
1656,NCT04401163,ClinicalTrials.gov,12.05.2020,1.05.2020,TRUE,Aarhus,University,Not,Recruiting,Not,Applicable,Observational,Denmark,Long-term,Pulmonary,Outcomes,After,Infection,With,Sars-CoV-2,,Clinical,Presentation,No,Intervention,No,Intervention,180,21.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04401163,No,Results,No,Results,No,Results,4.06.2020,None
1657,NCT04401202,ClinicalTrials.gov,21.05.2020,21.05.2020,FALSE,King,Abdulaziz,University,Recruiting,Phase,2,Interventional,Saudi,Arabia,Nigella,Sativa,in,COVID-19,,Traditional,Medicine,(Drug),Traditional,Medicine,Traditional,Medicine,200,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04401202,No,Results,No,Results,No,Results,4.06.2020,None,
1660,NCT04401371,ClinicalTrials.gov,21.05.2020,1.05.2020,TRUE,Cairo,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Distance,Learning,for,Dental,Student,During,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,418,10.05.2020,10.05.2020,https://clinicaltrials.gov/show/NCT04401371,No,Results,No,Results,No,Results,4.06.2020,None
1667,NCT04403477,ClinicalTrials.gov,20.05.2020,20.05.2020,FALSE,Bangabandhu,Sheikh,Mujib,Medical,University,Recruiting,Phase,2,Interventional,Bangladesh,Convalescent,Plasma,Therapy,in,Severe,COVID-19,Infection,,ATMP,Plasma,Plasma,20,20.07.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04403477,No,Results,No,Results,No,Results,4.06.2020,None,
1672,NCT04321421,ClinicalTrials.gov,23.03.2020,17.03.2020,TRUE,Foundation,IRCCS,San,Matteo,Hospital,Not,Recruiting,Not,Applicable,Interventional,Italy,Hyperimmune,Plasma,for,Critical,Patients,With,COVID-19,COV19-PLASMA,ATMP,Plasma,Plasma,49,28.04.2020,7.05.2020,https://clinicaltrials.gov/show/NCT04321421,Pre-Print,Article,29.05.2020,https://doi.org/10.1101/2020.05.26.20113373,8.06.2020,None,,
1673,NCT04327570,ClinicalTrials.gov,26.03.2020,27.03.2020,FALSE,UZ,Leuven,Recruiting,Not,Applicable,Observational,Belgium,In-depth,Immunological,Investigation,of,COVID-19.,COntAGIouS,Clinical,Presentation,No,Intervention,No,Intervention,100,30.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04327570,No,Results,No,Results,No,Results,8.06.2020,None,,,
1674,NCT04328467,ClinicalTrials.gov,27.03.2020,6.04.2020,FALSE,University,of,Minnesota,Not,Recruiting,Phase,3,Interventional,United,States,Pre-exposure,Prophylaxis,for,SARS-Coronavirus-2,,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,20.08.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04328467,No,Results,No,Results,No,Results,8.06.2020,None,,,
1675,NCT04328493,ClinicalTrials.gov,27.03.2020,7.04.2020,FALSE,University,of,Oxford,Recruiting,Phase,2,Interventional,Vietnam,The,Vietnam,Chloroquine,Treatment,on,COVID-19,VICO,Drug,Chloroquine,Chloroquine,250,1.04.2021,1.04.2022,https://clinicaltrials.gov/show/NCT04328493,No,Results,No,Results,No,Results,8.06.2020,None,,,,
1679,NCT04366141,ClinicalTrials.gov,24.04.2020,1.05.2020,FALSE,University,of,British,Columbia,Recruiting,Not,Applicable,Interventional,Canada,COVID-19,(Coronavirus,Disease,2019),Intubation,Barrier,Box,,Other,(device),Barrier,Barrier,120,1.01.2021,1.01.2021,https://clinicaltrials.gov/show/NCT04366141,No,Results,No,Results,No,Results,8.06.2020,None,
1682,NCT04378842,ClinicalTrials.gov,5.05.2020,18.05.2020,FALSE,University,Hospital,,Lille,Recruiting,Not,Applicable,Observational,France,COVID-19,and,ICU-acquired,MDR,Bacteria,COVID-BMR,Clinical,Presentation,No,Intervention,No,Intervention,690,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04378842,No,Results,No,Results,No,Results,8.06.2020,None,
1690,NCT04394104,ClinicalTrials.gov,15.05.2020,27.05.2020,FALSE,Rutgers,University,Not,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Wellness,Survey,,Other,(psych),No,Intervention,No,Intervention,1000,31.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04394104,No,Results,No,Results,No,Results,8.06.2020,None,,,
1704,NCT04405869,ClinicalTrials.gov,25.05.2020,29.04.2020,TRUE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,Thromboembolic,Events,in,Severe,COVID-19,Patients,COVICLOT,Clinical,Presentation,No,Intervention,No,Intervention,300,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04405869,No,Results,No,Results,No,Results,8.06.2020,None
1711,NCT04407221,ClinicalTrials.gov,3.05.2020,1.06.2020,FALSE,Vastra,Gotaland,Region,Not,Recruiting,Not,Applicable,Observational,Sweden,COVID-19,Research,in,Organ,Transplant,Recipients,CORONA,Other,No,Intervention,No,Intervention,1100,1.05.2024,1.05.2024,https://clinicaltrials.gov/show/NCT04407221,No,Results,No,Results,No,Results,8.06.2020,None,
1712,NCT04407429,ClinicalTrials.gov,27.05.2020,27.05.2020,FALSE,Medical,University,of,Vienna,Recruiting,Not,Applicable,Observational,Austria,Vienna,Versus,SARS-CoV-2,Virus,Study,VIVI,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,12000,27.06.2021,27.06.2021,https://clinicaltrials.gov/show/NCT04407429,No,Results,No,Results,No,Results,8.06.2020,None
1716,NCT04408222,ClinicalTrials.gov,25.05.2020,16.04.2020,TRUE,Columbia,University,Not,Recruiting,Not,Applicable,Observational,United,States,Awake,Proning,in,COVID-19,Patients,With,Hypoxemic,Respiratory,Failure,,Procedure,Positioning,Positioning,29,21.04.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04408222,No,Results,No,Results,No,Results,8.06.2020,None
1750,NCT04359407,ClinicalTrials.gov,20.04.2020,27.04.2020,FALSE,Walid,Habre,Recruiting,Not,Applicable,Observational,Switzerland,Prone,Positioning,and,Regional,Ventilation,in,Mechanically,Ventilated,COVID-19,Patients,COVID-19_EIT,Procedure,Positioning,Positioning,16,31.12.2020,31.01.2021,https://clinicaltrials.gov/show/NCT04359407,No,Results,No,Results,No,Results,11.06.2020,None,
1762,NCT04405986,ClinicalTrials.gov,8.05.2020,19.05.2020,FALSE,University,Hospital,,Bordeaux,Recruiting,Not,Applicable,Interventional,France,Exploring,Brain,Damages,After,COVID-19,Infection,BRAINCOV,Clinical,Presentation,No,Intervention,No,Intervention,38,19.12.2020,19.12.2020,https://clinicaltrials.gov/show/NCT04405986,No,Results,No,Results,No,Results,11.06.2020,None
1781,NCT04410692,ClinicalTrials.gov,27.05.2020,15.05.2020,TRUE,National,University,,Singapore,Not,Recruiting,Not,Applicable,Interventional,Singapore,Can,the,Prediction,Market,Improve,Predictions,of,COVID-19?,,Other,Other,Other,560,16.05.2020,17.05.2020,https://clinicaltrials.gov/show/NCT04410692,No,Results,No,Results,No,Results,11.06.2020,None
1785,NCT04411511,ClinicalTrials.gov,20.05.2020,6.05.2020,TRUE,Academic,Hospital,Maastricht,Recruiting,Not,Applicable,Observational,Netherlands,COVID-19,,Obesity,and,Lifestyle,in,Children,COLC,Clinical,Presentation,No,Intervention,No,Intervention,4000,6.11.2020,6.05.2021,https://clinicaltrials.gov/show/NCT04411511,No,Results,No,Results,No,Results,11.06.2020,None
1792,NCT04412460,ClinicalTrials.gov,20.05.2020,20.03.2020,TRUE,University,Hospital,,Tübingen,Recruiting,Not,Applicable,Observational,Germany,Echocardiography,in,Patients,With,Covid-19,,Clinical,Presentation,No,Intervention,No,Intervention,500,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04412460,No,Results,No,Results,No,Results,11.06.2020,None,
1801,NCT04332081,ClinicalTrials.gov,30.03.2020,6.04.2020,FALSE,NYU,Langone,Health,Not,Recruiting,Not,Applicable,Interventional,United,States,Hyperbaric,Oxygen,for,COVID-19,Patients,,Drug,Oxygen,Oxygen,20,29.05.2020,29.05.2020,https://clinicaltrials.gov/show/NCT04332081,No,Results,No,Results,No,Results,15.06.2020,None,,,
1804,NCT04347798,ClinicalTrials.gov,13.04.2020,1.09.2020,FALSE,University,of,Alberta,Recruiting,Not,Applicable,Observational,Canada,IMPACT:,IMPact,of,Antimalarials,on,Covid-19,Infections,in,RAPPORT,IMPACT,Drug,Hydroxychloroquine,or,Chloroquine,Hydroxychloroquine,,,,,,,,,,,
1805,NCT04347824,ClinicalTrials.gov,9.04.2020,27.04.2020,FALSE,University,Hospital,,Göttingen,Recruiting,Not,Applicable,Observational,Germany,Predict,Adverse,Events,by,Covid-19,Nephritis,,Clinical,Presentation,No,Intervention,No,Intervention,100,31.12.2020,31.12.2021,https://clinicaltrials.gov/show/NCT04347824,No,Results,No,Results,No,Results,15.06.2020,None
1808,NCT04361838,ClinicalTrials.gov,16.04.2020,1.06.2020,FALSE,Kansas,City,Heart,Rhythm,Institute,Recruiting,Not,Applicable,Interventional,United,States,The,COVID-19,ICU,PRAYER,Study,,Other,Other,Other,1000,31.08.2020,31.08.2020,https://clinicaltrials.gov/show/NCT04361838,No,Results,No,Results,No,Results,15.06.2020,None,,
1809,NCT04367870,ClinicalTrials.gov,28.04.2020,23.05.2020,FALSE,UNICANCER,Recruiting,Not,Applicable,Observational,France,COVID-19,Detection,Test,in,Oncology,EVIDENCE,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,2500,20.08.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04367870,No,Results,No,Results,No,Results,15.06.2020,None,,,
1815,NCT04385940,ClinicalTrials.gov,8.05.2020,1.06.2020,FALSE,University,of,Alberta,Not,Recruiting,Phase,3,Interventional,No,Country,Given,Vitamin,D,and,COVID-19,Management,,Drug,Vitamin,D,Vitamin,D,64,20.08.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04385940,No,Results,No,Results,No,Results,15.06.2020,None
1816,NCT04389567,ClinicalTrials.gov,13.05.2020,12.05.2020,TRUE,Northwell,Health,Not,Recruiting,Not,Applicable,Observational,United,States,Famotidine,Outpatient,COVID-19,Treatment,Study,,Drug,Famotidine,Famotidine,10,25.05.2020,25.05.2020,https://clinicaltrials.gov/show/NCT04389567,No,Results,No,Results,No,Results,15.06.2020,None,,,,
1819,NCT04395924,ClinicalTrials.gov,19.05.2020,5.05.2020,TRUE,Centre,Hospitalier,Régional,d'Orleans,Recruiting,Not,Applicable,Observational,France,Maternal-foetal,Transmission,of,SARS-Cov-2,TMF-COVID-19,Clinical,Presentation,No,Intervention,No,Intervention,50,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04395924,No,Results,No,Results,No,Results,15.06.2020,None,,
1830,NCT04412746,ClinicalTrials.gov,1.06.2020,1.04.2020,TRUE,University,of,Tlemcen,Recruiting,Not,Applicable,Observational,Algeria,Covid-19,and,Diabetes,in,West,of,Algeria,COVIDIAB-13,Clinical,Presentation,No,Intervention,No,Intervention,100,30.06.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04412746,No,Results,No,Results,No,Results,15.06.2020,None
1832,NCT04413006,ClinicalTrials.gov,21.05.2020,25.05.2020,FALSE,University,of,Manitoba,Recruiting,Not,Applicable,Interventional,Canada,Self-compassion,for,Chronic,Pain,Virtual,Group,Treatment,Program,,Other,(psych),Psychological,Psychological,28,31.12.2020,31.03.2021,https://clinicaltrials.gov/show/NCT04413006,No,Results,No,Results,No,Results,15.06.2020,None,
1835,NCT04414098,ClinicalTrials.gov,29.05.2020,1.06.2020,FALSE,Marcelo,Iastrebner,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Ruxolitinib,in,the,Treatment,of,Covid-19,,Drug,Ruxolitinib,Ruxolitinib,100,15.08.2020,15.09.2020,https://clinicaltrials.gov/show/NCT04414098,No,Results,No,Results,No,Results,15.06.2020,None,,
1837,NCT04414410,ClinicalTrials.gov,27.05.2020,12.05.2020,TRUE,CHU,Ambroise,Paré,Recruiting,Not,Applicable,Observational,France,Echocardiography,in,Critically-ill,Patients,With,COVID-19,Pneumonia,ECHO-COVID,Clinical,Presentation,No,Intervention,No,Intervention,1500,30.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04414410,No,Results,No,Results,No,Results,15.06.2020,None
1838,NCT04414657,ClinicalTrials.gov,2.06.2020,9.04.2020,TRUE,Regina,Grossmann,Recruiting,Not,Applicable,Observational,Switzerland,USZ,BioResource,COVID,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,500,30.04.2022,30.04.2022,https://clinicaltrials.gov/show/NCT04414657,No,Results,No,Results,No,Results,15.06.2020,None,,,,
1847,NCT04416373,ClinicalTrials.gov,29.05.2020,22.03.2020,TRUE,University,Nova,de,Lisboa,Recruiting,Not,Applicable,Observational,Portugal,COVID-19,and,Pregnancy,Outcomes,COVID&PREG,Clinical,Presentation,No,Intervention,No,Intervention,300,23.12.2020,23.12.2020,https://clinicaltrials.gov/show/NCT04416373,No,Results,No,Results,No,Results,15.06.2020,None,,
1849,NCT04417335,ClinicalTrials.gov,25.05.2020,16.04.2020,TRUE,Radboud,University,Not,Recruiting,Phase,4,Interventional,Netherlands,Reducing,COVID-19,Related,Hospital,Admission,in,Elderly,by,BCG,Vaccination,,ATMP,Vaccine,Vaccine,2014,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04417335,No,Results,No,Results,No,Results,15.06.2020,EUCTR2020-001591-15
1882,IRCT20190727044343N3,IRCT,12.06.2020,9.06.2020,TRUE,Mazandaran,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,ANIF1,effect,on,COVID-19,,Drug,ANIF1,ANIF1,60,Not,Available,Not,Available,http://en.irct.ir/trial/47062,No,Results,No,Results,No,Results,15.06.2020,None,
1887,IRCT20190418043307N1,IRCT,17.05.2020,26.04.2020,TRUE,Ilam,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Effect,of,selenium,on,covid-19,disease,,Drug,Selenium,Selenium,100,Not,Available,Not,Available,http://en.irct.ir/trial/47209,No,Results,No,Results,No,Results,15.06.2020,None
1889,IRCT20150303021315N19,IRCT,27.05.2020,6.06.2020,FALSE,CinnaGen,Company,Recruiting,Phase,2,Interventional,Iran,Pembrolizumab,(CinnaGen,Co,,Iran),in,COVID-19,,Drug,Pembrolizumab,Pembrolizumab,62,Not,Available,Not,Available,http://en.irct.ir/trial/47335,No,Results,No,Results,No,Results,15.06.2020,None,,
1892,IRCT20200501047259N1,IRCT,17.05.2020,9.05.2020,TRUE,Oroumia,University,of,Medical,Sciences,Not,Recruiting,Phase,3,Interventional,Iran,IVIG,and,COVID19,,ATMP,Immunoglobulin,Immunoglobulin,40,Not,Available,Not,Available,http://en.irct.ir/trial/47609,No,Results,No,Results,No,Results,15.06.2020,None,,
1899,IRCT20200405046951N1,IRCT,11.06.2020,21.05.2020,TRUE,Iran,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Vitamin,A,and,COVID-19,,Drug,Vitamin,A,Vitamin,A,120,Not,Available,Not,Available,http://en.irct.ir/trial/47722,No,Results,No,Results,No,Results,15.06.2020,None
1902,IRCT20200421047150N1,IRCT,14.05.2020,12.05.2020,TRUE,DEY,Company,Recruiting,Phase,2/Phase,3,Interventional,Iran,Stem,cell,treatment,for,COVID-19,,ATMP,Cells,(mesenchymal),Cells,(mesenchymal),90,Not,Available,Not,Available,http://en.irct.ir/trial/47964,No,Results,No,Results,No,Results,15.06.2020,None,
1905,IRCT20140428017469N1,IRCT,23.05.2020,13.06.2020,FALSE,Petroleum,Industry,Health,Organization,Recruiting,Phase,3,Interventional,Iran,Polio,Vaccine,and,COVID-19,,ATMP,Vaccine,Vaccine,130000,Not,Available,Not,Available,http://en.irct.ir/trial/47989,No,Results,No,Results,No,Results,15.06.2020,None,,,
1909,IRCT20150716023235N15,IRCT,29.05.2020,21.05.2020,TRUE,Mashhad,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,sex,hormones,in,coronavirus,,Drug,Hormones,Hormones,80,Not,Available,Not,Available,http://en.irct.ir/trial/48019,No,Results,No,Results,No,Results,15.06.2020,None,
1920,IRCT20200516047462N1,IRCT,17.05.2020,6.05.2020,TRUE,Kashan,University,of,Medical,Sciences,Not,Recruiting,Not,Applicable,Interventional,Iran,Intervention,,Traditional,Medicine,(Drug),Traditional,Medicine,Traditional,Medicine,50,Not,Available,Not,Available,http://en.irct.ir/trial/48141,No,Results,No,Results,No,Results,15.06.2020,None
1923,IRCT20150107020592N23,IRCT,31.05.2020,20.03.2020,TRUE,Shahid,Beheshti,University,of,Medical,Sciences,Recruiting,Phase,2,Interventional,Iran,Plasmapheresis,and,plasma,exchanges,,,,,,,,,,,,,,,,,,,
1948,JPRN-UMIN000040353,JPRN,11.05.2020,11.05.2020,FALSE,Oita,San-ai,Medical,Center,Not,Recruiting,Not,Applicable,Observational,Japan,Examination,in,COVID-19,pandemic,,,,,,,,,,,,,,,,,,,,
1954,JPRN-UMIN000040520,JPRN,26.05.2020,13.05.2020,TRUE,Oita,San-ai,Medical,Center,Not,Recruiting,Not,Applicable,Observational,Japan,Examination,in,COVID-19,pandemic,,,,,,,,,,,,,,,,,,,,
1963,NCT04316377,ClinicalTrials.gov,13.03.2020,25.03.2020,FALSE,University,Hospital,,Akershus,Not,Recruiting,Phase,4,Interventional,Norway,Norwegian,Coronavirus,Disease,2019,Study,NO,COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,53,25.05.2020,3.03.2025,https://clinicaltrials.gov/show/NCT04316377,No,Results,No,Results,No,Results,18.06.2020,None,,
1965,NCT04335851,ClinicalTrials.gov,2.04.2020,6.04.2020,FALSE,Biruni,University,Not,Recruiting,Not,Applicable,Interventional,Turkey,Video-Based,Exercises,and,Well-Being,During,Social,Isolation,,Other,(exercise),Exercise,Exercise,68,15.05.2020,3.06.2020,https://clinicaltrials.gov/show/NCT04335851,No,Results,No,Results,No,Results,18.06.2020,None,,
1966,NCT04339426,ClinicalTrials.gov,7.04.2020,20.04.2020,FALSE,HonorHealth,Research,Institute,Recruiting,Phase,2,Interventional,United,States,Atovaquone,and,Azithromycin,Combination,for,Confirmed,COVID-19,Infection,,Drug,Atovaquone,+,azithromycin,Atovaquone,,,,,,,,,,,
1973,NCT04355702,ClinicalTrials.gov,17.04.2020,1.03.2020,TRUE,University,Hospital,,Montpellier,Recruiting,Not,Applicable,Observational,France,Covid-19,in,Lupus,Patients,,Clinical,Presentation,No,Intervention,No,Intervention,130,1.12.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04355702,No,Results,No,Results,No,Results,18.06.2020,None,,
1979,NCT04370223,ClinicalTrials.gov,27.04.2020,25.05.2020,FALSE,Institut,d'Investigació,Biomèdica,de,Girona,Dr.,Josep,Trueta,Not,Recruiting,Phase,3,Interventional,Spain,Ozone,Auto-hemotherapy,for,COVID-19,Pneumonia,COVID-OZONE,Drug,Ozone,Ozone,208,25.10.2020,25.12.2020,https://clinicaltrials.gov/show/NCT04370223,Pre-Print,Article,5.06.2020,https://doi.org/10.1101/2020.06.03.20117994,18.06.2020,None,
1982,NCT04372017,ClinicalTrials.gov,25.04.2020,14.05.2020,FALSE,Sanford,Health,Not,Recruiting,Phase,3,Interventional,United,States,Hydroxychloroquine,as,Post-Exposure,Prophylaxis,Against,COVID-19,Infection,,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,4.06.2020,4.06.2021,https://clinicaltrials.gov/show/NCT04372017,No,Results,No,Results,No,Results,18.06.2020,None,
1986,NCT04393636,ClinicalTrials.gov,11.05.2020,5.06.2020,FALSE,Academic,Hospital,Maastricht,Recruiting,Not,Applicable,Interventional,Netherlands,Digital,Cardiac,Counseling,Trial:,DCC,Trial,DCC,Other,(software),eHealth,eHealth,394,31.12.2022,31.12.2022,https://clinicaltrials.gov/show/NCT04393636,No,Results,No,Results,No,Results,18.06.2020,None,,,
1987,NCT04395807,ClinicalTrials.gov,18.05.2020,3.06.2020,FALSE,Lund,University,Recruiting,Not,Applicable,Interventional,Sweden,Helmet,CPAP,Versus,HFNC,in,COVID-19,COVID,HELMET,Other,(device),CPAP,vs.,Nasal,cannula,CPAP,,,,,,,,,,,,
1992,NCT04412265,ClinicalTrials.gov,30.05.2020,1.03.2020,TRUE,University,of,Milano,Bicocca,Recruiting,Not,Applicable,Observational,Italy,Frailty,in,Elderly,Patients,With,COVID-19,FRA-COVID,Clinical,Presentation,No,Intervention,No,Intervention,300,1.03.2021,1.03.2021,https://clinicaltrials.gov/show/NCT04412265,No,Results,No,Results,No,Results,18.06.2020,None
1993,NCT04412356,ClinicalTrials.gov,24.05.2020,4.06.2020,FALSE,Sahlgrenska,University,Hospital,Recruiting,Not,Applicable,Interventional,Sweden,Timing,of,Tracheotomy,in,Covid-19,Patients,TTCOV19,Other,No,Intervention,No,Intervention,180,1.12.2020,1.02.2021,https://clinicaltrials.gov/show/NCT04412356,No,Results,No,Results,No,Results,18.06.2020,None,,
1998,NCT04418531,ClinicalTrials.gov,3.06.2020,1.06.2020,TRUE,Piero,Luigi,Ruggenenti,Not,Recruiting,Not,Applicable,Interventional,Italy,Convalescent,Antibodies,Infusion,in,COVID,19,Patients,,ATMP,Plasma,Plasma,10,20.09.2020,20.09.2020,https://clinicaltrials.gov/show/NCT04418531,No,Results,No,Results,No,Results,18.06.2020,None,,
1999,NCT04418557,ClinicalTrials.gov,3.06.2020,28.04.2020,TRUE,University,Hospitals,Cleveland,Medical,Center,Recruiting,Not,Applicable,Observational,United,States,COVID-19,and,Obstetric,Transmission,COVIDOB,Clinical,Presentation,No,Intervention,No,Intervention,200,31.07.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04418557,No,Results,No,Results,No,Results,18.06.2020,None
2000,NCT04418609,ClinicalTrials.gov,28.05.2020,1.05.2020,TRUE,Emanuela,Keller,Recruiting,Not,Applicable,Observational,Switzerland,Neuro-COVID-19:,Neurological,Complications,of,COVID-19,Neuro-COVID,Clinical,Presentation,No,Intervention,No,Intervention,30,30.04.2022,30.05.2022,https://clinicaltrials.gov/show/NCT04418609,No,Results,No,Results,No,Results,18.06.2020,None,,,
2004,NCT04420390,ClinicalTrials.gov,14.05.2020,1.05.2020,TRUE,Hospital,San,Carlos,,Madrid,Recruiting,Not,Applicable,Interventional,Spain,Low,Dose,Radiotherapy,for,COVID-19,Pneumonitis,LOWRAD-Cov19,Other,Radiation,Radiation,41,31.07.2020,8.09.2020,https://clinicaltrials.gov/show/NCT04420390,No,Results,No,Results,No,Results,18.06.2020,None,,
2007,NCT04421391,ClinicalTrials.gov,4.06.2020,8.06.2020,FALSE,Therapeutic,Solutions,International,Recruiting,Not,Applicable,Interventional,United,States,QuadraMune(TM),for,Prevention,of,COVID-19,,Supplement,Nutritional,Supplement,Nutritional,Supplement,500,1.11.2020,8.11.2020,https://clinicaltrials.gov/show/NCT04421391,No,Results,No,Results,No,Results,18.06.2020,None,,
2019,NCT04342884,ClinicalTrials.gov,8.04.2020,8.04.2020,FALSE,Wake,Forest,University,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Community,Research,Partnership,,Clinical,Presentation,No,Intervention,No,Intervention,150000,21.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04342884,No,Results,No,Results,No,Results,22.06.2020,None,,
2024,NCT04353596,ClinicalTrials.gov,14.04.2020,15.04.2020,TRUE,Medical,University,Innsbruck,Recruiting,Phase,4,Interventional,Austria,,Germany,Stopping,ACE-inhibitors,in,COVID-19,ACEI-COVID,Drug,ACE,inhibitors,or,ARBs,ACE,inhibitors,,,,,,,,,,,,
2028,NCT04365595,ClinicalTrials.gov,24.04.2020,3.06.2020,FALSE,University,of,Zurich,Recruiting,Not,Applicable,Observational,Switzerland,SARS-CoV-2,Associated,Respiratory,Failure,Recovery,(COVID-19,CAir),,Clinical,Presentation,No,Intervention,No,Intervention,200,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04365595,No,Results,No,Results,No,Results,22.06.2020,None
2032,NCT04373798,ClinicalTrials.gov,1.05.2020,4.05.2020,FALSE,Henning,Bliddal,Recruiting,Not,Applicable,Observational,Denmark,C-reactive,Protein,Levels,Among,Individuals,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,3000,30.11.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04373798,No,Results,No,Results,No,Results,22.06.2020,None,
2036,NCT04382768,ClinicalTrials.gov,6.05.2020,1.05.2020,TRUE,Quimica,Luar,SRL,Recruiting,Not,Applicable,Interventional,Argentina,Inhaled,Ibuprofen,to,Treat,COVID-19,CórdobaTrail,Drug,Ibuprofen,Ibuprofen,40,21.01.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04382768,No,Results,No,Results,No,Results,22.06.2020,None,,,,,
2038,NCT04386850,ClinicalTrials.gov,11.05.2020,14.04.2020,TRUE,Tehran,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,Oral,25-hydroxyvitamin,D3,and,COVID-19,,Drug,Vitamin,D,Vitamin,D,1500,15.11.2020,15.03.2021,https://clinicaltrials.gov/show/NCT04386850,No,Results,No,Results,No,Results,22.06.2020,IRCT20200401046909N1
2043,NCT04409886,ClinicalTrials.gov,27.05.2020,1.06.2020,FALSE,Maimonides,Medical,Center,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Hyperbaric,Oxygen,Therapy,in,Non-ventilated,COVID-19,Patients,HBOT,Drug,Oxygen,Oxygen,30,31.12.2020,30.03.2021,https://clinicaltrials.gov/show/NCT04409886,No,Results,No,Results,No,Results,22.06.2020,None
2053,NCT04422522,ClinicalTrials.gov,7.06.2020,15.03.2020,TRUE,Al-Azhar,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Fibromyalgia,During,the,COVID-19,Pandemic,,Clinical,Presentation,No,Intervention,No,Intervention,45,15.05.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04422522,No,Results,No,Results,No,Results,22.06.2020,None,,
2054,NCT04422574,ClinicalTrials.gov,8.06.2020,1.05.2020,TRUE,University,Hospital,,Montpellier,Not,Recruiting,Not,Applicable,Observational,France,COVID,19,Serology,in,Pulmonologists,Pneumoserocov,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,97,1.05.2020,30.05.2020,https://clinicaltrials.gov/show/NCT04422574,No,Results,No,Results,No,Results,22.06.2020,None,,
2057,NCT04423003,ClinicalTrials.gov,8.06.2020,1.03.2020,TRUE,University,Hospital,,Tübingen,Not,Recruiting,Not,Applicable,Observational,Germany,Endoscopic,Interventions,in,Patients,With,COVID-19,,Procedure,Endoscopy,Endoscopy,10,15.05.2020,15.05.2020,https://clinicaltrials.gov/show/NCT04423003,No,Results,No,Results,No,Results,22.06.2020,None,,
2060,NCT04424082,ClinicalTrials.gov,7.06.2020,7.06.2020,FALSE,Karolinska,Institutet,Recruiting,Not,Applicable,Interventional,Sweden,External,Dead,Space,in,Ventilated,COVID-19,Patients,,Other,(physical),Mechanical,ventilation,Mechanical,ventilation,40,7.11.2020,7.11.2020,https://clinicaltrials.gov/show/NCT04424082,No,Results,No,Results,No,Results,22.06.2020,None,
2062,NCT04424901,ClinicalTrials.gov,29.05.2020,3.05.2020,TRUE,UConn,Health,Recruiting,Phase,2,Interventional,United,States,Trial,of,Open,Label,Dipyridamole-,In,Hospitalized,Patients,With,COVID-19,TOLD,Drug,Dipyridamole,Dipyridamole,100,1.05.2021,30.05.2021,https://clinicaltrials.gov/show/NCT04424901,No,Results,No,Results,No,Results,22.06.2020,None
2064,NCT04425005,ClinicalTrials.gov,8.06.2020,10.05.2020,TRUE,University,of,São,Paulo,Recruiting,Not,Applicable,Interventional,Brazil,Home-based,Exercise,Training,During,Covid-19,Pandemic,in,Post-bariatric,,Other,(exercise),Exercise,Exercise,70,20.11.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04425005,No,Results,No,Results,No,Results,22.06.2020,None
2065,NCT04425044,ClinicalTrials.gov,9.06.2020,12.04.2020,TRUE,Aarogyam,UK,Not,Recruiting,Not,Applicable,Observational,India,AiM,Covid,Self,Monitoring,,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,1000,18.05.2020,28.05.2020,https://clinicaltrials.gov/show/NCT04425044,No,Results,No,Results,No,Results,22.06.2020,None
2066,NCT04425382,ClinicalTrials.gov,21.05.2020,1.03.2020,TRUE,Hamad,Medical,Corporation,Recruiting,Not,Applicable,Observational,Qatar,Darunavir/Cobicistat,vs.,Lopinavir/Ritonavir,in,COVID-19,Pneumonia,in,Qatar,DOLCI,Drug,Darunavir/Cobicistat,vs.,Lopinavir/Ritonavir,Darunavir/Cobicistat,,,,,,,,,,,,
2080,NCT04426305,ClinicalTrials.gov,3.06.2020,21.05.2020,TRUE,University,of,Ghent,Recruiting,Not,Applicable,Interventional,Belgium,Community,Health,Workers,Against,COVID19,,Other,(psych),Psychological,Psychological,140,20.06.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04426305,No,Results,No,Results,No,Results,22.06.2020,None,,,,
2083,NCT04427345,ClinicalTrials.gov,4.06.2020,1.03.2020,TRUE,University,of,Milano,Bicocca,Recruiting,Not,Applicable,Observational,Italy,Predictive,Factors,COVID-19,Patients,MI-COVID,Prognosis,No,Intervention,No,Intervention,1000,30.04.2021,30.04.2021,https://clinicaltrials.gov/show/NCT04427345,No,Results,No,Results,No,Results,22.06.2020,None,,,
2090,NCT04429854,ClinicalTrials.gov,9.06.2020,2.05.2020,TRUE,UZ,Leuven,Recruiting,Phase,2,Interventional,Belgium,Donated,Antibodies,Working,Against,nCoV,DAWN-Plasma,ATMP,Plasma,Plasma,483,2.11.2021,2.11.2021,https://clinicaltrials.gov/show/NCT04429854,No,Results,No,Results,No,Results,22.06.2020,None,,,,,,
2097,ISRCTN40092247,ISRCTN,1.04.2020,20.03.2020,TRUE,University,of,Oxford,Recruiting,Not,Applicable,Observational,United,Kingdom,UKOSS:,Pandemic,COVID-19,in,pregnancy,,Clinical,Presentation,No,Intervention,No,Intervention,500,Not,Available,31.12.2022,http://isrctn.com/ISRCTN40092247,No,Results,No,Results,No,Results,22.06.2020,None
2106,EUCTR2020-002293-28-SE,EU,Clinical,Trials,Register,13.05.2020,29.05.2020,FALSE,Karolinska,University,Hospital,Authorised,Phase,2,Interventional,Sweden,Treatment,with,Omega-3,polyunsaturated,fatty,acids,in,COVID-19,patients.,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
A,single-blind,,randomized,"""",placebo-controlled,feasibility,"study.""""""",,Drug,Omega,3,Omega,3,20,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002293-28,No,Results,No,Results,No,Results,22.06.2020,None,,,,,,,,,,,,
2113,NCT04312243,ClinicalTrials.gov,15.03.2020,7.04.2020,FALSE,Massachusetts,General,Hospital,Recruiting,Phase,2,Interventional,United,States,NO,Prevention,of,COVID-19,for,Healthcare,Providers,NOpreventCOVID,Drug,Nitric,oxide,Nitric,oxide,470,7.04.2021,7.04.2022,https://clinicaltrials.gov/show/NCT04312243,No,Results,No,Results,No,Results,25.06.2020,None
2121,NCT04370262,ClinicalTrials.gov,27.04.2020,7.04.2020,TRUE,Northwell,Health,Recruiting,Phase,3,Interventional,United,States,Multi-site,Adaptive,Trials,for,COVID-19,,Drug,Hydroxychloroquine,+,Famotidine,vs.,Hydroxychloroquine,Hydroxychloroquine,,,,,,,,,,,,,
2131,NCT04413071,ClinicalTrials.gov,23.05.2020,25.05.2020,FALSE,AORTICA,Group,Not,Recruiting,Not,Applicable,Observational,Spain,Cardiac,COVID-19,Health,Care,Workers,CCC,Clinical,Presentation,No,Intervention,No,Intervention,142,12.06.2020,12.06.2020,https://clinicaltrials.gov/show/NCT04413071,Pre-Print,Article,14.07.2020,https://doi.org/10.1101/2020.07.12.20151316,25.06.2020,None,,,,
2141,NCT04429828,ClinicalTrials.gov,11.06.2020,13.06.2020,FALSE,University,of,Nottingham,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,COVID-19,Psychological,Wellbeing,for,Healthcare,Students,PoWerS,Other,(psych),Psychological,Psychological,45,30.09.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04429828,No,Results,No,Results,No,Results,25.06.2020,None
2158,NCT04363853,ClinicalTrials.gov,17.04.2020,1.06.2020,FALSE,Instituto,Nacional,de,Cancerología,Recruiting,Phase,2,Interventional,Mexico,Tocilizumab,Treatment,in,Patients,With,COVID-19,,Drug,Tocilizumab,Tocilizumab,200,1.06.2021,1.08.2021,https://clinicaltrials.gov/show/NCT04363853,No,Results,No,Results,No,Results,29.06.2020,None,,,
2159,NCT04366778,ClinicalTrials.gov,23.04.2020,1.05.2020,FALSE,Hospices,Civils,de,Lyon,Recruiting,Not,Applicable,Observational,France,Thrombosis,and,Covid-19,COVBIO,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,325,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04366778,No,Results,No,Results,No,Results,29.06.2020,None
2162,NCT04371354,ClinicalTrials.gov,28.04.2020,27.04.2020,TRUE,Fundación,Miguel,Servet,Recruiting,Not,Applicable,Observational,Spain,Outcomes,of,Covid-19,Protective,Measures,in,Endoscopy,,Clinical,Presentation,No,Intervention,No,Intervention,100,14.06.2020,27.07.2020,https://clinicaltrials.gov/show/NCT04371354,No,Results,No,Results,No,Results,29.06.2020,None
2165,NCT04383457,ClinicalTrials.gov,4.05.2020,15.06.2020,FALSE,Vastra,Gotaland,Region,Recruiting,Not,Applicable,Observational,Sweden,Covid-19,Triage,Using,Camera-based,AI,,Other,(device),Other,Other,500,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04383457,No,Results,No,Results,No,Results,29.06.2020,None,,,,
2167,NCT04390126,ClinicalTrials.gov,14.05.2020,20.04.2020,TRUE,CHU,Dijon,Not,Recruiting,Not,Applicable,Observational,France,COVID-19,Related,Lockdown,Effects,On,Chronic,Diseases,CLEO-CD,Other,Other,Other,1200,7.05.2021,7.11.2021,https://clinicaltrials.gov/show/NCT04390126,No,Results,No,Results,No,Results,29.06.2020,None,,,
2172,NCT04427098,ClinicalTrials.gov,29.05.2020,22.05.2020,FALSE,AOU,di,Bologna,Policlinico,S.Orsola-Malpighi,Recruiting,Phase,2,Interventional,Italy,Enoxaparin,in,COVID-19,Moderate,to,Severe,Hospitalized,Patients,INHIXACOV19,Drug,Enoxaparin,Enoxaparin,300,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04427098,No,Results,No,Results,No,Results,29.06.2020,EUCTR2020-001308-40
2177,NCT04432987,ClinicalTrials.gov,15.06.2020,25.05.2020,TRUE,Acibadem,University,Recruiting,Phase,2,Interventional,Turkey,Dornase,Alpha,for,the,Treatment,of,COVID-19,,Drug,Dornase,alfa,Dornase,alfa,60,25.08.2020,25.09.2020,https://clinicaltrials.gov/show/NCT04432987,No,Results,No,Results,No,Results,29.06.2020,None,,
2187,NCT04435041,ClinicalTrials.gov,16.06.2020,1.06.2020,TRUE,University,of,Oxford,Not,Recruiting,Not,Applicable,Observational,United,Kingdom,Remote-by-Default,Care,in,the,COVID-19,Pandemic,,Telehealth,Telehealth,Telehealth,1,31.05.2021,30.11.2021,https://clinicaltrials.gov/show/NCT04435041,No,Results,No,Results,No,Results,29.06.2020,None,,
2190,NCT04435119,ClinicalTrials.gov,12.06.2020,15.03.2020,TRUE,University,Hospital,,Angers,Not,Recruiting,Not,Applicable,Observational,France,Covid-19,and,Vitamin,D,in,Nursing-home,COVIT-EHPAD,Drug,Vitamin,D,Vitamin,D,96,15.05.2020,15.05.2020,https://clinicaltrials.gov/show/NCT04435119,No,Results,No,Results,No,Results,29.06.2020,None
2191,NCT04435275,ClinicalTrials.gov,9.06.2020,30.06.2020,FALSE,University,Health,Network,,Toronto,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Virtual,Assistant,for,COVID-19,PPE,,Telehealth,Telehealth,Telehealth,50,31.03.2021,1.05.2021,https://clinicaltrials.gov/show/NCT04435275,No,Results,No,Results,No,Results,29.06.2020,None
2208,ChiCTR2000034112,ChiCTR,24.06.2020,25.06.2020,FALSE,Shulan,(Hangzhou),Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2224,NCT04360824,ClinicalTrials.gov,13.04.2020,6.05.2020,FALSE,University,of,Iowa,Recruiting,Phase,4,Interventional,United,States,Covid-19,Associated,Coagulopathy,,Drug,Enoxaparin,Enoxaparin,170,16.04.2021,16.04.2021,https://clinicaltrials.gov/show/NCT04360824,No,Results,No,Results,No,Results,2.07.2020,None,,,,,,
2226,NCT04368923,ClinicalTrials.gov,24.04.2020,15.03.2020,TRUE,Cairo,University,Not,Recruiting,Not,Applicable,Interventional,Egypt,Management,of,Covid-19,Patients,During,Home,Isolation,,Drug,Oxygen,Oxygen,60,21.06.2020,23.06.2020,https://clinicaltrials.gov/show/NCT04368923,No,Results,No,Results,No,Results,2.07.2020,None,,,
2230,NCT04395300,ClinicalTrials.gov,19.05.2020,30.03.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Sleep,Quality,in,Healthcare,Personnel,During,COVID-19,,Other,(psych),No,Intervention,No,Intervention,143,30.04.2020,16.05.2020,https://clinicaltrials.gov/show/NCT04395300,No,Results,No,Results,No,Results,2.07.2020,None
2231,NCT04399889,ClinicalTrials.gov,21.05.2020,18.06.2020,FALSE,Joanne,Kurtzberg,,MD,Recruiting,Phase,1/Phase,2,Interventional,United,States,hCT-MSCs,for,COVID19,ARDS,,ATMP,Cells,(mesenchymal),Cells,(mesenchymal),30,1.04.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04399889,No,Results,No,Results,No,Results,2.07.2020,None,
2235,NCT04412304,ClinicalTrials.gov,30.05.2020,6.03.2020,TRUE,Karolinska,Institutet,Not,Recruiting,Not,Applicable,Observational,Sweden,Anticoagulant,Therapy,and,28-days,Mortality,in,Critically,Ill,COVID-19,Patients,,Drug,Anticoagulants,Anticoagulants,166,30.04.2020,28.05.2020,https://clinicaltrials.gov/show/NCT04412304,No,Results,No,Results,No,Results,2.07.2020,None
2244,NCT04438629,ClinicalTrials.gov,16.06.2020,26.03.2020,TRUE,AOUI,Verona,Recruiting,Not,Applicable,Observational,Italy,Evaluation,of,Immune,Response,in,COVID-19,Patients,IMMUNOVID,Clinical,Presentation,No,Intervention,No,Intervention,80,10.06.2020,26.11.2020,https://clinicaltrials.gov/show/NCT04438629,No,Results,No,Results,No,Results,2.07.2020,None,
2247,NCT04438980,ClinicalTrials.gov,18.06.2020,15.05.2020,TRUE,Fundación,Miguel,Servet,Recruiting,Phase,3,Interventional,Spain,Glucocorticoids,in,COVID-19,(CORTIVID),CORTIVID,Drug,Corticosteroids,Methylprednisolone,72,20.12.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04438980,No,Results,No,Results,No,Results,2.07.2020,EUCTR2020-001827-15,,,,,,
2248,NCT04438993,ClinicalTrials.gov,18.06.2020,29.05.2020,TRUE,NHS,Lanarkshire,Recruiting,Not,Applicable,Observational,United,Kingdom,The,COVID-19,Disease,and,CARdiac,Events,Study,COVICARE,Clinical,Presentation,No,Intervention,No,Intervention,100,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04438993,No,Results,No,Results,No,Results,2.07.2020,None
2257,NCT04442152,ClinicalTrials.gov,19.06.2020,1.06.2020,TRUE,Promundo,Recruiting,Not,Applicable,Interventional,Rwanda,Impact,of,COVID-19,on,Family,Dynamics,on,Bandebereho,Study,Participants,,Other,Other,Other,1000,20.08.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04442152,No,Results,No,Results,No,Results,2.07.2020,None,,
2269,NCT04444310,ClinicalTrials.gov,19.06.2020,15.06.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Antibody,Responses,in,Contacts,of,COVID-19,Patients,,Clinical,Presentation,No,Intervention,No,Intervention,100,18.06.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04444310,No,Results,No,Results,No,Results,2.07.2020,None
2272,NCT04445311,ClinicalTrials.gov,19.06.2020,31.05.2020,TRUE,Zagazig,University,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Ivermectin,in,Treatment,of,COVID-19,,Drug,Ivermectin,Ivermectin,100,30.07.2020,15.08.2020,https://clinicaltrials.gov/show/NCT04445311,No,Results,No,Results,No,Results,2.07.2020,None,,,,,
2273,NCT04314232,ClinicalTrials.gov,17.03.2020,18.03.2020,FALSE,University,Hospital,,Akershus,Recruiting,Not,Applicable,Observational,Norway,Mechanisms,for,Covid-19,Disease,Complications,COVID,MECH,Prognosis,No,Intervention,No,Intervention,200,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04314232,No,Results,No,Results,No,Results,6.07.2020,None,
2275,NCT04323592,ClinicalTrials.gov,19.03.2020,23.03.2020,FALSE,University,of,Trieste,Not,Recruiting,Not,Applicable,Observational,Italy,Methylprednisolone,for,Patients,With,COVID-19,Severe,Acute,Respiratory,Syndrome,MP-C19,Drug,Corticosteroids,Methylprednisolone,173,10.05.2020,10.05.2020,https://clinicaltrials.gov/show/NCT04323592,Registry,Results,4.06.2020,https://clinicaltrials.gov/ct2/show/results/NCT04323592,6.07.2020,None,,
2276,NCT04323592,ClinicalTrials.gov,19.03.2020,23.03.2020,FALSE,University,of,Trieste,Not,Recruiting,Not,Applicable,Observational,Italy,Methylprednisolone,for,Patients,With,COVID-19,Severe,Acute,Respiratory,Syndrome,MP-C19,Drug,Corticosteroids,Methylprednisolone,173,10.05.2020,10.05.2020,https://clinicaltrials.gov/show/NCT04323592,Pre-Print,Article,20.06.2020,https://doi.org/10.1101/2020.06.17.20134031,6.07.2020,None,,
2281,NCT04343976,ClinicalTrials.gov,9.04.2020,22.06.2020,FALSE,Raymond,Chung,Recruiting,Phase,2,Interventional,United,States,Pegylated,Interferon,Lambda,Treatment,for,COVID-19,,Drug,Interferon,lambda,Interferon,lambda,20,1.03.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04343976,No,Results,No,Results,No,Results,6.07.2020,None,,
2284,NCT04349241,ClinicalTrials.gov,13.04.2020,18.04.2020,FALSE,Ain,Shams,University,Not,Recruiting,Phase,3,Interventional,Egypt,Efficacy,and,Safety,of,Favipiravir,in,Management,of,COVID-19,FAV-001,Drug,Favipiravir,Favipiravir,100,1.06.2020,20.06.2020,https://clinicaltrials.gov/show/NCT04349241,No,Results,No,Results,No,Results,6.07.2020,None
2285,NCT04366986,ClinicalTrials.gov,23.04.2020,23.06.2020,FALSE,Pregistry,Recruiting,Not,Applicable,Observational,United,States,International,Registry,of,Coronavirus,(COVID-19),Exposure,in,Pregnancy,IRCEP,Clinical,Presentation,No,Intervention,No,Intervention,25000,30.04.2024,30.04.2024,https://clinicaltrials.gov/show/NCT04366986,No,Results,No,Results,No,Results,6.07.2020,None
2291,NCT04389710,ClinicalTrials.gov,27.04.2020,15.04.2020,TRUE,Thomas,Jefferson,University,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,for,the,Treatment,of,COVID-19,,ATMP,Plasma,Plasma,100,14.04.2021,14.04.2021,https://clinicaltrials.gov/show/NCT04389710,No,Results,No,Results,No,Results,6.07.2020,None,,
2292,NCT04391309,ClinicalTrials.gov,14.05.2020,1.07.2020,FALSE,Implicit,Bioscience,Not,Recruiting,Phase,2,Interventional,United,States,IC14,(Anti-CD14),Treatment,in,Patients,With,SARS-CoV-2,(COVID-19),,Drug,IC14,IC14,300,21.07.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04391309,No,Results,No,Results,No,Results,6.07.2020,None,
2293,NCT04393948,ClinicalTrials.gov,15.05.2020,1.06.2020,FALSE,Brigham,and,Women's,Hospital,Recruiting,Not,Applicable,Interventional,United,States,Lung,Irradiation,for,COVID-19,Pneumonia,,Other,Radiation,Radiation,48,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04393948,No,Results,No,Results,No,Results,6.07.2020,None,,,
2297,NCT04405726,ClinicalTrials.gov,25.05.2020,27.03.2020,TRUE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,Prognostic,Factors,of,COVID19,Covid-HUS,Prognosis,No,Intervention,No,Intervention,500,22.03.2020,22.03.2020,https://clinicaltrials.gov/show/NCT04405726,No,Results,No,Results,No,Results,6.07.2020,None,,,
2298,NCT04405908,ClinicalTrials.gov,25.05.2020,19.06.2020,FALSE,Clover,Biopharmaceuticals,Recruiting,Phase,1,Interventional,Australia,SCB-2019,as,COVID-19,Vaccine,,ATMP,Vaccine,Vaccine,150,20.10.2020,30.03.2021,https://clinicaltrials.gov/show/NCT04405908,No,Results,No,Results,No,Results,6.07.2020,None,,,,,,,
2307,NCT04433078,ClinicalTrials.gov,10.06.2020,22.06.2020,FALSE,Temple,University,Recruiting,Phase,2,Interventional,United,States,RepurpoSing,Old,Drugs,TO,SuppRess,a,Modern,Threat:,COVID-19,STORM,STORM,Drug,Doxycycline,Doxycycline,20,21.01.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04433078,No,Results,No,Results,No,Results,6.07.2020,None
2313,NCT04443179,ClinicalTrials.gov,19.06.2020,5.04.2013,TRUE,King's,College,London,Recruiting,Not,Applicable,Observational,United,Kingdom,Brain,Imaging,in,Babies,Study,BIBS,Clinical,Presentation,No,Intervention,No,Intervention,790,23.12.2020,23.12.2020,https://clinicaltrials.gov/show/NCT04443179,No,Results,No,Results,No,Results,6.07.2020,None,
2314,NCT04443361,ClinicalTrials.gov,19.06.2020,22.06.2020,FALSE,University,of,Oslo,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,Insomnia,After,the,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,5000,13.07.2020,13.07.2020,https://clinicaltrials.gov/show/NCT04443361,No,Results,No,Results,No,Results,6.07.2020,None
2323,NCT04445246,ClinicalTrials.gov,9.06.2020,23.05.2020,TRUE,Hamad,Medical,Corporation,Recruiting,Phase,2,Interventional,Qatar,Inhaled,Iloprost,for,Suspected,COVID-19,Respiratory,Failure,ILOCOVID,Drug,Iloprost,Iloprost,40,31.05.2021,31.05.2021,https://clinicaltrials.gov/show/NCT04445246,No,Results,No,Results,No,Results,6.07.2020,None,,,
2330,NCT04445506,ClinicalTrials.gov,19.06.2020,1.04.2020,TRUE,The,Miriam,Hospital,Not,Recruiting,Not,Applicable,Observational,United,States,Short,Term,Corticosteroids,in,SARS-CoV2,Patients,,Drug,Corticosteroids,Dexamethasone,50,31.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04445506,Pre-Print,Article,23.06.2020,https://doi.org/10.1101/2020.06.19.20109173,6.07.2020,None,,,,
2331,NCT04445597,ClinicalTrials.gov,22.06.2020,7.05.2020,TRUE,UZ,Leuven,Recruiting,Not,Applicable,Interventional,Belgium,Unraveling,the,Mechanisms,of,Olfactory,Dysfunction,in,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,8,30.06.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04445597,No,Results,No,Results,No,Results,6.07.2020,None
2333,NCT04445623,ClinicalTrials.gov,4.06.2020,1.07.2020,FALSE,AOUI,Verona,Not,Recruiting,Phase,3,Interventional,Italy,Prasugrel,in,Severe,COVID-19,Pneumonia,PARTISAN,Drug,Prasugrel,Prasugrel,128,20.10.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04445623,No,Results,No,Results,No,Results,6.07.2020,None,,,,,
2334,NCT04445935,ClinicalTrials.gov,23.06.2020,28.06.2020,FALSE,Hamad,Medical,Corporation,Recruiting,Phase,4,Interventional,Qatar,Anticoagulation,in,Patients,Suffering,From,COVID-19,Disease,The,ANTI-CO,Trial,,Drug,Bivalirudin,Bivalirudin,100,28.09.2020,28.03.2021,https://clinicaltrials.gov/show/NCT04445935,No,Results,No,Results,No,Results,6.07.2020,None
2339,NCT04448145,ClinicalTrials.gov,24.06.2020,26.03.2020,TRUE,Columbia,University,Recruiting,Not,Applicable,Observational,United,States,Determinants,of,SARS-COV2,(COVID-19),Persistence,After,Convalescence,,Clinical,Presentation,No,Intervention,No,Intervention,250,1.03.2021,1.03.2021,https://clinicaltrials.gov/show/NCT04448145,No,Results,No,Results,No,Results,6.07.2020,None
2360,NCT04407208,ClinicalTrials.gov,16.05.2020,1.05.2020,TRUE,Biofarma,Not,Recruiting,Phase,1,Interventional,Indonesia,Convalescent,Plasma,Therapy,in,Patients,With,COVID-19,,ATMP,Plasma,Plasma,10,22.06.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04407208,No,Results,No,Results,No,Results,9.07.2020,None,,,,
2363,NCT04444271,ClinicalTrials.gov,27.05.2020,1.05.2020,TRUE,Dr.,Zaineb,Akram,Recruiting,Phase,2,Interventional,Pakistan,Mesenchymal,Stem,Cell,Infusion,for,COVID-19,Infection,,ATMP,Cells,(mesenchymal),Cells,(mesenchymal),20,30.08.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04444271,No,Results,No,Results,No,Results,9.07.2020,None,
2369,NCT04449718,ClinicalTrials.gov,16.06.2020,1.06.2020,TRUE,University,of,São,Paulo,Recruiting,Not,Applicable,Interventional,Brazil,Vitamin,D,Supplementation,in,Patients,With,COVID-19,,Drug,Vitamin,D,Vitamin,D,200,7.10.2020,7.10.2020,https://clinicaltrials.gov/show/NCT04449718,No,Results,No,Results,No,Results,9.07.2020,None
2375,NCT04451694,ClinicalTrials.gov,15.06.2020,1.04.2020,TRUE,CHU,de,Nancy,Recruiting,Not,Applicable,Observational,France,Nutritional,Follow,up,After,Hospital,Discharge,for,Coronavirus,Disease-19,NutriCoviDom,Other,(nutrition),Nutrition,Nutrition,800,30.07.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04451694,No,Results,No,Results,No,Results,9.07.2020,None
2379,NCT04452630,ClinicalTrials.gov,26.06.2020,23.06.2020,TRUE,Assistance,Publique,–,Hôpitaux,de,Marseille,Recruiting,Not,Applicable,Observational,France,Cardiovascular,Consequences,After,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,200,23.07.2020,30.11.2021,https://clinicaltrials.gov/show/NCT04452630,No,Results,No,Results,No,Results,9.07.2020,None
2390,NCT04365985,ClinicalTrials.gov,26.04.2020,29.04.2020,FALSE,William,Beaumont,Hospitals,Recruiting,Phase,2,Interventional,United,States,Study,of,Immunomodulation,Using,Naltrexone,and,Ketamine,for,COVID-19,SINK,COVID-19,Drug,Ketamine,,Naltrexone,Ketamine,,,,,,,,,
2391,NCT04369742,ClinicalTrials.gov,25.04.2020,15.04.2020,TRUE,NYU,Langone,Health,Not,Recruiting,Phase,2,Interventional,United,States,Treating,COVID-19,With,Hydroxychloroquine,(TEACH),,Drug,Hydroxychloroquine,Hydroxychloroquine,626,21.06.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04369742,No,Results,No,Results,No,Results,13.07.2020,None,,,
2396,NCT04377724,ClinicalTrials.gov,5.05.2020,27.04.2020,TRUE,Jörg,Goldhahn,Not,Recruiting,Not,Applicable,Observational,Switzerland,Spread,and,Course,of,COVID-19,Infections,CoV-ETH,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,3000,30.06.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04377724,No,Results,No,Results,No,Results,13.07.2020,None
2406,NCT04406324,ClinicalTrials.gov,13.05.2020,1.06.2020,FALSE,University,Hospital,,Grenoble,Recruiting,Not,Applicable,Observational,France,COVID-19:,Respiratory,and,Sleep,Follow-up,Co-SURVIVORS,Other,No,Intervention,No,Intervention,400,5.03.2021,5.03.2026,https://clinicaltrials.gov/show/NCT04406324,No,Results,No,Results,No,Results,13.07.2020,None,,
2408,NCT04412486,ClinicalTrials.gov,28.05.2020,1.06.2020,FALSE,Dr.,Gailen,D.,Marshall,Jr.,Recruiting,Phase,1,Interventional,United,States,COVID-19,Convalescent,Plasma,(CCP),Transfusion,,ATMP,Plasma,Plasma,100,31.05.2022,31.05.2022,https://clinicaltrials.gov/show/NCT04412486,No,Results,No,Results,No,Results,13.07.2020,None,,
2411,NCT04442958,ClinicalTrials.gov,17.06.2020,15.05.2020,TRUE,Bagcilar,Training,and,Research,Hospital,Not,Recruiting,Not,Applicable,Interventional,Turkey,Effectiveness,of,Convalescent,Immune,Plasma,Therapy,,ATMP,Plasma,Plasma,60,15.06.2020,17.06.2020,https://clinicaltrials.gov/show/NCT04442958,No,Results,No,Results,No,Results,13.07.2020,None,
2415,NCT04448405,ClinicalTrials.gov,19.06.2020,18.06.2020,TRUE,University,Hospital,,Montpellier,Recruiting,Not,Applicable,Observational,France,Covid-19,Lockdown,and,Deviant,Sexual,Fantasies,,Other,(psych),No,Intervention,No,Intervention,100,1.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04448405,No,Results,No,Results,No,Results,13.07.2020,None
2421,NCT04452799,ClinicalTrials.gov,29.06.2020,1.07.2020,FALSE,Tanta,University,Not,Recruiting,Phase,1,Interventional,No,Country,Given,Hesperidin,and,Diosmin,for,Treatment,of,COVID-19,,Drug,Hesperidin,+,Diosmin,Hesperidin,,,,,,,,,,,
2429,NCT04453852,ClinicalTrials.gov,3.06.2020,30.06.2020,FALSE,Vaxine,Pty,Ltd,Recruiting,Phase,1,Interventional,Australia,Monovalent,Recombinant,COVID19,Vaccine,COVAX19,ATMP,Vaccine,Vaccine,40,1.07.2021,1.07.2021,https://clinicaltrials.gov/show/NCT04453852,No,Results,No,Results,No,Results,13.07.2020,None,,,,,,
2434,NCT04454606,ClinicalTrials.gov,26.06.2020,1.05.2020,TRUE,Bangkok,Metropolitan,Administration,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2436,NCT04456010,ClinicalTrials.gov,15.06.2020,1.06.2020,TRUE,University,Hospital,,Montpellier,Recruiting,Not,Applicable,Observational,France,COVID-19,in,ART:,Perception,and,Experience,COVAPEX,Other,No,Intervention,No,Intervention,600,30.07.2020,30.07.2020,https://clinicaltrials.gov/show/NCT04456010,No,Results,No,Results,No,Results,13.07.2020,None,
2453,IRCT20200416047099N2,IRCT,4.07.2020,21.06.2020,TRUE,Shahid,Beheshti,University,of,Medical,Sciences,Recruiting,Phase,2,Interventional,Iran,Plasma,exchange,in,COVID-19,patients,,ATMP,Plasma,Plasma,10,Not,Available,Not,Available,http://en.irct.ir/trial/47357,No,Results,No,Results,No,Results,13.07.2020,None
2454,IRCT20200428047229N1,IRCT,27.06.2020,29.03.2020,TRUE,Esfahan,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Effect,of,Medical,Beer,on,COVID-19,,Drug,Other,Other,60,Not,Available,Not,Available,http://en.irct.ir/trial/47530,No,Results,No,Results,No,Results,13.07.2020,None
2457,IRCT20171105037262N4,IRCT,18.06.2020,29.04.2020,TRUE,Bagheiat-allah,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Adalimumab,effect,on,COVID-19,,Drug,Adalimumab,+,Chloroquine,vs.,Chloroquine,Adalimumab,,,,,,,,,,,,
2464,IRCT20200112046089N1,IRCT,25.06.2020,14.06.2020,TRUE,Ahvaz,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Resveratrol,in,COVID19,,Drug,Resveratrol,Resveratrol,50,Not,Available,Not,Available,http://en.irct.ir/trial/48330,No,Results,No,Results,No,Results,13.07.2020,None,,,
2468,IRCT20200317046797N6,IRCT,18.06.2020,21.06.2020,FALSE,Tabriz,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Edaravone,in,COVID-19,,Drug,Edaravone,Edaravone,30,Not,Available,Not,Available,http://en.irct.ir/trial/48500,No,Results,No,Results,No,Results,13.07.2020,None,,,
2469,IRCT20200504047298N1,IRCT,14.06.2020,14.06.2020,FALSE,Alborz,University,of,Medical,Sciences,Not,Recruiting,Phase,3,Interventional,Iran,Effect,of,Atazanavir/Ritonavirin,treatment,of,COViD-19,,Drug,Atazanavir/ritonavir,vs.,Lopinavir/ritonavir,Atazanavir/ritonavir,,,,,,,,,,,
2495,JPRN-jRCTs031190226,JPRN,27.02.2020,14.03.2020,FALSE,Tokue,Yutaka,Recruiting,Phase,2,Interventional,Japan,Favipiravir,in,patients,infected,with,COVID-19,,Drug,Favipiravir,Favipiravir,100,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,No,Results,No,Results,No,Results,13.07.2020,None,,,
2496,JPRN-jRCTs041200025,JPRN,1.07.2020,1.07.2020,FALSE,Yuichiro,Shindo,Recruiting,Phase,2,Interventional,Japan,Phase,II,trial,of,combination,therapy,with,favipiravir,and,corticosteroids,for,COVID-19,,Drug,Favipiravir,+,Corticosteroids,Favipiravir,,,,,,,,,
2505,NCT04305574,ClinicalTrials.gov,8.03.2020,7.03.2020,TRUE,Jean,Liu,Not,Recruiting,Not,Applicable,Observational,Singapore,Social,Media,Use,During,COVID-19,,Other,No,Intervention,No,Intervention,1145,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04305574,No,Results,No,Results,No,Results,16.07.2020,None,,,
2508,NCT04357431,ClinicalTrials.gov,21.04.2020,22.04.2020,FALSE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,COVID-19,Among,Egyptian,Health,Care,Providers,,Other,No,Intervention,No,Intervention,565,26.05.2020,30.05.2020,https://clinicaltrials.gov/show/NCT04357431,No,Results,No,Results,No,Results,16.07.2020,None,,
2514,NCT04400929,ClinicalTrials.gov,8.05.2020,2.06.2020,FALSE,Singapore,General,Hospital,Recruiting,Phase,2,Interventional,Singapore,Using,GM-CSF,as,a,Host,Directed,Therapeutic,Against,COVID-19,,Drug,Sargramostim,Sargramostim,30,21.06.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04400929,No,Results,No,Results,No,Results,16.07.2020,None,
2516,NCT04438967,ClinicalTrials.gov,15.06.2020,16.06.2020,FALSE,Miro,Health,Recruiting,Not,Applicable,Observational,United,States,Brain,Health,in,the,Time,of,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,10000,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04438967,No,Results,No,Results,No,Results,16.07.2020,None
2517,NCT04444297,ClinicalTrials.gov,20.06.2020,31.07.2020,FALSE,NHS,Greater,Glasgow,and,Clyde,Not,Recruiting,Not,Applicable,Interventional,United,Kingdom,3D,Telemedicine,During,COVID-19:,Non-clinical,Validation,,Telehealth,Telehealth,Telehealth,40,31.01.2021,31.01.2021,https://clinicaltrials.gov/show/NCT04444297,No,Results,No,Results,No,Results,16.07.2020,None
2518,NCT04444323,ClinicalTrials.gov,20.06.2020,1.09.2020,FALSE,NHS,Greater,Glasgow,and,Clyde,Not,Recruiting,Not,Applicable,Interventional,United,Kingdom,3D,Telemedicine,During,COVID-19:,Cohort,Study,,Telehealth,Telehealth,Telehealth,50,1.01.2021,1.01.2021,https://clinicaltrials.gov/show/NCT04444323,No,Results,No,Results,No,Results,16.07.2020,None
2525,NCT04458363,ClinicalTrials.gov,25.06.2020,1.07.2020,FALSE,Emory,University,Recruiting,Phase,1,Interventional,United,States,Convalescent,Plasma,in,Pediatric,COVID-19,,ATMP,Plasma,Plasma,50,22.06.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04458363,No,Results,No,Results,No,Results,16.07.2020,None,,,,,
2528,NCT04459637,ClinicalTrials.gov,25.06.2020,1.07.2020,FALSE,Peking,University,First,Hospital,Not,Recruiting,Not,Applicable,Observational,China,COVID-19,Surveillance,Based,on,Smart,Wearable,Device,COVID-19SWD,Other,(device),Biosensors,Biosensors,200,10.03.2021,10.03.2021,https://clinicaltrials.gov/show/NCT04459637,No,Results,No,Results,No,Results,16.07.2020,None
2529,NCT04459689,ClinicalTrials.gov,2.07.2020,15.03.2020,TRUE,Imagine,Institute,Recruiting,Not,Applicable,Observational,France,COVID-19,in,PID,Survey,COPID19,Clinical,Presentation,No,Intervention,No,Intervention,200,31.03.2022,31.03.2022,https://clinicaltrials.gov/show/NCT04459689,No,Results,No,Results,No,Results,16.07.2020,None,,,,
2531,NCT04459962,ClinicalTrials.gov,3.07.2020,29.06.2020,TRUE,Ancon,Technologies,Ltd,Recruiting,Not,Applicable,Interventional,United,Kingdom,Covid-19,Breath,Test,,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,250,28.08.2020,14.06.2021,https://clinicaltrials.gov/show/NCT04459962,No,Results,No,Results,No,Results,16.07.2020,None
2538,NCT04322565,ClinicalTrials.gov,24.03.2020,20.04.2020,FALSE,AOU,di,Parma,Recruiting,Phase,2,Interventional,Italy,Colchicine,Counteracting,Inflammation,in,COVID-19,Pneumonia,ColCOVID-19,Drug,Colchicine,Colchicine,310,20.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04322565,No,Results,No,Results,No,Results,20.07.2020,None,,,,
2542,NCT04337983,ClinicalTrials.gov,30.03.2020,13.03.2020,TRUE,Bicetre,Hospital,Recruiting,Not,Applicable,Observational,France,Hemodynamic,Characteristics,of,Patients,With,SARS-CoV-2,PiCCOVID,Clinical,Presentation,No,Intervention,No,Intervention,200,20.10.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04337983,No,Results,No,Results,No,Results,20.07.2020,None,,
2544,NCT04342195,ClinicalTrials.gov,8.04.2020,25.03.2020,TRUE,Columbia,University,Recruiting,Not,Applicable,Observational,United,States,Acquiring,Convalescent,Specimens,for,COVID-19,Antibodies,,Clinical,Presentation,No,Intervention,No,Intervention,50,21.03.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04342195,No,Results,No,Results,No,Results,20.07.2020,None,
2546,NCT04344964,ClinicalTrials.gov,10.04.2020,15.04.2020,FALSE,Austin,Health,Not,Recruiting,Not,Applicable,Observational,Australia,Endoscopy-related,Phone,Consultation,During,the,COVID-19,Outbreak,,Telehealth,Telehealth,Telehealth,186,29.05.2020,3.07.2020,https://clinicaltrials.gov/show/NCT04344964,No,Results,No,Results,No,Results,20.07.2020,None,,,
2550,NCT04354805,ClinicalTrials.gov,17.04.2020,1.08.2020,FALSE,Cairo,University,Not,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Administration,of,Chlorpromazine,as,a,Treatment,for,COVID-19,,Drug,Chlorpromazine,Chlorpromazine,100,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04354805,No,Results,No,Results,No,Results,20.07.2020,None,
2555,NCT04366050,ClinicalTrials.gov,24.04.2020,11.05.2020,FALSE,University,of,California,,San,Diego,Recruiting,Phase,2,Interventional,United,States,Ramipril,for,the,Treatment,of,COVID-19,RAMIC,Drug,Ramipril,Ramipril,560,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04366050,No,Results,No,Results,No,Results,20.07.2020,None
2562,NCT04382794,ClinicalTrials.gov,8.05.2020,14.05.2020,FALSE,University,of,Milan,Not,Recruiting,Not,Applicable,Observational,Italy,Sitagliptin,Treatment,in,Diabetic,COVID-19,Positive,Patients,SIDIACO-RETRO',Drug,Sitagliptin,Sitagliptin,338,15.06.2020,15.06.2020,https://clinicaltrials.gov/show/NCT04382794,No,Results,No,Results,No,Results,20.07.2020,None,,
2571,NCT04395716,ClinicalTrials.gov,19.05.2020,1.07.2020,FALSE,ProgenaBiome,Not,Recruiting,Phase,1,Interventional,United,States,A,Study,of,ResCure™,to,Treat,COVID-19,Infection,,Drug,Unspecified,Therapy,Unspecified,Therapy,50,21.06.2020,21.11.2020,https://clinicaltrials.gov/show/NCT04395716,No,Results,No,Results,No,Results,20.07.2020,None
2575,NCT04412382,ClinicalTrials.gov,26.05.2020,1.06.2020,FALSE,AOUI,Verona,Recruiting,Not,Applicable,Observational,Italy,Covid-19:,Possible,Role,of,Neutrophil,Extracellular,Traps,NETSINCOVID,Clinical,Presentation,No,Intervention,No,Intervention,100,31.12.2020,31.12.2021,https://clinicaltrials.gov/show/NCT04412382,No,Results,No,Results,No,Results,20.07.2020,None,
2587,NCT04457388,ClinicalTrials.gov,30.06.2020,25.03.2020,TRUE,Aarogyam,UK,Not,Recruiting,Not,Applicable,Interventional,United,Kingdom,Tele-Yoga,Therapy,for,Chronic,Pain,,Traditional,Medicine,(Other),Traditional,Medicine,Traditional,Medicine,18,15.06.2020,15.06.2020,https://clinicaltrials.gov/show/NCT04457388,Pre-Print,Article,17.07.2020,https://doi.org/10.1101/2020.07.16.20154229,20.07.2020,None,,
2588,NCT04459312,ClinicalTrials.gov,3.07.2020,1.06.2020,TRUE,Heinrich-Heine,University,Recruiting,Not,Applicable,Observational,Germany,National,Covid-19,Surveillance,Physicians,NAT-COV-SURV,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,600,10.07.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04459312,No,Results,No,Results,No,Results,20.07.2020,None,,,
2590,NCT04459403,ClinicalTrials.gov,2.07.2020,8.06.2020,TRUE,Cairo,University,Recruiting,Not,Applicable,Observational,Egypt,Psychiatric,Disturbances,and,COVID-19,Infection,,Other,(psych),No,Intervention,No,Intervention,200,15.09.2020,15.09.2020,https://clinicaltrials.gov/show/NCT04459403,No,Results,No,Results,No,Results,20.07.2020,None,,,
2594,NCT04460599,ClinicalTrials.gov,6.07.2020,8.03.2020,TRUE,Centre,d'Investigation,Clinique,et,Technologique,805,Recruiting,Not,Applicable,Observational,France,Neurological,Features,During,COVID19,NeuroSARS,Clinical,Presentation,No,Intervention,No,Intervention,30,30.07.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04460599,No,Results,No,Results,No,Results,20.07.2020,None
2605,NCT04463823,ClinicalTrials.gov,3.07.2020,6.07.2020,FALSE,Oslo,University,Hospital,Not,Recruiting,Not,Applicable,Observational,Norway,"""""""NORPLASMA""""",Covid-19,Convalescent,Plasma,Treatment,Monitoring,"Study""",MONITOR,ATMP,Plasma,Plasma,500,31.05.2022,31.05.2025,https://clinicaltrials.gov/show/NCT04463823,No,Results,No,Results,No,Results,20.07.2020,None,,
2608,NCT04465058,ClinicalTrials.gov,8.07.2020,8.07.2020,FALSE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Characteristics,of,Critically,Ill,COVID,19,Patients,,Clinical,Presentation,No,Intervention,No,Intervention,50,8.08.2020,10.08.2020,https://clinicaltrials.gov/show/NCT04465058,No,Results,No,Results,No,Results,20.07.2020,None,
2610,NCT04465604,ClinicalTrials.gov,2.07.2020,1.07.2020,TRUE,King,Faisal,Specialist,Hospital,&,Research,Center,Recruiting,Not,Applicable,Interventional,Saudi,Arabia,Hypertonic,Saline,for,COVID-19,Symptoms,,Other,(device),Masks,+,Saline,Masks,,,,,,,,,
2646,NCT04312009,ClinicalTrials.gov,13.03.2020,13.04.2020,FALSE,University,of,Minnesota,Recruiting,Phase,2,Interventional,United,States,Losartan,for,Patients,With,COVID-19,Requiring,Hospitalization,,Drug,ARB,(Losartan),ARB,(Losartan),200,1.04.2021,1.04.2021,https://clinicaltrials.gov/show/NCT04312009,No,Results,No,Results,No,Results,27.07.2020,None
2651,NCT04336956,ClinicalTrials.gov,30.03.2020,7.04.2020,FALSE,Centre,Hospitalier,Intercommunal,Creteil,Recruiting,Not,Applicable,Observational,France,Covid-19,Pediatric,Observatory,PANDOR,Clinical,Presentation,No,Intervention,No,Intervention,250,30.06.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04336956,No,Results,No,Results,No,Results,27.07.2020,None,,,
2656,NCT04353206,ClinicalTrials.gov,16.04.2020,27.06.2020,FALSE,Noah,Merin,Recruiting,Phase,1,Interventional,United,States,Convalescent,Plasma,in,ICU,Patients,With,COVID-19-induced,Respiratory,Failure,,ATMP,Plasma,Plasma,60,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04353206,No,Results,No,Results,No,Results,27.07.2020,None,
2657,NCT04357028,ClinicalTrials.gov,19.04.2020,13.07.2020,FALSE,Kasr,El,Aini,Hospital,Recruiting,Phase,3,Interventional,Egypt,Measles,Vaccine,in,HCW,MV-COVID19,ATMP,Vaccine,Vaccine,200,1.10.2020,1.11.2020,https://clinicaltrials.gov/show/NCT04357028,No,Results,No,Results,No,Results,27.07.2020,None,,,,,
2658,NCT04358042,ClinicalTrials.gov,8.04.2020,24.04.2020,FALSE,Nantes,University,Hospital,Recruiting,Not,Applicable,Observational,France,PSYCHIATRIC,Disorders,and,Covid-19,PSYCHIC,Other,(psych),No,Intervention,No,Intervention,250,1.01.2022,1.01.2023,https://clinicaltrials.gov/show/NCT04358042,No,Results,No,Results,No,Results,27.07.2020,None,,,
2659,NCT04358380,ClinicalTrials.gov,18.04.2020,15.04.2020,TRUE,Austral,University,Recruiting,Not,Applicable,Observational,Argentina,Liver,Injury,in,Patients,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,320,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04358380,No,Results,No,Results,No,Results,27.07.2020,None,,
2663,NCT04368299,ClinicalTrials.gov,25.04.2020,1.05.2020,FALSE,Chinese,University,of,Hong,Kong,Recruiting,Not,Applicable,Interventional,Hong,Kong,Telemedicine,for,Follow-up,of,Systemic,Lupus,Erythematosus,,Telehealth,Telehealth,Telehealth,150,31.10.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04368299,No,Results,No,Results,No,Results,27.07.2020,None
2668,NCT04389333,ClinicalTrials.gov,9.05.2020,26.03.2020,TRUE,Changhai,Hospital,Not,Recruiting,Not,Applicable,Interventional,China,Feasibility,of,Non-contact,Magnetically-controlled,Capsule,Endoscopy,During,COVID-19,Pandemic,,Other,Other,Other,40,26.04.2020,20.05.2020,https://clinicaltrials.gov/show/NCT04389333,No,Results,No,Results,No,Results,27.07.2020,None,
2674,NCT04400799,ClinicalTrials.gov,15.05.2020,15.06.2020,FALSE,University,of,Zurich,Recruiting,Phase,3,Interventional,Switzerland,Enoxaparin,for,Primary,Thromboprophylaxis,in,Ambulatory,Patients,With,COVID-19,,Drug,Heparin,Heparin,1000,14.03.2021,14.04.2021,https://clinicaltrials.gov/show/NCT04400799,No,Results,No,Results,No,Results,27.07.2020,None,
2677,NCT04407299,ClinicalTrials.gov,23.05.2020,20.04.2020,TRUE,Cairo,University,Not,Recruiting,Not,Applicable,Observational,Egypt,COVID-19,Impact,on,Rheumatic,Patients,,Other,No,Intervention,No,Intervention,360,10.05.2020,20.05.2020,https://clinicaltrials.gov/show/NCT04407299,No,Results,No,Results,No,Results,27.07.2020,None,,,
2681,NCT04416048,ClinicalTrials.gov,2.06.2020,1.08.2020,FALSE,Charité,University,Not,Recruiting,Phase,3,Interventional,Germany,Effect,of,Anticoagulation,Therapy,on,Clinical,Outcomes,in,COVID-19,COVID-PREVENT,Drug,Rivaroxaban,Rivaroxaban,400,30.04.2021,30.05.2021,https://clinicaltrials.gov/show/NCT04416048,No,Results,No,Results,No,Results,27.07.2020,None,
2682,NCT04423692,ClinicalTrials.gov,7.06.2020,1.06.2020,TRUE,Aljazeera,Hospital,Recruiting,Not,Applicable,Observational,Egypt,Knowledge,About,Covid-19,Infection,in,Pregnant,Women,,Other,No,Intervention,No,Intervention,30,15.08.2020,20.08.2020,https://clinicaltrials.gov/show/NCT04423692,No,Results,No,Results,No,Results,27.07.2020,None,,
2686,NCT04429724,ClinicalTrials.gov,10.06.2020,6.07.2020,FALSE,Tourcoing,Hospital,Recruiting,Not,Applicable,Interventional,France,Health,Professional,Exposure,Assessment,to,Covid-19,SERODRON,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,6000,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04429724,No,Results,No,Results,No,Results,27.07.2020,None,
2687,NCT04441996,ClinicalTrials.gov,19.06.2020,17.07.2020,FALSE,Emory,University,Recruiting,Phase,4,Interventional,United,States,Therapeutic,Plasma,Exchange,for,COVID-19-associated,Hyperviscosity,,ATMP,Plasma,Plasma,20,20.10.2020,20.10.2020,https://clinicaltrials.gov/show/NCT04441996,No,Results,No,Results,No,Results,27.07.2020,None,,,,
2689,NCT04445428,ClinicalTrials.gov,22.06.2020,15.07.2020,FALSE,Bandim,Health,Project,Recruiting,Phase,4,Interventional,Guinea-Bissau,OPV,as,Potential,Protection,Against,COVID-19,,ATMP,Vaccine,Vaccine,3400,21.06.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04445428,No,Results,No,Results,No,Results,27.07.2020,None,,,,
2696,NCT04460703,ClinicalTrials.gov,2.07.2020,3.07.2020,FALSE,Yale,University,Not,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,Vaccine,Messaging,,Part,1,,Other,Other,Other,4000,8.07.2020,8.07.2020,https://clinicaltrials.gov/show/NCT04460703,No,Results,No,Results,No,Results,27.07.2020,None,,,
2697,NCT04463706,ClinicalTrials.gov,6.07.2020,1.06.2020,TRUE,Hospital,Galdakao-Usansolo,Recruiting,Not,Applicable,Observational,Spain,COVID19,Severity,Prediction,and,Health,Services,Research,Evaluation,,Prognosis,No,Intervention,No,Intervention,20000,30.06.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04463706,No,Results,No,Results,No,Results,27.07.2020,None,
2704,NCT04470531,ClinicalTrials.gov,11.07.2020,12.07.2020,FALSE,Bangabandhu,Sheikh,Mujib,Medical,University,Recruiting,Phase,2,Interventional,Bangladesh,Role,of,Co-trimoxazole,in,Severe,COVID-19,Patients,,Drug,Co-trimoxazole,Co-trimoxazole,94,12.10.2020,30.01.2021,https://clinicaltrials.gov/show/NCT04470531,No,Results,No,Results,No,Results,27.07.2020,None,
2721,NCT04473261,ClinicalTrials.gov,14.07.2020,14.07.2020,FALSE,Sohaib,Ashraf,Recruiting,Phase,1/Phase,2,Interventional,Pakistan,Efficacy,of,Iodine,Complex,Against,COVID-19,Patients,I-COVID-PK,Drug,Iodine,Complex,Iodine,Complex,30,15.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04473261,No,Results,No,Results,No,Results,27.07.2020,None,
2722,NCT04473547,ClinicalTrials.gov,14.07.2020,15.07.2020,FALSE,Mansoura,University,Recruiting,Not,Applicable,Observational,Egypt,COVID,19,Preventive,Measures,Among,Mansoura,Nursing,Students,,Other,No,Intervention,No,Intervention,215,30.08.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04473547,No,Results,No,Results,No,Results,27.07.2020,None,
2724,NCT04474249,ClinicalTrials.gov,29.06.2020,25.06.2020,TRUE,Uppsala,University,Recruiting,Not,Applicable,Observational,Sweden,Follow-up,of,Critical,COVID-19,Patients,FUP-COVID,Clinical,Presentation,No,Intervention,No,Intervention,300,22.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04474249,No,Results,No,Results,No,Results,27.07.2020,None,,,
2726,NCT04474340,ClinicalTrials.gov,15.07.2020,21.05.2020,TRUE,Ministry,of,Health,,Kuwait,Recruiting,Phase,1,Interventional,Kuwait,COVID-19,Convalescent,Plasma,Treatment,in,SARS-CoV-2,Infected,Patients,,ATMP,Plasma,Plasma,300,30.09.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04474340,No,Results,No,Results,No,Results,27.07.2020,None
2735,NCT04475588,ClinicalTrials.gov,16.07.2020,1.05.2020,TRUE,Biocon,Limited,Not,Recruiting,Phase,2,Interventional,India,Efficacy,and,Safety,of,Itolizumab,in,COVID-19,Complications,,Drug,Itolizumab,vs.,Hydroxychloroquine,Itolizumab,,,,,,,,,,,,
2736,NCT04475601,ClinicalTrials.gov,8.06.2020,15.07.2020,FALSE,Andreas,Josefsson,Recruiting,Phase,2,Interventional,Sweden,Enzalutamide,Treatment,in,COVID-19,COVIDENZA,Drug,Enzalutamide,Enzalutamide,500,8.07.2021,8.05.2022,https://clinicaltrials.gov/show/NCT04475601,No,Results,No,Results,No,Results,27.07.2020,None,,,,,,,
2742,NCT04476823,ClinicalTrials.gov,16.07.2020,15.03.2020,TRUE,CHU,de,Nice,Not,Recruiting,Not,Applicable,Observational,France,European,Pathology,Laboratories,and,COVID-19,,Health,System,No,Intervention,No,Intervention,71,31.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04476823,No,Results,No,Results,No,Results,27.07.2020,None,
2744,NCT04476940,ClinicalTrials.gov,13.07.2020,1.09.2020,FALSE,Meharry,Medical,College,Not,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,Breastfeeding,Guideline,for,African-Americans,COVID-BF,Other,Health,Education,Health,Education,200,21.10.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04476940,No,Results,No,Results,No,Results,27.07.2020,None,
2748,NCT04477993,ClinicalTrials.gov,13.07.2020,17.07.2020,FALSE,Vanderson,Geraldo,Rocha,Recruiting,Phase,2/Phase,3,Interventional,Brazil,Ruxolitinib,for,Acute,Respiratory,Disorder,Syndrome,Due,to,COVID-19,RUXO-COVID,Drug,Ruxolitinib,Ruxolitinib,200,17.02.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04477993,No,Results,No,Results,No,Results,27.07.2020,None
2768,EUCTR2020-002310-41-ES,EU,Clinical,Trials,Register,22.07.2020,15.06.2020,TRUE,IIS,Fundación,Jiménez,Díaz,Authorised,Phase,2,Interventional,Spain,“MADRID-COVID”,,Drug,Metoprolol,Metoprolol,20,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002310-41,No,Results,No,Results,No,Results,27.07.2020,None,,,
2770,EUCTR2020-002166-13-ES,EU,Clinical,Trials,Register,22.07.2020,9.07.2020,TRUE,Dr.,Ramn,Lleonart,Bellfill,,,,,,,,,,,,,,,,,,,,,,,,,,,
2771,EUCTR2020-002449-41-ES,EU,Clinical,Trials,Register,22.07.2020,15.06.2020,TRUE,Antonio,Antela,Lopez,Authorised,Phase,3,Interventional,Spain,Pilot,trial,on,early,treatment,with,hydroxychloroquine,in,patients,with,,,,,,,,,,,,,
"""",COVID-19,who,do,not,have,hospital,admission,at,"diagnosis.""""""",,Drug,Hydroxychloroquine,Hydroxychloroquine,340,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41,No,Results,No,Results,No,Results,27.07.2020,None,,,,,,,,,,,,
2786,NCT04354155,ClinicalTrials.gov,13.04.2020,2.06.2020,FALSE,Neil,Goldenberg,Recruiting,Phase,2,Interventional,United,States,COVID-19,Anticoagulation,in,Children,-,Thromboprophlaxis,(COVAC-TP),Trial,,Drug,Heparin,Heparin,38,22.09.2020,15.10.2022,https://clinicaltrials.gov/show/NCT04354155,No,Results,No,Results,No,Results,3.08.2020,None,,
2788,NCT04355637,ClinicalTrials.gov,15.04.2020,21.04.2020,TRUE,Sara,Varea,Recruiting,Phase,4,Interventional,Spain,Inhaled,Corticosteroid,Treatment,of,COVID19,Patients,With,Pneumonia,,Drug,Corticosteroids,Budesonide,300,31.08.2020,18.10.2020,https://clinicaltrials.gov/show/NCT04355637,No,Results,No,Results,No,Results,3.08.2020,EUCTR2020-001616-18,,,
2793,NCT04363333,ClinicalTrials.gov,19.04.2020,27.04.2020,FALSE,Koç,University,Not,Recruiting,Not,Applicable,Observational,Turkey,Obstructive,Sleep,Apnea,&,Covid-19,Outcomes,OSACOVID-19,Clinical,Presentation,No,Intervention,No,Intervention,320,30.11.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04363333,No,Results,No,Results,No,Results,3.08.2020,None,
2798,NCT04368234,ClinicalTrials.gov,27.04.2020,18.04.2020,TRUE,Duke,University,Recruiting,Not,Applicable,Observational,United,States,Duke,COVID-19,Shared,Data,and,Specimen,Repository,,Clinical,Presentation,No,Intervention,No,Intervention,100000,30.04.2025,30.04.2025,https://clinicaltrials.gov/show/NCT04368234,No,Results,No,Results,No,Results,3.08.2020,None
2806,NCT04386083,ClinicalTrials.gov,4.05.2020,10.06.2020,FALSE,University,of,the,Philippines,Recruiting,Not,Applicable,Observational,Philippines,Neurologic,Manifestations,of,COVID-19,CORONA,Clinical,Presentation,No,Intervention,No,Intervention,1342,20.12.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04386083,No,Results,No,Results,No,Results,3.08.2020,None,,
2809,NCT04392973,ClinicalTrials.gov,10.05.2020,21.05.2020,FALSE,King,Abdullah,International,Medical,Research,Center,Recruiting,Not,Applicable,Interventional,Saudi,Arabia,FAvipiravir,and,HydroxyChloroquine,Combination,Therapy,FACCT,Drug,Favipiravir,+,Hydroxychloroquine,Favipiravir,,,,,,,,,,,
2812,NCT04399733,ClinicalTrials.gov,21.05.2020,1.02.2021,FALSE,Future,Genetics,Limited,Not,Recruiting,Not,Applicable,Observational,United,Kingdom,EMPOWER,-,BAME,vs,COVID,,Genomics,No,Intervention,No,Intervention,12800,1.02.2023,1.02.2024,https://clinicaltrials.gov/show/NCT04399733,No,Results,No,Results,No,Results,3.08.2020,None,
2817,NCT04408040,ClinicalTrials.gov,15.05.2020,14.07.2020,FALSE,Northside,Hospital,,Inc.,Recruiting,Phase,2,Interventional,United,States,Use,of,Convalescent,Plasma,for,COVID-19,,ATMP,Plasma,Plasma,700,31.07.2022,31.07.2022,https://clinicaltrials.gov/show/NCT04408040,No,Results,No,Results,No,Results,3.08.2020,None,,
2820,NCT04409951,ClinicalTrials.gov,22.05.2020,1.11.2020,FALSE,Damanhour,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Pharmacy,Education,During,Covid-19,Outbreak,,Other,No,Intervention,No,Intervention,100,21.03.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04409951,No,Results,No,Results,No,Results,3.08.2020,None,,,
2821,NCT04416399,ClinicalTrials.gov,3.06.2020,16.07.2020,FALSE,University,of,Oxford,Recruiting,Phase,2,Interventional,United,Kingdom,STerOids,in,COVID-19,Study,STOIC,Drug,Corticosteroids,Budesonide,478,15.11.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04416399,No,Results,No,Results,No,Results,3.08.2020,None,,,,,
2823,NCT04423042,ClinicalTrials.gov,5.06.2020,30.07.2020,FALSE,University,of,Calgary,Not,Recruiting,Phase,3,Interventional,No,Country,Given,Tocilizumab,in,Coronavirus-19,Positive,Patients,,Drug,Tocilizumab,Tocilizumab,30,21.06.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04423042,No,Results,No,Results,No,Results,3.08.2020,None,,
2826,NCT04439084,ClinicalTrials.gov,17.06.2020,6.03.2020,TRUE,Stanford,University,Recruiting,Not,Applicable,Observational,United,States,COVID-19,in,Patients,With,Chronic,Liver,Diseases,COLD,Clinical,Presentation,No,Intervention,No,Intervention,1000,21.06.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04439084,No,Results,No,Results,No,Results,3.08.2020,None
2833,NCT04463862,ClinicalTrials.gov,8.07.2020,4.06.2020,TRUE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,,Belgium,COVID,-,AirPollution,,Clinical,Presentation,No,Intervention,No,Intervention,250,4.09.2020,4.09.2020,https://clinicaltrials.gov/show/NCT04463862,No,Results,No,Results,No,Results,3.08.2020,None,
2840,NCT04473898,ClinicalTrials.gov,14.07.2020,19.06.2020,TRUE,KTO,Karatay,University,Recruiting,Not,Applicable,Interventional,Turkey,Telerehabilitation,After,Coronavirus,,Other,(physio),Physio,&,Rehabilitation,Physio,&,Rehabilitation,36,19.10.2020,19.12.2020,https://clinicaltrials.gov/show/NCT04473898,No,Results,No,Results,No,Results,3.08.2020,None,,
2842,NCT04476888,ClinicalTrials.gov,16.07.2020,26.04.2020,TRUE,Aga,Khan,University,Recruiting,Not,Applicable,Interventional,Pakistan,Convalescent,Plasma,Treatment,in,COVID-19,COLLATE,ATMP,Plasma,Plasma,100,20.08.2020,20.09.2020,https://clinicaltrials.gov/show/NCT04476888,No,Results,No,Results,No,Results,3.08.2020,None,,,,,
2861,NCT04482595,ClinicalTrials.gov,17.07.2020,1.09.2020,FALSE,Humanetics,Corporation,Not,Recruiting,Phase,2,Interventional,United,States,BIO,300,Oral,Suspension,in,Discharged,COVID-19,Patients,,Drug,Genistein,Genistein,66,21.08.2020,22.05.2020,https://clinicaltrials.gov/show/NCT04482595,No,Results,No,Results,No,Results,3.08.2020,None,
2865,NCT04483635,ClinicalTrials.gov,29.06.2020,1.09.2020,FALSE,St.,Justine's,Hospital,Not,Recruiting,Phase,3,Interventional,Canada,Preventing,COVID-19,With,High-dose,Vitamin,D,Supplements,PROTECT,Drug,Vitamin,D,Vitamin,D,2414,1.04.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04483635,No,Results,No,Results,No,Results,3.08.2020,None
2868,NCT04483960,ClinicalTrials.gov,22.07.2020,21.07.2020,TRUE,University,of,Melbourne,Recruiting,Phase,3,Interventional,Australia,Australasian,COVID-19,Trial,(ASCOT),ASCOT,Drug,(+,ATMP),Lopinavir/ritonavir,vs.,Hydroxychloroquine,+,Lopinavir/ritonavir,vs.,Plasma,Hydroxychloroquine,,,,,,,,,,
2869,NCT04483973,ClinicalTrials.gov,13.07.2020,1.08.2020,FALSE,Sound,Pharmaceuticals,,Incorporated,Not,Recruiting,Phase,2,Interventional,No,Country,Given,SPI-1005,Treatment,in,Severe,COVID-19,Patients,,Drug,Ebselen,Ebselen,60,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04483973,No,Results,No,Results,No,Results,3.08.2020,None
2870,NCT04484025,ClinicalTrials.gov,13.07.2020,1.08.2020,FALSE,Sound,Pharmaceuticals,,Incorporated,Not,Recruiting,Phase,2,Interventional,No,Country,Given,SPI-1005,Treatment,in,Moderate,COVID-19,Patients,,Drug,Ebselen,Ebselen,60,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04484025,No,Results,No,Results,No,Results,3.08.2020,None
2872,NCT04484597,ClinicalTrials.gov,14.07.2020,15.03.2020,TRUE,Port,Said,University,Recruiting,Not,Applicable,Observational,Egypt,Predictors,of,COVID-19,Infection,and,Disease,Progression,Portsaiduni,Prognosis,No,Intervention,No,Intervention,100,15.08.2020,15.09.2020,https://clinicaltrials.gov/show/NCT04484597,No,Results,No,Results,No,Results,3.08.2020,None,
2873,NCT04485130,ClinicalTrials.gov,22.07.2020,1.09.2020,FALSE,University,of,California,,San,Francisco,Not,Recruiting,Phase,2,Interventional,United,States,DISulfiram,for,COvid-19,(DISCO),Trial,DISCO,Drug,Disulfiram,Disulfiram,60,30.11.2021,1.06.2022,https://clinicaltrials.gov/show/NCT04485130,No,Results,No,Results,No,Results,3.08.2020,None
2874,NCT04485338,ClinicalTrials.gov,23.07.2020,1.08.2020,FALSE,UMC,Amsterdam,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,Chest,Radiography,in,COVID?19,Patients,,Prognosis,No,Intervention,No,Intervention,200,31.12.2020,1.03.2021,https://clinicaltrials.gov/show/NCT04485338,No,Results,No,Results,No,Results,3.08.2020,None,
2885,NCT04487769,ClinicalTrials.gov,24.07.2020,1.06.2020,TRUE,UMC,Amsterdam,Recruiting,Not,Applicable,Observational,Netherlands,Lung,Ultrasound,in,COVID-19,Patients,LUS-COVID,Prognosis,No,Intervention,No,Intervention,30,20.08.2020,20.10.2020,https://clinicaltrials.gov/show/NCT04487769,No,Results,No,Results,No,Results,3.08.2020,None,,,,
2889,NCT04487964,ClinicalTrials.gov,24.07.2020,1.01.2020,TRUE,Egyptian,Biomedical,Research,Network,Recruiting,Not,Applicable,Interventional,Egypt,Complementary,Intervention,for,COVID-19,,Traditional,Medicine,(Drug),Traditional,Medicine,Traditional,Medicine,70,1.12.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04487964,No,Results,No,Results,No,Results,3.08.2020,None,
2905,EUCTR2020-002494-10-GB,EU,Clinical,Trials,Register,8.06.2020,17.07.2020,FALSE,Queen,Mary,University,of,London,Authorised,Phase,4,Interventional,United,Kingdom,PERSONAL-COVIDBP,,Drug,Amlodipine,Amlodipine,1000,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10,No,Results,No,Results,No,Results,3.08.2020,None,
2909,EUCTR2020-002091-12-BG,EU,Clinical,Trials,Register,5.05.2020,15.05.2020,FALSE,Huvepharma,EOOD,Authorised,Phase,2,Interventional,Bulgaria,Study,of,ivermectin,against,COVID-19,,Drug,Ivermectin,Ivermectin,120,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,No,Results,No,Results,No,Results,3.08.2020,None,
2913,NCT04333355,ClinicalTrials.gov,31.03.2020,8.05.2020,FALSE,Hospital,San,Jose,Tec,de,Monterrey,Recruiting,Phase,1,Interventional,Mexico,Safety,in,Convalescent,Plasma,Transfusion,to,COVID-19,,ATMP,Plasma,Plasma,20,20.12.2020,30.04.2021,https://clinicaltrials.gov/show/NCT04333355,No,Results,No,Results,No,Results,10.08.2020,None
2930,NCT04358406,ClinicalTrials.gov,16.04.2020,30.07.2020,FALSE,BioAegis,Therapeutics,Inc.,Recruiting,Phase,2,Interventional,Spain,Rhu-pGSN,for,Severe,Covid-19,Pneumonia,,ATMP,Plasma,Plasma,60,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04358406,No,Results,No,Results,No,Results,10.08.2020,None,,,,,
2933,NCT04361643,ClinicalTrials.gov,23.04.2020,27.10.2020,FALSE,Hospital,Universitario,Getafe,Not,Recruiting,Phase,4,Interventional,Spain,Low-dose,Lenalidomide,for,Non-severe,COVID-19,Treatment,Trial,GETAFE,Drug,Lenalidomide,Lenalidomide,120,31.08.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04361643,No,Results,No,Results,No,Results,10.08.2020,None,,
2937,NCT04368026,ClinicalTrials.gov,27.04.2020,30.03.2020,TRUE,Jagiellonian,University,Recruiting,Not,Applicable,Observational,Poland,SARS-CoV-2,(COVID-19),and,Surgery,,Health,System,No,Intervention,No,Intervention,350,1.12.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04368026,No,Results,No,Results,No,Results,10.08.2020,None,,,,
2942,NCT04380727,ClinicalTrials.gov,28.04.2020,20.03.2020,TRUE,CHU,de,Nancy,Not,Recruiting,Not,Applicable,Observational,France,Almitrine,and,COVID-19,Related,Hypoxemia,,Clinical,Presentation,No,Intervention,No,Intervention,17,14.04.2020,25.04.2020,https://clinicaltrials.gov/show/NCT04380727,No,Results,No,Results,No,Results,10.08.2020,None,
2945,NCT04384380,ClinicalTrials.gov,7.04.2020,1.04.2020,TRUE,Taoyuan,General,Hospital,Not,Recruiting,Not,Applicable,Interventional,Taiwan,Efficacy,and,Tolerability,of,Hydroxychloroquine,in,Adult,Patients,With,COVID-19,,Drug,Hydroxychloroquine,Hydroxychloroquine,33,31.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04384380,Pre-Print,Article,10.07.2020,https://doi.org/10.1101/2020.07.08.20148841,10.08.2020,None,
2947,NCT04385108,ClinicalTrials.gov,5.05.2020,4.03.2020,TRUE,University,Hospital,,Toulouse,Recruiting,Not,Applicable,Interventional,France,Predictive,Immune,Biomarkers,for,COVID-19,Pathogenesis,COVIDBioToul,Clinical,Presentation,No,Intervention,No,Intervention,170,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04385108,No,Results,No,Results,No,Results,10.08.2020,None
2956,NCT04403555,ClinicalTrials.gov,23.05.2020,1.06.2020,FALSE,Tanta,University,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Ivermectin,and,Doxycycine,in,COVID-19,Treatment,,Drug,Ivermectin,+,Doxycycine,vs.,Chloroquine,Ivermectin,,,,,,,,,,,,
2959,NCT04406090,ClinicalTrials.gov,26.05.2020,1.04.2020,TRUE,University,Hospital,,Montpellier,Not,Recruiting,Not,Applicable,Observational,France,Endovascular,Thrombectomy,in,COVID-19,Infected,Patients,ET-COVID-19,Procedure,Mechanical,Trombectomy,Mechanical,Trombectomy,50,30.06.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04406090,No,Results,No,Results,No,Results,10.08.2020,None
2962,NCT04409496,ClinicalTrials.gov,26.05.2020,2.06.2020,FALSE,University,of,Hong,Kong,Not,Recruiting,Not,Applicable,Interventional,Hong,Kong,Chat-based,Support,for,Preveting,Smoking,Relapse,,Other,Other,Other,108,31.03.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04409496,No,Results,No,Results,No,Results,10.08.2020,None,
2963,NCT04413045,ClinicalTrials.gov,1.06.2020,20.05.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Novel,COVID-19,,A,National,Analysis,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,61,28.07.2020,28.07.2020,https://clinicaltrials.gov/show/NCT04413045,No,Results,No,Results,No,Results,10.08.2020,None
2966,NCT04418947,ClinicalTrials.gov,29.05.2020,15.06.2020,FALSE,University,of,Pennsylvania,Not,Recruiting,Not,Applicable,Interventional,United,States,Project,Resurgence,Communication,Trial,,Other,Other,Other,11120,17.07.2020,17.07.2020,https://clinicaltrials.gov/show/NCT04418947,No,Results,No,Results,No,Results,10.08.2020,None,,,,
2968,NCT04422340,ClinicalTrials.gov,8.06.2020,1.04.2020,TRUE,Hospices,Civils,de,Lyon,Recruiting,Not,Applicable,Observational,France,Senior-COVID-Rea,Multicentric,Survey,SeniorCOVIDRea,Clinical,Presentation,No,Intervention,No,Intervention,185,15.08.2020,15.08.2020,https://clinicaltrials.gov/show/NCT04422340,No,Results,No,Results,No,Results,10.08.2020,None,,,
2975,NCT04446429,ClinicalTrials.gov,22.06.2020,2.07.2020,FALSE,Applied,Biology,,Inc.,Recruiting,Not,Applicable,Interventional,Brazil,Anti-Androgen,Treatment,for,COVID-19,,Drug,Ivermectin,+,Azythromycin,+,Dutasteride,vs.,Ivermectin,+,Azythromycin,Ivermectin,,,,,,,,,
2977,NCT04452669,ClinicalTrials.gov,29.06.2020,15.08.2020,FALSE,Aerogen,Pharma,Limited,Not,Recruiting,Phase,2,Interventional,United,States,VentaProst,in,Subjects,With,COVID-19,Requiring,Mechanical,Ventilation,VPCOVID,Drug,Epoprostenol,Epoprostenol,20,1.12.2020,1.02.2021,https://clinicaltrials.gov/show/NCT04452669,No,Results,No,Results,No,Results,10.08.2020,None
2980,NCT04456153,ClinicalTrials.gov,30.06.2020,22.07.2020,FALSE,University,of,Texas,Southwestern,Medical,Center,Recruiting,Phase,2,Interventional,United,States,Atovaquone,for,Treatment,of,COVID-19,,Drug,Atovaquone,Atovaquone,60,20.12.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04456153,No,Results,No,Results,No,Results,10.08.2020,None,
2981,NCT04460170,ClinicalTrials.gov,29.06.2020,1.07.2020,FALSE,University,Medical,Center,Groningen,Recruiting,Not,Applicable,Observational,Netherlands,COVID-19,Follow,up,Intensive,Care,Studies,COFICS,Clinical,Presentation,No,Intervention,No,Intervention,100,1.02.2022,1.02.2022,https://clinicaltrials.gov/show/NCT04460170,No,Results,No,Results,No,Results,10.08.2020,None
2985,NCT04472611,ClinicalTrials.gov,14.07.2020,1.08.2020,FALSE,Yale,University,Not,Recruiting,Phase,3,Interventional,United,States,Colchicine/Statins,for,the,Prevention,of,COVID-19,Complications,(COLSTAT),Trial,COLSTAT,Drug,Colchicine,+,Rosuvastatin,Colchicine,,,,,,,,,,
2987,NCT04477902,ClinicalTrials.gov,16.07.2020,1.07.2020,TRUE,Altura,Recruiting,Not,Applicable,Observational,United,States,Long-Term,Experience,and,Health,Effects,of,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,50000,1.07.2022,1.07.2022,https://clinicaltrials.gov/show/NCT04477902,No,Results,No,Results,No,Results,10.08.2020,None,
2997,NCT04490850,ClinicalTrials.gov,28.07.2020,15.07.2020,TRUE,Institut,Pasteur,Recruiting,Not,Applicable,Interventional,French,Guiana,COVID-19,Seroprevalence,Study,in,French,Guiana,EPI-COVID-POP,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1500,15.07.2021,15.07.2021,https://clinicaltrials.gov/show/NCT04490850,No,Results,No,Results,No,Results,10.08.2020,None
2998,NCT04491201,ClinicalTrials.gov,27.07.2020,27.07.2020,FALSE,Lei,Li,Recruiting,Not,Applicable,Observational,China,National,Survey,of,the,Impact,of,COVID-19,Pandemics,CMDA-SURVEY2,Other,No,Intervention,No,Intervention,6000,27.09.2020,27.09.2020,https://clinicaltrials.gov/show/NCT04491201,No,Results,No,Results,No,Results,10.08.2020,None,
3002,NCT04492189,ClinicalTrials.gov,19.04.2020,1.04.2020,TRUE,University,Hospital,,Montpellier,Not,Recruiting,Not,Applicable,Observational,France,Containment,Measures,and,Eating,Disorders,COVITA,Other,No,Intervention,No,Intervention,40,30.05.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04492189,No,Results,No,Results,No,Results,10.08.2020,None,
3013,NCT04492527,ClinicalTrials.gov,28.07.2020,28.07.2020,FALSE,University,of,British,Columbia,Recruiting,Not,Applicable,Interventional,Canada,Student-delivered,Telehealth,Program,for,COVID-19,Education,and,Health,Promotion,,Telehealth,Telehealth,Telehealth,75,30.06.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04492527,No,Results,No,Results,No,Results,10.08.2020,None
3015,NCT04492891,ClinicalTrials.gov,20.07.2020,20.08.2020,FALSE,Bryan,Burt,,MD,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Cyclosporine,For,The,Treatment,Of,Covid-19(+),,Drug,Cyclosporine,Cyclosporine,75,20.08.2025,20.08.2025,https://clinicaltrials.gov/show/NCT04492891,No,Results,No,Results,No,Results,10.08.2020,None
3018,NCT04493268,ClinicalTrials.gov,28.07.2020,7.03.2020,TRUE,Hospital,Nacional,Profesor,Alejandro,Posadas,Not,Recruiting,Not,Applicable,Observational,Argentina,HYPONATREMIA,IN,COVID-19,PATIENTS,,Clinical,Presentation,No,Intervention,No,Intervention,250,20.07.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04493268,No,Results,No,Results,No,Results,10.08.2020,None
3021,NCT04494399,ClinicalTrials.gov,28.07.2020,29.07.2020,FALSE,University,of,Hong,Kong,Recruiting,Phase,2,Interventional,Hong,Kong,IFN,Beta-1b,and,Ribavirin,for,Covid-19,,Drug,Interferon,beta,+,Ribavirin,Interferon,beta,,,,,,,,,,
3022,NCT04494724,ClinicalTrials.gov,21.07.2020,13.07.2020,TRUE,The,Methodist,Hospital,System,Recruiting,Phase,2,Interventional,United,States,Clazakizumab,vs.,Placebo,-,COVID-19,Infection,,Drug,Clazakizumab,Clazakizumab,60,31.12.2020,31.07.2021,https://clinicaltrials.gov/show/NCT04494724,No,Results,No,Results,No,Results,10.08.2020,None,,
3027,NCT04495816,ClinicalTrials.gov,30.07.2020,15.07.2020,TRUE,Icahn,School,of,Medicine,at,Mount,Sinai,Recruiting,Phase,2,Interventional,United,States,COVID-19,Anosmia,Study,,Drug,Omega,3,Omega,3,126,21.04.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04495816,No,Results,No,Results,No,Results,10.08.2020,None
3030,NCT04497441,ClinicalTrials.gov,1.08.2020,10.06.2020,TRUE,Qassim,University,Recruiting,Not,Applicable,Observational,Saudi,Arabia,Netizens',Perception,of,COVID-19,Information,&,Information,Sources.,,Other,No,Intervention,No,Intervention,385,10.08.2020,15.08.2020,https://clinicaltrials.gov/show/NCT04497441,No,Results,No,Results,No,Results,10.08.2020,None
3047,ISRCTN17896927,ISRCTN,27.07.2020,17.07.2020,TRUE,Yale,University,Not,Recruiting,Not,Applicable,Interventional,United,States,Encouraging,behavior,to,reduce,the,spread,of,COVID-19,,Other,Other,Other,3000,Not,Available,24.07.2020,http://isrctn.com/ISRCTN17896927,No,Results,No,Results,No,Results,10.08.2020,None
3055,JPRN-jRCTs051200036,JPRN,27.07.2020,27.07.2020,FALSE,Umemura,Yutaka,Recruiting,Phase,2,Interventional,Japan,Efficacy,,of,nintedanib,on,severe,COVID-19,pneumonia.,,Drug,Nintedanib,Nintedanib,30,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,No,Results,No,Results,No,Results,11.08.2020,None,
3057,JPRN-UMIN000040602,JPRN,1.06.2020,15.06.2020,FALSE,Federal,University,of,São,Carlos,Recruiting,Phase,2,Interventional,South,America,Homeopathy,for,Covid-19,in,primary,care,,Other,Homeopathy,Homeopathy,100,Not,Available,15.12.2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,No,Results,No,Results,No,Results,11.08.2020,None
3069,NCT04327401,ClinicalTrials.gov,26.03.2020,13.04.2020,FALSE,Hospital,Sírio-Libanês,Not,Recruiting,Phase,3,Interventional,Brazil,COVID-19-associated,ARDS,Treated,With,Dexamethasone:,Alliance,Covid-19,Brasil,III,CoDEX,Drug,Dexamethasone,Dexamethasone,299,22.07.2020,22.07.2020,https://clinicaltrials.gov/show/NCT04327401,Journal,Article,2.09.2020,https://doi.org/10.1001/jama.2020.17021,17.08.2020,None,,,
3073,NCT04353336,ClinicalTrials.gov,15.04.2020,23.03.2020,TRUE,Tanta,University,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Efficacay,of,Chloroquine,or,Hydroxychloroquine,in,COVID-19,Treatment,,Drug,Chloroquine,Chloroquine,200,23.09.2020,23.12.2020,https://clinicaltrials.gov/show/NCT04353336,No,Results,No,Results,No,Results,17.08.2020,None,,
3074,NCT04355936,ClinicalTrials.gov,17.04.2020,19.05.2020,FALSE,Laboratorio,Elea,Recruiting,Phase,4,Interventional,Argentina,Telmisartan,for,Treatment,of,COVID-19,Patients,,Drug,Telmisartan,Telmisartan,400,1.10.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04355936,Pre-Print,Article,11.08.2020,https://doi.org/10.1101/2020.08.04.20167205,17.08.2020,None,,,,,,,
3075,NCT04357613,ClinicalTrials.gov,20.04.2020,1.09.2020,FALSE,Versailles,Hospital,Not,Recruiting,Phase,2,Interventional,France,IMATINIB,IN,COVID-19,DISEASE,IN,AGED,PATIENTS.,IMAGE-19,Drug,Imatinib,Imatinib,99,1.12.2020,1.12.2021,https://clinicaltrials.gov/show/NCT04357613,No,Results,No,Results,No,Results,17.08.2020,None,,,
3080,NCT04368143,ClinicalTrials.gov,27.04.2020,1.04.2020,TRUE,Institute,of,Tropical,Medicine,Recruiting,Not,Applicable,Observational,Belgium,COVID-19,Immune,Repertoire,Sequencing,IMSEQ,Genomics,No,Intervention,No,Intervention,100,30.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04368143,No,Results,No,Results,No,Results,17.08.2020,None,,,
3087,NCT04391738,ClinicalTrials.gov,14.05.2020,1.02.2020,TRUE,University,Hospital,,Lille,Not,Recruiting,Not,Applicable,Observational,France,Association,Between,BMI,and,COVID-19,BMI-SARS-CoV-2,Clinical,Presentation,No,Intervention,No,Intervention,1200,15.05.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04391738,No,Results,No,Results,No,Results,17.08.2020,None
3089,NCT04395144,ClinicalTrials.gov,15.05.2020,15.05.2020,FALSE,Hôpital,de,Verdun,Recruiting,Not,Applicable,Interventional,Canada,COVid-19:,Awake,Proning,and,High-flow,Nasal,Cannula,in,respiratorY,DistrEss,COVAYDE,Procedure,Positioning,Positioning,346,30.10.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04395144,No,Results,No,Results,No,Results,17.08.2020,None
3093,NCT04400812,ClinicalTrials.gov,20.05.2020,19.05.2020,TRUE,Zagazig,University,Recruiting,Not,Applicable,Observational,Egypt,Attitude,and,Perception,Towards,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,5000,20.09.2020,20.10.2020,https://clinicaltrials.gov/show/NCT04400812,No,Results,No,Results,No,Results,17.08.2020,None,,,
3095,NCT04404218,ClinicalTrials.gov,24.05.2020,4.08.2020,FALSE,University,Health,Network,,Toronto,Recruiting,Phase,2,Interventional,Canada,The,Açaí,Berry,COVID-19,Anti-Inflammation,Trial,ACAI,Supplement,Acai,Berry,Acai,Berry,480,21.03.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04404218,No,Results,No,Results,No,Results,17.08.2020,None
3106,NCT04459390,ClinicalTrials.gov,5.07.2020,20.07.2020,FALSE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Association,of,Comorbidities,With,COVID19,,Clinical,Presentation,No,Intervention,No,Intervention,100,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04459390,No,Results,No,Results,No,Results,17.08.2020,None,,,
3109,NCT04470323,ClinicalTrials.gov,12.07.2020,22.07.2020,FALSE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Functional,Exhaustion,of,T,Cells,in,COVID19,Patients,,Clinical,Presentation,No,Intervention,No,Intervention,100,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04470323,No,Results,No,Results,No,Results,17.08.2020,None
3113,NCT04487691,ClinicalTrials.gov,23.07.2020,3.08.2020,FALSE,Regenexx,,LLC,Not,Recruiting,Not,Applicable,Interventional,United,States,Nebulized,PL,for,Post-COVID-19,Syndrome,,Drug,Platelet,Lysate,Platelet,Lysate,40,1.06.2021,30.12.2021,https://clinicaltrials.gov/show/NCT04487691,No,Results,No,Results,No,Results,17.08.2020,None,
3115,NCT04497194,ClinicalTrials.gov,18.05.2020,1.03.2020,TRUE,AOUI,Verona,Recruiting,Not,Applicable,Observational,Italy,Registry,of,COVID-19,Patients,at,AOUI,Verona,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,500,30.08.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04497194,No,Results,No,Results,No,Results,17.08.2020,None
3118,NCT04497311,ClinicalTrials.gov,31.07.2020,15.06.2020,TRUE,Universidad,de,Guanajuato,Recruiting,Not,Applicable,Observational,Mexico,Tomographic,Findings,in,COVID-19,and,Influenza,TOMOCOVIDMX,Clinical,Presentation,No,Intervention,No,Intervention,100,30.04.2021,30.04.2022,https://clinicaltrials.gov/show/NCT04497311,No,Results,No,Results,No,Results,17.08.2020,None,
3119,NCT04497922,ClinicalTrials.gov,30.07.2020,20.08.2020,FALSE,Brigham,and,Women's,Hospital,Not,Recruiting,Not,Applicable,Interventional,United,States,Virtual,White,Boards,for,Patient,Satisfaction,,Other,Other,Other,100,15.04.2021,17.04.2021,https://clinicaltrials.gov/show/NCT04497922,No,Results,No,Results,No,Results,17.08.2020,None,
3120,NCT04498065,ClinicalTrials.gov,3.08.2020,1.03.2020,TRUE,CHU,Dijon,Not,Recruiting,Not,Applicable,Observational,France,MYocardial,DOmmages,Related,to,COVID-19,DOMY,COVID,Clinical,Presentation,No,Intervention,No,Intervention,200,1.07.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04498065,No,Results,No,Results,No,Results,17.08.2020,None,
3123,NCT04498546,ClinicalTrials.gov,27.07.2020,20.07.2020,TRUE,KTO,Karatay,University,Recruiting,Not,Applicable,Observational,Turkey,Mask,Usage,and,Exercise,During,the,COVID-19,Pandemic,,Other,(exercise),Exercise,Exercise,60,30.08.2020,30.09.2021,https://clinicaltrials.gov/show/NCT04498546,No,Results,No,Results,No,Results,17.08.2020,None,
3124,NCT04498936,ClinicalTrials.gov,14.04.2020,15.07.2020,FALSE,Assiut,University,Recruiting,Phase,4,Interventional,Egypt,Sofosbuvir/Ledipasvir,and,Nitazoxanide,for,Treatment,of,COVID-19,,Drug,Sofosbuvir,+,Ledipasvir,vs.,Nitazoxanide,Sofosbuvir,,,,,,,,,,,,
3130,NCT04500639,ClinicalTrials.gov,4.08.2020,23.07.2020,TRUE,University,of,Alberta,Recruiting,Not,Applicable,Observational,Canada,Over-the-counter,Medications,&,COVID-19,OTC?&COVID19,Drug,Other,Other,14000,Not,Available,Not,Available,https://clinicaltrials.gov/show/NCT04500639,No,Results,No,Results,No,Results,17.08.2020,None,,,,
3134,NCT04501796,ClinicalTrials.gov,27.07.2020,1.08.2020,FALSE,NeoImmuneTech,Recruiting,Phase,1,Interventional,United,States,A,Trial,of,NT-I7,in,COVID-19,(SPESELPIS),,Drug,NT-I7,NT-I7,30,21.10.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04501796,No,Results,No,Results,No,Results,17.08.2020,None,,,,
3139,NCT04502108,ClinicalTrials.gov,5.08.2020,1.04.2020,TRUE,Slavko,Rogan,Recruiting,Not,Applicable,Observational,Switzerland,Behavior,During,and,After,COVID-19,Crisis,,Other,No,Intervention,No,Intervention,1000,31.12.2022,31.12.2022,https://clinicaltrials.gov/show/NCT04502108,No,Results,No,Results,No,Results,17.08.2020,None,,,
3146,NCT04503525,ClinicalTrials.gov,4.08.2020,25.05.2020,TRUE,Lille,Catholic,University,Recruiting,Not,Applicable,Observational,France,Nutritional,Assessment,of,Hospitalized,Patients,With,COVID-19,DenutCOVID,Other,(nutrition),No,Intervention,No,Intervention,50,25.05.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04503525,No,Results,No,Results,No,Results,17.08.2020,None
3147,NCT04504240,ClinicalTrials.gov,6.08.2020,1.08.2020,TRUE,Chattogram,General,Hospital,Recruiting,Phase,3,Interventional,Bangladesh,Role,of,Famotidine,in,the,Symptomatic,Improvement,of,COVID-19,Patients,,Drug,Famotidine,Famotidine,200,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04504240,No,Results,No,Results,No,Results,17.08.2020,None
3156,ACTRN12620000795998,ANZCTR,7.08.2020,31.05.2020,TRUE,Monash,University,Not,Recruiting,Not,Applicable,Interventional,Bangladesh,COVID-19,Health,and,wellbeing,Trial,in,Bangladesh,,Other,(psych),Psychological,Psychological,2402,Not,Available,15.06.2020,https://anzctr.org.au/ACTRN12620000795998.aspx,No,Results,No,Results,No,Results,17.08.2020,None,
3166,ISRCTN58667920,ISRCTN,4.08.2020,1.08.2020,TRUE,University,of,Leeds,Recruiting,Not,Applicable,Observational,United,Kingdom,COVID-19,effects,on,the,heart,,Clinical,Presentation,No,Intervention,No,Intervention,370,Not,Available,31.07.2022,http://isrctn.com/ISRCTN58667920,No,Results,No,Results,No,Results,17.08.2020,None
3167,ISRCTN17782018,ISRCTN,31.07.2020,5.08.2020,FALSE,Cardiff,University,Recruiting,Not,Applicable,Observational,United,Kingdom,COVID-19,cancer,attitudes,and,behaviour,study,,Other,No,Intervention,No,Intervention,3535,Not,Available,29.12.2021,http://isrctn.com/ISRCTN17782018,No,Results,No,Results,No,Results,17.08.2020,None,
3192,IRCT20190602043787N3,IRCT,20.07.2020,22.07.2020,FALSE,Mashhad,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Ivermectin,effect,in,the,treatment,of,patients,with,covid-19,,Drug,Ivermectin,vs.,Hydroxychloroquine,Ivermectin,,,,,,,,,
3206,IRCT20200506047323N4,IRCT,1.08.2020,10.08.2020,FALSE,Bandare-abbas,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,Desferal,in,COVID-19,,Drug,Deferoxamine,vs.,Hydroxychloroquine,Deferoxamine,,,,,,,,,,,,,,
3207,IRCT20200723048178N1,IRCT,28.07.2020,28.07.2020,FALSE,Shaheed,Zulfiqar,Ali,Bhutto,Medical,University,Recruiting,Not,Applicable,Interventional,Pakistan,nimesulide,in,COVID-19,infection,,Drug,Nimesulide,Nimesulide,60,Not,Available,Not,Available,http://en.irct.ir/trial/49901,No,Results,No,Results,No,Results,17.08.2020,None,
3221,NCT04332380,ClinicalTrials.gov,30.03.2020,1.05.2020,FALSE,Del,Rosario,University,Not,Recruiting,Phase,2,Interventional,Colombia,Convalescent,Plasma,for,Patients,With,COVID-19:,A,Pilot,Study,CP-COVID-19,ATMP,Plasma,Plasma,10,28.07.2020,28.07.2020,https://clinicaltrials.gov/show/NCT04332380,No,Results,No,Results,No,Results,24.08.2020,None
3228,NCT04355728,ClinicalTrials.gov,13.04.2020,25.04.2020,FALSE,Camillo,Ricordi,Not,Recruiting,Phase,1/Phase,2,Interventional,United,States,Use,of,UC-MSCs,for,COVID-19,Patients,,ATMP,Cells,(mesenchymal),Cells,(mesenchymal),24,31.10.2020,31.10.2020,https://clinicaltrials.gov/show/NCT04355728,No,Results,No,Results,No,Results,24.08.2020,None
3233,NCT04378803,ClinicalTrials.gov,4.05.2020,13.05.2020,FALSE,University,of,Miami,Not,Recruiting,Not,Applicable,Interventional,United,States,Mindfulness,Training,for,Seniors,,Other,(psych),Psychological,Psychological,53,4.08.2020,4.08.2020,https://clinicaltrials.gov/show/NCT04378803,No,Results,No,Results,No,Results,24.08.2020,None,,,
3239,NCT04394208,ClinicalTrials.gov,15.05.2020,16.08.2020,FALSE,Cairo,University,Recruiting,Phase,3,Interventional,Egypt,Silymarin,in,COVID-19,Pneumonia,SCOPE,Drug,Silymarin,Silymarin,50,30.01.2021,28.02.2021,https://clinicaltrials.gov/show/NCT04394208,No,Results,No,Results,No,Results,24.08.2020,None,,,,,,,
3240,NCT04397510,ClinicalTrials.gov,19.05.2020,1.06.2020,FALSE,Frederick,Health,Recruiting,Phase,4,Interventional,United,States,Nebulized,Heparin,for,the,Treatment,of,COVID-19,Induced,Lung,Injury,,Drug,Heparin,Heparin,50,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04397510,No,Results,No,Results,No,Results,24.08.2020,None
3242,NCT04401150,ClinicalTrials.gov,21.05.2020,14.08.2020,FALSE,University,of,Sherbrooke,Recruiting,Phase,3,Interventional,Canada,Lessening,Organ,Dysfunction,With,VITamin,C,-,COVID-19,LOVIT-COVID,Drug,Vitamin,C,Vitamin,C,800,21.11.2020,22.01.2020,https://clinicaltrials.gov/show/NCT04401150,No,Results,No,Results,No,Results,24.08.2020,None
3256,NCT04445467,ClinicalTrials.gov,22.06.2020,1.08.2020,FALSE,Bayside,Health,Recruiting,Phase,2,Interventional,Australia,An,Adaptive,Clinical,Trial,of,Antivirals,for,COVID-19,Infection,VIRCO,Drug,Favipiravir,Favipiravir,190,20.11.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04445467,No,Results,No,Results,No,Results,24.08.2020,None,,
3257,NCT04447534,ClinicalTrials.gov,23.06.2020,23.06.2020,FALSE,Tanta,University,Recruiting,Phase,3,Interventional,Egypt,Zinc,With,Chloroquine/Hydroxychloroquine,in,Treatment,of,COVID-19,,Drug,Chloroquine,+,Zinc,vs.,Chloroquine,Chloroquine,,,,,,,,,,,,
3260,NCT04460027,ClinicalTrials.gov,1.07.2020,22.06.2020,TRUE,Athena,Robinson,Recruiting,Phase,1,Interventional,United,States,W-SUDs,for,COVID-19,,Other,(psych),Psychological,Psychological,160,31.08.2020,31.08.2020,https://clinicaltrials.gov/show/NCT04460027,No,Results,No,Results,No,Results,24.08.2020,None,,,,,,
3262,NCT04463602,ClinicalTrials.gov,7.07.2020,25.07.2020,FALSE,Cadila,Healthcare,Ltd,Recruiting,Phase,2,Interventional,Mexico,Desidustat,in,the,Management,of,COVID-19,Patients,,Drug,Desidustat,Desidustat,24,15.12.2020,30.01.2021,https://clinicaltrials.gov/show/NCT04463602,No,Results,No,Results,No,Results,24.08.2020,None,,,
3266,NCT04474067,ClinicalTrials.gov,15.07.2020,28.06.2020,TRUE,Hadassah,Medical,Organization,Recruiting,Not,Applicable,Observational,Israel,COVID-19,-,Cytokine,Storm,,Clinical,Presentation,No,Intervention,No,Intervention,300,1.12.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04474067,No,Results,No,Results,No,Results,24.08.2020,None,,,
3268,NCT04480138,ClinicalTrials.gov,20.07.2020,11.08.2020,FALSE,Cadila,Healthcare,Ltd,Recruiting,Phase,2,Interventional,Mexico,Pegylated,Interferon,-,a2b,With,SARSCoV-,2,(COVID-19),,Drug,Interferon,alpha,Interferon,alpha,40,15.12.2020,30.01.2021,https://clinicaltrials.gov/show/NCT04480138,No,Results,No,Results,No,Results,24.08.2020,None
3275,NCT04507282,ClinicalTrials.gov,7.08.2020,15.05.2020,TRUE,Bursa,Postgraduate,Hospital,Not,Recruiting,Not,Applicable,Observational,Turkey,Eosinophil,and,Anticoagulation,in,COVID-19,Patients,,Drug,Heparin,Heparin,80,1.07.2020,15.07.2020,https://clinicaltrials.gov/show/NCT04507282,No,Results,No,Results,No,Results,24.08.2020,None,,,
3278,NCT04508959,ClinicalTrials.gov,10.08.2020,15.04.2020,TRUE,McMaster,University,Recruiting,Not,Applicable,Observational,Canada,The,McMaster,Multi-Regional,COVID-19,Hospital,Case,Registry,COREG,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1500,21.07.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04508959,No,Results,No,Results,No,Results,24.08.2020,None
3279,NCT04509752,ClinicalTrials.gov,11.08.2020,20.08.2020,FALSE,Hacettepe,University,Not,Recruiting,Not,Applicable,Observational,Turkey,Dysphagia,Management,During,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,50,15.11.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04509752,No,Results,No,Results,No,Results,24.08.2020,None,,,
3280,NCT04509986,ClinicalTrials.gov,11.08.2020,1.10.2020,FALSE,University,of,Birmingham,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,GlobalSurg-CovidSurg,Week,,Health,System,No,Intervention,No,Intervention,1000,31.10.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04509986,No,Results,No,Results,No,Results,24.08.2020,None,,
3282,NCT04510025,ClinicalTrials.gov,14.07.2020,13.05.2020,TRUE,University,of,Oxford,Recruiting,Not,Applicable,Observational,United,Kingdom,Capturing,MultiORgan,Effects,of,COVID-19,C-MORE,Clinical,Presentation,No,Intervention,No,Intervention,616,1.05.2023,1.05.2023,https://clinicaltrials.gov/show/NCT04510025,No,Results,No,Results,No,Results,24.08.2020,None,
3284,NCT04510233,ClinicalTrials.gov,10.08.2020,1.09.2020,FALSE,Tanta,University,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Ivermectin,Nasal,Spray,for,COVID19,Patients,,Drug,Ivermectin,Ivermectin,60,20.10.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04510233,No,Results,No,Results,No,Results,24.08.2020,None,,
3291,NCT04510662,ClinicalTrials.gov,11.08.2020,1.08.2020,TRUE,Abraham,Edgar,Gracia-Ramos,Recruiting,Phase,2,Interventional,Mexico,Telmisartan,in,Respiratory,Failure,Due,to,COVID-19,STAR-COVID,Drug,Telmisartan,Telmisartan,60,21.03.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04510662,No,Results,No,Results,No,Results,24.08.2020,None,,,
3292,NCT04511429,ClinicalTrials.gov,24.07.2020,30.06.2020,TRUE,D'Or,Institute,for,Research,and,Education,Recruiting,Not,Applicable,Observational,Brazil,COVID-19,in,Immunosuppressed,Children,,Clinical,Presentation,No,Intervention,No,Intervention,200,20.10.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04511429,No,Results,No,Results,No,Results,24.08.2020,None
3302,NCT04514016,ClinicalTrials.gov,13.08.2020,12.08.2020,TRUE,University,of,Miami,Recruiting,Not,Applicable,Observational,United,States,Cross,Sectional,CFAR,HIV/COVID,Study,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,100,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04514016,No,Results,No,Results,No,Results,24.08.2020,None
3304,NCT04514705,ClinicalTrials.gov,11.08.2020,11.08.2020,FALSE,Universidade,Metodista,de,Piracicaba,Recruiting,Not,Applicable,Interventional,Brazil,Characteristics,in,Post,Covid-19,Patients,,Clinical,Presentation,No,Intervention,No,Intervention,20,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04514705,No,Results,No,Results,No,Results,24.08.2020,None,
3306,NCT04515199,ClinicalTrials.gov,7.08.2020,1.07.2020,TRUE,Cairo,University,Recruiting,Not,Applicable,Observational,Egypt,Home,Management,of,Adult,Egyptian,Mild,COVID-19,Cases,COVID-19,Telehealth,Telehealth,Telehealth,400,21.01.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04515199,No,Results,No,Results,No,Results,24.08.2020,None,,,
3310,NCT04518514,ClinicalTrials.gov,28.07.2020,20.04.2020,TRUE,RWTH,Aachen,University,Recruiting,Not,Applicable,Interventional,Germany,Telemedical,Risk,Assessment,and,Preoperative,Evaluation,(TAPE),,Telehealth,Telehealth,Telehealth,100,31.10.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04518514,No,Results,No,Results,No,Results,24.08.2020,None,,,
3314,ISRCTN40302986,ISRCTN,26.05.2020,22.06.2020,FALSE,Lagos,University,Teaching,Hospital,Recruiting,Phase,3,Interventional,Nigeria,Does,ivermectin,cure,and/or,prevent,COVID-19?,,Drug,(+,Chemoprophylaxis),Ivermectin,Ivermectin,45,Not,Available,6.10.2020,http://isrctn.com/ISRCTN40302986,No,Results,No,Results,No,Results,24.08.2020,None
3323,NCT04342169,ClinicalTrials.gov,7.04.2020,4.04.2020,TRUE,University,of,Utah,Recruiting,Phase,2,Interventional,United,States,University,of,Utah,COVID-19,Hydrochloroquine,Trial,,Drug,Hydroxychloroquine,Hydroxychloroquine,400,21.04.2020,22.04.2020,https://clinicaltrials.gov/show/NCT04342169,No,Results,No,Results,No,Results,31.08.2020,None,,,
3331,NCT04353271,ClinicalTrials.gov,25.03.2020,17.04.2020,FALSE,University,of,South,Alabama,Not,Recruiting,Phase,2/Phase,3,Interventional,United,States,Trial,of,Hydroxychloroquine,In,Covid-19,Kinetics,THICK,Drug,Hydroxychloroquine,Hydroxychloroquine,58,8.07.2020,8.07.2020,https://clinicaltrials.gov/show/NCT04353271,No,Results,No,Results,No,Results,31.08.2020,None
3334,NCT04356937,ClinicalTrials.gov,19.04.2020,20.04.2020,FALSE,Massachusetts,General,Hospital,Not,Recruiting,Phase,3,Interventional,United,States,Efficacy,of,Tocilizumab,on,Patients,With,COVID-19,,Drug,Tocilizumab,Tocilizumab,243,1.10.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04356937,No,Results,No,Results,No,Results,31.08.2020,None,
3346,NCT04400279,ClinicalTrials.gov,21.05.2020,1.06.2020,FALSE,University,of,British,Columbia,Not,Recruiting,Not,Applicable,Interventional,Canada,The,COVID-19,Pandemic,and,Exercise,Study,COPE,Other,(exercise),Exercise,Exercise,334,20.09.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04400279,No,Results,No,Results,No,Results,31.08.2020,None,
3347,NCT04401423,ClinicalTrials.gov,21.05.2020,1.08.2020,FALSE,Columbia,University,Recruiting,Phase,2,Interventional,United,States,TXA127,for,the,Treatment,of,Severe,COVID-19,,Drug,TXA127,TXA127,100,21.06.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04401423,No,Results,No,Results,No,Results,31.08.2020,None,,,
3354,NCT04422561,ClinicalTrials.gov,6.06.2020,31.05.2020,TRUE,Zagazig,University,Not,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Prophylactic,Ivermectin,in,COVID-19,Contacts,,Drug,(Chemoprophylaxis),Ivermectin,Ivermectin,340,14.07.2020,27.07.2020,https://clinicaltrials.gov/show/NCT04422561,Registry,Results,27.08.2020,https://clinicaltrials.gov/ct2/show/results/NCT04422561,31.08.2020,None,,,,,
3357,NCT04432272,ClinicalTrials.gov,12.06.2020,16.07.2020,FALSE,William,Beaumont,Hospitals,Recruiting,Phase,2,Interventional,United,States,ANTIBODY-LEVEL,BASED,ANALYSIS,OF,COVID-19,CONVALESCENT,SERUM,(ABACCuS),ABACCuS,ATMP,Plasma,Plasma,500,21.06.2020,21.08.2020,https://clinicaltrials.gov/show/NCT04432272,No,Results,No,Results,No,Results,31.08.2020,None,
3360,NCT04439006,ClinicalTrials.gov,17.06.2020,22.07.2020,FALSE,Jennifer,Woyach,Recruiting,Phase,2,Interventional,United,States,Ibrutinib,for,the,Treatment,of,COVID-19,in,Patients,Requiring,Hospitalization,,Drug,Ibrutinib,Ibrutinib,72,31.12.2021,31.12.2022,https://clinicaltrials.gov/show/NCT04439006,No,Results,No,Results,No,Results,31.08.2020,None
3362,NCT04443673,ClinicalTrials.gov,18.06.2020,20.08.2020,FALSE,Instituto,Nacional,de,Enfermedades,Respiratorias,Recruiting,Not,Applicable,Interventional,Mexico,Glycine,Supplement,for,Severe,COVID-19,,Supplement,Glycine,Glycine,82,28.02.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04443673,No,Results,No,Results,No,Results,31.08.2020,None,,,
3369,NCT04463472,ClinicalTrials.gov,8.07.2020,29.06.2020,TRUE,AnGes,,Inc.,Not,Recruiting,Phase,1/Phase,2,Interventional,Japan,Study,of,COVID-19,DNA,Vaccine,(AG0301-COVID19),,ATMP,Vaccine,Vaccine,30,28.09.2020,31.07.2021,https://clinicaltrials.gov/show/NCT04463472,No,Results,No,Results,No,Results,31.08.2020,None,,
3370,NCT04473053,ClinicalTrials.gov,9.07.2020,3.07.2020,TRUE,University,of,Edinburgh,Recruiting,Phase,2/Phase,3,Interventional,United,Kingdom,Rapid,Experimental,Medicine,for,COVID-19,DEFINE,Drug,Nafamostat,Mesilate,vs.,TD139,Nafamostat,Mesilate,,,,,,,,,,,
3371,NCT04473053,ClinicalTrials.gov,9.07.2020,3.07.2020,TRUE,University,of,Edinburgh,Recruiting,Phase,2/Phase,3,Interventional,United,Kingdom,Rapid,Experimental,Medicine,for,COVID-19,DEFINE,Drug,Nafamostat,Mesilate,vs.,TD139,Nafamostat,Mesilate,,,,,,,,,,,
3376,NCT04491994,ClinicalTrials.gov,28.07.2020,10.04.2020,TRUE,UNICEF,Not,Recruiting,Phase,3,Interventional,Pakistan,Clearing,the,Fog:,Is,Hydroxychloroquine,Effective,in,Reducing,COVID-19,Progression,COVID-19,Other,Hydroxychloroquine,Hydroxychloroquine,540,31.05.2020,31.05.2020,https://clinicaltrials.gov/show/NCT04491994,Pre-Print,Article,8.04.2020,https://doi.org/10.1101/2020.07.30.20165365,31.08.2020,None,,,
3377,NCT04499313,ClinicalTrials.gov,27.07.2020,2.08.2020,FALSE,Chattogram,General,Hospital,Recruiting,Phase,3,Interventional,Bangladesh,Dexamethasone,Vs,Methylprednisolone,for,the,Treatment,of,Patients,With,ARDS,Caused,by,COVID-19,,Drug,Corticosteroids,Dexamethasone,,,,,,,,,
3379,NCT04508075,ClinicalTrials.gov,7.08.2020,10.08.2020,FALSE,PT,Bio,Farma,Recruiting,Phase,3,Interventional,Indonesia,Efficacy,,Safety,and,Immunogenicity,Study,of,SARS-CoV-2,Inactivated,Vaccine,COVID-19,ATMP,Vaccine,Vaccine,1620,21.01.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04508075,No,Results,No,Results,No,Results,31.08.2020,None
3381,NCT04508985,ClinicalTrials.gov,10.08.2020,1.09.2020,FALSE,McGill,University,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,The,McGill,RAAS-COVID-19,Trial,RAAS-COVID,Drug,RAAS,inhibitor,RAAS,inhibitor,40,1.01.2021,1.09.2021,https://clinicaltrials.gov/show/NCT04508985,No,Results,No,Results,No,Results,31.08.2020,None,,
3395,NCT04519216,ClinicalTrials.gov,12.08.2020,31.07.2020,TRUE,University,of,California,,Davis,Recruiting,Not,Applicable,Interventional,United,States,Breastfeeding,Education,in,the,Time,of,COVID-19,,Other,Other,Other,39,30.06.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04519216,No,Results,No,Results,No,Results,31.08.2020,None
3399,NCT04519385,ClinicalTrials.gov,17.08.2020,1.03.2020,TRUE,South,Valley,University,Not,Recruiting,Not,Applicable,Interventional,Egypt,Toclizumam,Versus,Dexamethasone,in,Severe,Covid-19,Cases,,Drug,Tocilizumab,vs.,Dexamethasone,Tocilizumab,,,,,,,,,,,,
3427,NCT04526717,ClinicalTrials.gov,30.07.2020,1.12.2020,FALSE,Joseah,Bio,Not,Recruiting,Phase,1,Interventional,No,Country,Given,Heat,Shock,Protein,Inhibitor-,MPT0B640,for,COVID-19,Infection,,Drug,MPT0B640,MPT0B640,15,21.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04526717,No,Results,No,Results,No,Results,31.08.2020,None
3431,ACTRN12620000843954,ANZCTR,26.08.2020,1.09.2020,FALSE,Peter,MacCallum,Cancer,Centre,Not,Recruiting,Phase,3,Interventional,Australia,C-SMART.,,,,,,,,,,,,,,,,,,,,,,,
3432,ACTRN12620000842965,ANZCTR,26.08.2020,1.09.2020,FALSE,Peter,MacCallum,Cancer,Centre,Not,Recruiting,Phase,3,Interventional,Australia,C-SMART.,,,,,,,,,,,,,,,,,,,,,,,
COVID-19,Prevention,and,Treatment,in,Cancer.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3433,ACTRN12620000841976,ANZCTR,26.08.2020,1.09.2020,FALSE,Peter,MacCallum,Cancer,Centre,Not,Recruiting,Phase,3,Interventional,Australia,C-SMART.,,,,,,,,,,,,,,,,,,,,,,,
COVID-19,Prevention,and,Treatment,in,Cancer.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3434,ACTRN12620000844943,ANZCTR,26.08.2020,1.09.2020,FALSE,Peter,MacCallum,Cancer,Centre,Not,Recruiting,Phase,3,Interventional,Australia,C-SMART.,,,,,,,,,,,,,,,,,,,,,,,
COVID-19,Prevention,and,Treatment,in,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3443,NCT04334148,ClinicalTrials.gov,2.04.2020,22.04.2020,FALSE,Adrian,Hernandez,Recruiting,Phase,3,Interventional,United,States,Healthcare,Worker,Exposure,Response,and,Outcomes,of,Hydroxychloroquine,HERO-HCQ,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,20.12.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04334148,No,Results,No,Results,No,Results,7.09.2020,None,
3452,NCT04362176,ClinicalTrials.gov,21.04.2020,24.04.2020,FALSE,Vanderbilt,University,Recruiting,Phase,3,Interventional,United,States,Passive,Immunity,Trial,Of,the,Nation,for,COVID-19,PassItOnII,ATMP,Plasma,Plasma,500,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04362176,No,Results,No,Results,No,Results,7.09.2020,None,,
3457,NCT04372056,ClinicalTrials.gov,29.04.2020,6.05.2020,FALSE,Oslo,University,Hospital,Recruiting,Not,Applicable,Observational,Norway,The,COVID-ICU,Healthcare,Professional,Study,,Other,No,Intervention,No,Intervention,2200,6.05.2021,6.05.2021,https://clinicaltrials.gov/show/NCT04372056,No,Results,No,Results,No,Results,7.09.2020,None,,,
3464,NCT04397588,ClinicalTrials.gov,19.05.2020,21.04.2020,TRUE,Rennes,University,Hospital,Recruiting,Not,Applicable,Observational,France,Extracorporeal,Membrane,Oxygenation,(ECMO),and,Coronavirus,Disease,(COVID),19,ECMO-SARS,Other,Oxygen,Oxygen,300,21.10.2020,21.10.2020,https://clinicaltrials.gov/show/NCT04397588,No,Results,No,Results,No,Results,7.09.2020,None,
3470,NCT04425720,ClinicalTrials.gov,2.06.2020,31.08.2020,FALSE,Montefiore,Medical,Center,Not,Recruiting,Not,Applicable,Interventional,United,States,Use,of,Remote,Monitoring,for,COVID-19,Patient,RPM,Other,(device),Biosensors,Biosensors,300,1.06.2021,1.06.2021,https://clinicaltrials.gov/show/NCT04425720,No,Results,No,Results,No,Results,7.09.2020,None
3486,NCT04500418,ClinicalTrials.gov,4.08.2020,25.08.2020,FALSE,Charité,University,Recruiting,Phase,2,Interventional,Germany,Charité,Trial,of,Cenicriviroc,(CVC),Treatment,for,COVID-19,Patients,,Drug,Cenicriviroc,Cenicriviroc,183,30.09.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04500418,No,Results,No,Results,No,Results,7.09.2020,None,,
3489,NCT04517396,ClinicalTrials.gov,17.08.2020,18.08.2020,FALSE,University,of,Pennsylvania,Recruiting,Not,Applicable,Interventional,United,States,FEnofibRate,as,a,Metabolic,INtervention,for,COVID-19,FERMIN,Drug,Fenofibrate,Fenofibrate,300,31.08.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04517396,No,Results,No,Results,No,Results,7.09.2020,None,,
3494,NCT04523090,ClinicalTrials.gov,20.08.2020,27.08.2020,FALSE,University,of,Cape,Town,Recruiting,Phase,2/Phase,3,Interventional,South,Africa,Catalysing,the,Containment,of,COVID-19,C3-RCT,Drug,Nitazoxanide,Nitazoxanide,960,21.04.2020,21.08.2020,https://clinicaltrials.gov/show/NCT04523090,No,Results,No,Results,No,Results,7.09.2020,None,,
3502,NCT04527315,ClinicalTrials.gov,24.08.2020,17.07.2020,TRUE,NYU,Langone,Health,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Survivorship,Registry,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,350,23.08.2020,23.08.2020,https://clinicaltrials.gov/show/NCT04527315,No,Results,No,Results,No,Results,7.09.2020,None,,
3506,NCT04527562,ClinicalTrials.gov,25.08.2020,14.07.2020,TRUE,Dhaka,Medical,College,Recruiting,Not,Applicable,Interventional,Bangladesh,Colchicine,in,Moderate,Symptomatic,COVID-19,Patients,COLCOVIDBD,Drug,Colchicine,Colchicine,300,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04527562,No,Results,No,Results,No,Results,7.09.2020,None,,,,
3508,NCT04528641,ClinicalTrials.gov,19.08.2020,10.08.2020,TRUE,ReiThera,Srl,Recruiting,Phase,1,Interventional,Italy,GRAd-COV2,Vaccine,Against,COVID-19,,ATMP,Vaccine,Vaccine,90,31.07.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04528641,No,Results,No,Results,No,Results,7.09.2020,None,,,,,,,
3510,NCT04528771,ClinicalTrials.gov,25.08.2020,31.10.2020,FALSE,Robert,Schilz,Not,Recruiting,Phase,1,Interventional,United,States,S-Nitrosylation,Therapy,of,COVID-19,,Drug,S-Nitrosylation,S-Nitrosylation,21,31.03.2021,30.04.2021,https://clinicaltrials.gov/show/NCT04528771,No,Results,No,Results,No,Results,7.09.2020,None,,,,,
3513,NCT04529421,ClinicalTrials.gov,25.08.2020,1.09.2020,FALSE,Oslo,Metropolitan,University,Not,Recruiting,Not,Applicable,Observational,Norway,Assocation,Between,In-person,Instruction,and,COVID-19,Risk,Campus&Corona,Other,Other,Other,70000,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04529421,No,Results,No,Results,No,Results,7.09.2020,None,,
3518,NCT04530474,ClinicalTrials.gov,26.08.2020,1.10.2020,FALSE,Temple,University,Not,Recruiting,Phase,3,Interventional,United,States,Outpatient,Use,of,Ivermectin,in,COVID-19,,Drug,Ivermectin,Ivermectin,200,30.06.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04530474,No,Results,No,Results,No,Results,7.09.2020,None,,,
3520,NCT04530578,ClinicalTrials.gov,17.08.2020,1.06.2020,TRUE,Clinica,San,Camilo,,Argentina,Recruiting,Phase,4,Interventional,Argentina,Nebulized,Heparin,in,Severe,Acute,Respiratory,Syndrome,COVID-19,NEBUHEPA,Drug,Heparin,Heparin,200,30.10.2020,1.06.2021,https://clinicaltrials.gov/show/NCT04530578,No,Results,No,Results,No,Results,7.09.2020,None
3524,NCT04531202,ClinicalTrials.gov,26.08.2020,2.03.2020,TRUE,D'Or,Institute,for,Research,and,Education,Recruiting,Not,Applicable,Observational,Brazil,CORE,Study,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,2000,30.09.2020,30.09.2021,https://clinicaltrials.gov/show/NCT04531202,No,Results,No,Results,No,Results,7.09.2020,None,
3525,NCT04531254,ClinicalTrials.gov,24.08.2020,10.08.2020,TRUE,The,Hospital,for,Sick,Children,Not,Recruiting,Not,Applicable,Observational,Canada,Back,to,School,COVID-19,Simulation,Study,,Other,Other,Other,240,20.10.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04531254,No,Results,No,Results,No,Results,7.09.2020,None,
3529,NCT04531618,ClinicalTrials.gov,19.08.2020,13.08.2020,TRUE,Columbia,University,Recruiting,Not,Applicable,Interventional,United,States,Mother-infant,Bonding,During,COVID-19,,Other,Other,Other,280,21.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04531618,No,Results,No,Results,No,Results,7.09.2020,None,,,,,,
3532,NCT04532411,ClinicalTrials.gov,25.08.2020,1.03.2020,TRUE,Massachusetts,General,Hospital,Not,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Testing,Sample,Acquisition,Throughput,and,Efficiency,HexapodBooth,Other,Other,Other,25000,30.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04532411,No,Results,No,Results,No,Results,7.09.2020,None,
3543,ISRCTN33260034,ISRCTN,20.08.2020,20.10.2020,FALSE,University,of,Oxford,Recruiting,Phase,2,Interventional,United,Kingdom,Adalimumab,for,coronavirus,in,community,care,,Drug,Adalimumab,Adalimumab,750,Not,Available,31.12.2021,http://isrctn.com/ISRCTN33260034,No,Results,No,Results,No,Results,7.09.2020,None,,
3554,JPRN-jRCT2071200023,JPRN,21.07.2020,22.07.2020,FALSE,Miyazaki,Taiga,Recruiting,Phase,1/Phase,2,Interventional,Japan,Evaluation,of,Nelfinavir,for,asymptomatic,and,mild,COVID-19,,Drug,Nelfinavir,Nelfinavir,120,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,No,Results,No,Results,No,Results,7.09.2020,None
3556,JPRN-jRCTs041190120,JPRN,2.03.2020,2.03.2020,FALSE,Doi,Yohei,Not,Recruiting,Phase,2,Interventional,Japan,Favipiravir,for,SARS-CoV-infected,patients,,Drug,Favipiravir,Favipiravir,86,Not,Available,15.06.2020,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,Registry,Results,31.08.2020,https://jrct.niph.go.jp/en-latest-detail/jRCTs041190120,7.09.2020,None,,,,,,,
3582,IRCT20200509047364N2,IRCT,17.08.2020,21.06.2020,TRUE,Bandare-abbas,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Famotidine,and,COVID-19,,Drug,Famotidine,+,Hydroxychloroquine/Chloroquine,+,Lopinavir/Atazanavir/Ritonavir,vs.,Hydroxychloroquine/Chloroquine,+,Lopinavir/Atazanavir/Ritonavir,Famotidine,,,,,,,,,
3591,IRCT20200506047323N5,IRCT,14.08.2020,22.08.2020,FALSE,Bandare-abbas,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Melatonin,in,COVID-19,,Drug,Melatonin,+,Hydroxychloroquine,vs.,Hydroxychloroquine,Melatonin,,,,,,,,,,,,,
3609,NCT04348305,ClinicalTrials.gov,11.04.2020,17.04.2020,TRUE,Scandinavian,Critical,Care,Trials,Group,Not,Recruiting,Phase,3,Interventional,Denmark,Hydrocortisone,for,COVID-19,and,Severe,Hypoxia,COVID,STEROID,Drug,Corticosteroids,Hydrocortisone,1000,10.09.2020,8.06.2021,https://clinicaltrials.gov/show/NCT04348305,No,Results,No,Results,No,Results,14.09.2020,EUCTR2020-001395-15
3611,NCT04353284,ClinicalTrials.gov,16.04.2020,19.06.2020,FALSE,Yale,University,Recruiting,Phase,2,Interventional,United,States,Camostat,Mesylate,in,COVID-19,Outpatients,,Drug,Camostat,Mesilate,Camostat,Mesilate,114,31.05.2021,31.05.2021,https://clinicaltrials.gov/show/NCT04353284,No,Results,No,Results,No,Results,14.09.2020,None,,,
3612,NCT04354701,ClinicalTrials.gov,16.04.2020,17.03.2020,TRUE,Vanderbilt-Ingram,Cancer,Center,Recruiting,Not,Applicable,Observational,United,States,COVID-19,and,Cancer,Consortium,Registry,CCC19,Clinical,Presentation,No,Intervention,No,Intervention,10000,21.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04354701,No,Results,No,Results,No,Results,14.09.2020,None,
3614,NCT04356690,ClinicalTrials.gov,17.04.2020,8.05.2020,FALSE,Boston,Medical,Center,Recruiting,Phase,2,Interventional,United,States,Etoposide,in,Patients,With,COVID-19,Infection,,Drug,Etoposide,Etoposide,64,20.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04356690,No,Results,No,Results,No,Results,14.09.2020,None,,,
3621,NCT04372628,ClinicalTrials.gov,30.04.2020,1.06.2020,FALSE,Vanderbilt,University,Recruiting,Phase,2,Interventional,United,States,Trial,of,Early,Therapies,During,Non-hospitalized,Outpatient,Window,for,COVID-19,TREATNOW,Drug,Hydroxychloroquein,vs.,Lopinavir/ritonavir,Hydroxychloroquein,,,,,,,,,,
3627,NCT04382625,ClinicalTrials.gov,14.04.2020,1.10.2020,FALSE,Kootenai,Health,Not,Recruiting,Phase,4,Interventional,United,States,Hydroxychloroquine,in,SARS-CoV-2,(COVID-19),Pneumonia,Trial,,Drug,Hydroxychloroquine,Hydroxychloroquine,120,1.01.2022,1.06.2022,https://clinicaltrials.gov/show/NCT04382625,No,Results,No,Results,No,Results,14.09.2020,None,,,
3629,NCT04384055,ClinicalTrials.gov,8.05.2020,21.03.2020,TRUE,Stanford,University,Recruiting,Not,Applicable,Observational,United,States,Predicting,Outcomes,for,Covid-19,Using,Sonography,POCUS,Prognosis,No,Intervention,No,Intervention,200,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04384055,Pre-Print,Article,28.06.2020,https://doi.org/10.1101/2020.06.25.20140392,14.09.2020,None,,,,
3632,NCT04389411,ClinicalTrials.gov,13.05.2020,1.10.2020,FALSE,McGill,University,Not,Recruiting,Phase,3,Interventional,No,Country,Given,The,COvid-19,Symptom,MOntelukast,Trial,COSMO,Drug,Montelukast,Montelukast,600,21.09.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04389411,No,Results,No,Results,No,Results,14.09.2020,None,,,
3636,NCT04390269,ClinicalTrials.gov,12.05.2020,10.09.2020,FALSE,Mansoura,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Immunogenetics,Predictors,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,200,10.10.2020,9.05.2022,https://clinicaltrials.gov/show/NCT04390269,No,Results,No,Results,No,Results,14.09.2020,None,,,
3638,NCT04391127,ClinicalTrials.gov,12.05.2020,4.05.2020,TRUE,Centenario,Hospital,Miguel,Hidalgo,Not,Recruiting,Phase,3,Interventional,Mexico,Hydroxychloroquine,and,Ivermectin,for,the,Treatment,of,COVID-19,Infection,,Drug,Hydroxychloroquine,vs.,Ivermectin,Hydroxychloroquine,,,,,,,,,
3639,NCT04392427,ClinicalTrials.gov,12.05.2020,1.10.2020,FALSE,Mansoura,University,Not,Recruiting,Phase,3,Interventional,Egypt,New,Antiviral,Drugs,for,Treatment,of,COVID-19,,Drug,Nitazoxanide,+,Ribavirin,+,Ivermectin,Nitazoxanide,,,,,,,,,,,
3642,NCT04396600,ClinicalTrials.gov,23.04.2020,8.06.2020,FALSE,University,of,Minnesota,Recruiting,Not,Applicable,Observational,United,States,The,Professional,Peer,Resilience,Initiative,PPRI,Other,(psych),Psychological,Psychological,1200,25.05.2022,25.05.2022,https://clinicaltrials.gov/show/NCT04396600,No,Results,No,Results,No,Results,14.09.2020,None,,,
3657,NCT04457349,ClinicalTrials.gov,30.06.2020,25.07.2020,FALSE,Alexandria,University,Recruiting,Not,Applicable,Interventional,Egypt,Therapeutic,Plasma,Exchange,in,Resistant,Cytokine,Storm,of,COVID,19,,ATMP,Plasma,Plasma,10,29.11.2020,29.12.2020,https://clinicaltrials.gov/show/NCT04457349,No,Results,No,Results,No,Results,14.09.2020,None,
3658,NCT04460664,ClinicalTrials.gov,30.06.2020,14.08.2020,FALSE,HemoSonics,LLC,Recruiting,Not,Applicable,Observational,United,States,Coagulation,Changes,Associated,With,COVID-19,Infection,,Clinical,Presentation,No,Intervention,No,Intervention,50,31.01.2021,15.02.2021,https://clinicaltrials.gov/show/NCT04460664,No,Results,No,Results,No,Results,14.09.2020,None,
3659,NCT04460677,ClinicalTrials.gov,6.07.2020,12.08.2020,FALSE,Rutgers,University,Recruiting,Not,Applicable,Interventional,United,States,ASD,(Autism,Spectrum,Disorder),Telehealth,for,Distress,Related,to,COVID-19,,Telehealth,Telehealth,Telehealth,80,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04460677,No,Results,No,Results,No,Results,14.09.2020,None
3660,NCT04461340,ClinicalTrials.gov,4.07.2020,15.08.2020,FALSE,Alexandria,University,Recruiting,Phase,2,Interventional,Egypt,Efficacy,and,Safety,of,Sirolimus,in,COVID-19,Infection,,Drug,Sirolimus,Sirolimus,40,30.10.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04461340,No,Results,No,Results,No,Results,14.09.2020,None,,,
3661,NCT04466657,ClinicalTrials.gov,9.07.2020,1.11.2020,FALSE,Obafemi,Awolowo,University,Not,Recruiting,Not,Applicable,Interventional,Nigeria,Antioxidant,Therapy,for,COVID-19,Study,GSHSOD-COVID,Supplement,Nutritional,Supplement,Nutritional,Supplement,90,28.02.2021,30.04.2021,https://clinicaltrials.gov/show/NCT04466657,No,Results,No,Results,No,Results,14.09.2020,None,,
3662,NCT04468256,ClinicalTrials.gov,9.07.2020,26.07.2020,FALSE,Imperial,College,London,Recruiting,Not,Applicable,Observational,United,Kingdom,The,Heart,Hive,COVID-19,Study,,Clinical,Presentation,No,Intervention,No,Intervention,1000,22.07.2020,22.07.2020,https://clinicaltrials.gov/show/NCT04468256,No,Results,No,Results,No,Results,14.09.2020,None,
3663,NCT04468386,ClinicalTrials.gov,8.07.2020,7.07.2020,TRUE,Biomerica,Not,Recruiting,Not,Applicable,Observational,United,States,Specimen,Collection,Study,Protocol,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,40,30.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04468386,No,Results,No,Results,No,Results,14.09.2020,None,,
3671,NCT04484493,ClinicalTrials.gov,22.07.2020,8.08.2020,FALSE,Benha,University,Not,Recruiting,Phase,3,Interventional,Egypt,Corticosteroid,Nasal,Spray,in,COVID-19,Anosmia,,Drug,Corticosteroids,momentasone,furatenasal,50,25.10.2020,3.11.2020,https://clinicaltrials.gov/show/NCT04484493,No,Results,No,Results,No,Results,14.09.2020,None,,,
3673,NCT04492943,ClinicalTrials.gov,24.04.2020,20.04.2020,TRUE,Massachusetts,General,Hospital,Not,Recruiting,Not,Applicable,Observational,United,States,To,Observe,Whether,Isoflurane,Can,Treat,COVID-19,Patients,,Drug,Isoflurane,Isoflurane,35,30.06.2020,30.06.2020,https://clinicaltrials.gov/show/NCT04492943,No,Results,No,Results,No,Results,14.09.2020,None
3699,NCT04536298,ClinicalTrials.gov,27.08.2020,15.09.2020,FALSE,Brigham,and,Women's,Hospital,Not,Recruiting,Phase,3,Interventional,United,States,Vitamin,D,and,COVID-19,Trial,VIVID,Drug,Vitamin,D,Vitamin,D,2700,1.03.2021,1.03.2021,https://clinicaltrials.gov/show/NCT04536298,No,Results,No,Results,No,Results,14.09.2020,None
3700,NCT04536350,ClinicalTrials.gov,21.08.2020,1.09.2020,FALSE,Dr.,Jorg,Leuppi,Not,Recruiting,Phase,1,Interventional,Switzerland,Inhaled,Aviptadil,for,the,Prevention,of,COVID-19,Related,ARDS,,Drug,Aviptadil,Aviptadil,80,21.12.2020,22.03.2020,https://clinicaltrials.gov/show/NCT04536350,No,Results,No,Results,No,Results,14.09.2020,None
3716,NCT04539834,ClinicalTrials.gov,1.09.2020,1.05.2020,TRUE,Zagazig,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Electrolyte,State,in,Patients,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,52,1.08.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04539834,No,Results,No,Results,No,Results,14.09.2020,None,
3720,NCT04540393,ClinicalTrials.gov,26.08.2020,26.08.2020,FALSE,AstraZeneca,Not,Recruiting,Phase,3,Interventional,Russian,Federation,AZD1222,Vaccine,for,the,Prevention,of,COVID-19,,ATMP,Vaccine,Vaccine,100,12.03.2021,12.03.2021,https://clinicaltrials.gov/show/NCT04540393,No,Results,No,Results,No,Results,14.09.2020,None,,,
3725,NCT04542434,ClinicalTrials.gov,4.09.2020,1.11.2020,FALSE,First,Wave,Bio,,Inc.,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Niclosamide,in,COVID-19,,Drug,Niclosamide,Niclosamide,148,1.05.2021,1.05.2021,https://clinicaltrials.gov/show/NCT04542434,No,Results,No,Results,No,Results,14.09.2020,None,,
3752,NCT04338958,ClinicalTrials.gov,7.04.2020,22.04.2020,TRUE,University,of,Jena,Recruiting,Phase,2,Interventional,Germany,Ruxolitinib,in,Covid-19,Patients,With,Defined,Hyperinflammation,RuxCoFlam,Drug,Ruxolitinib,Ruxolitinib,200,31.01.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04338958,No,Results,No,Results,No,Results,21.09.2020,EUCTR2020-001481-11,,,
3753,NCT04341506,ClinicalTrials.gov,7.04.2020,8.09.2020,FALSE,Northwestern,Medicine,Recruiting,Not,Applicable,Observational,United,States,Non-contact,ECG,Sensor,System,for,COVID19,,Clinical,Presentation,No,Intervention,No,Intervention,100,15.07.2021,15.12.2021,https://clinicaltrials.gov/show/NCT04341506,No,Results,No,Results,No,Results,21.09.2020,None,
3756,NCT04355962,ClinicalTrials.gov,26.03.2020,23.04.2020,FALSE,University,of,Zurich,Recruiting,Phase,3,Interventional,Switzerland,Sevoflurane,in,COVID-19,ARDS,(SevCov),,Drug,Sevoflurane,Sevoflurane,64,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04355962,No,Results,No,Results,No,Results,21.09.2020,None,,,,,
3757,NCT04359901,ClinicalTrials.gov,20.04.2020,10.04.2020,TRUE,Westyn,Branch-Elliman,Recruiting,Phase,2,Interventional,United,States,Sarilumab,for,Patients,With,Moderate,COVID-19,Disease,,Drug,Sarilumab,Sarilumab,120,22.04.2020,23.04.2020,https://clinicaltrials.gov/show/NCT04359901,No,Results,No,Results,No,Results,21.09.2020,None,,,
3766,NCT04365127,ClinicalTrials.gov,24.04.2020,27.04.2020,FALSE,Sara,Ghandehari,Not,Recruiting,Phase,1,Interventional,United,States,Progesterone,for,the,Treatment,of,COVID-19,in,Hospitalized,Men,,Drug,Progesterone,Progesterone,40,20.08.2020,17.04.2021,https://clinicaltrials.gov/show/NCT04365127,No,Results,No,Results,No,Results,21.09.2020,None
3770,NCT04377607,ClinicalTrials.gov,4.05.2020,1.11.2020,FALSE,Nevsehir,Public,Hospital,Recruiting,Not,Applicable,Observational,Turkey,Haemoglobin,Concentration,on,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,200,20.11.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04377607,No,Results,No,Results,No,Results,21.09.2020,None,,,
3783,NCT04407195,ClinicalTrials.gov,27.05.2020,1.06.2020,FALSE,Northeastern,University,Not,Recruiting,Not,Applicable,Observational,United,States,COVID-19,and,Mental,Health,,Other,(psych),No,Intervention,No,Intervention,2000,1.06.2021,1.06.2021,https://clinicaltrials.gov/show/NCT04407195,No,Results,No,Results,No,Results,21.09.2020,None,,
3789,NCT04422509,ClinicalTrials.gov,3.06.2020,3.10.2020,FALSE,Radboud,University,Recruiting,Phase,1/Phase,2,Interventional,Netherlands,Lanadelumab,for,Treatment,of,COVID-19,Disease,COVID_LAN,Drug,Lanadelumab,Lanadelumab,80,3.08.2021,3.08.2021,https://clinicaltrials.gov/show/NCT04422509,No,Results,No,Results,No,Results,21.09.2020,None,,,,
3790,NCT04436458,ClinicalTrials.gov,16.06.2020,1.12.2020,FALSE,First,Wave,Bio,,Inc.,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Niclosamide,In,Moderate,COVID-19,,Drug,Niclosamide,Niclosamide,100,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04436458,No,Results,No,Results,No,Results,21.09.2020,None,
3795,NCT04471649,ClinicalTrials.gov,7.07.2020,15.06.2020,TRUE,Tanta,University,Recruiting,Not,Applicable,Observational,Egypt,Hydroxy,Chloroquine,and,Covid,in,RA,Patients,Covid-19,Drug,Hydroxychloroquine,Hydroxychloroquine,80,20.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04471649,No,Results,No,Results,No,Results,21.09.2020,None,,,,
3798,NCT04479293,ClinicalTrials.gov,19.07.2020,1.07.2020,TRUE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Post,COVID-19,Functional,Status,in,Egypt,,Clinical,Presentation,No,Intervention,No,Intervention,400,30.10.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04479293,Pre-Print,Article,1.09.2020,https://doi.org/10.1101/2020.08.26.20182618,21.09.2020,None,,,,
3801,NCT04483830,ClinicalTrials.gov,22.07.2020,5.06.2020,TRUE,CLINEDEM,Not,Recruiting,Phase,2/Phase,3,Interventional,Mexico,Suloexide,in,the,Treatment,of,Early,Stages,of,COVID-19,SulES-COVID,Drug,Suloexide,Suloexide,243,6.08.2020,7.09.2020,https://clinicaltrials.gov/show/NCT04483830,No,Results,No,Results,No,Results,21.09.2020,None,
3811,NCT04529525,ClinicalTrials.gov,21.08.2020,19.08.2020,TRUE,Instituto,de,Cardiología,de,Corrientes,Recruiting,Phase,2/Phase,3,Interventional,Argentina,Ivermectin,to,Prevent,Hospitalizations,in,COVID-19,IVERCORCOVID19,Drug,Ivermectin,Ivermectin,500,31.12.2020,31.01.2021,https://clinicaltrials.gov/show/NCT04529525,No,Results,No,Results,No,Results,21.09.2020,None,
3813,NCT04536051,ClinicalTrials.gov,1.09.2020,2.06.2020,TRUE,University,of,Oxford,Recruiting,Phase,3,Interventional,Brazil,A,Study,of,a,Candidate,COVID-19,Vaccine,(COV003),,ATMP,Vaccine,Vaccine,5000,21.09.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04536051,No,Results,No,Results,No,Results,21.09.2020,None,,
3827,NCT04542941,ClinicalTrials.gov,31.08.2020,16.06.2020,TRUE,Makerere,University,Not,Recruiting,Not,Applicable,Interventional,Uganda,Assessment,of,Safety,and,Efficacy,of,CCP,COVIDIT,ATMP,Plasma,Plasma,136,31.10.2020,31.10.2020,https://clinicaltrials.gov/show/NCT04542941,No,Results,No,Results,No,Results,21.09.2020,None,,,
3833,NCT04544150,ClinicalTrials.gov,8.09.2020,1.06.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Gastrointestinal,Manifestations,Among,Patients,With,COVID19,,Clinical,Presentation,No,Intervention,No,Intervention,220,1.09.2020,1.09.2020,https://clinicaltrials.gov/show/NCT04544150,No,Results,No,Results,No,Results,21.09.2020,None,
3836,NCT04544878,ClinicalTrials.gov,3.09.2020,26.03.2020,TRUE,Bicetre,Hospital,Recruiting,Not,Applicable,Observational,France,Pediatric,Intensive,Care,and,COVID-19,CLOVIS,Clinical,Presentation,No,Intervention,No,Intervention,100,1.06.2021,1.06.2021,https://clinicaltrials.gov/show/NCT04544878,No,Results,No,Results,No,Results,21.09.2020,None,,,
3837,NCT04544891,ClinicalTrials.gov,9.09.2020,1.10.2020,FALSE,CHU,de,Nancy,Not,Recruiting,Not,Applicable,Observational,France,TREM-1,Pathway,Activation,in,COVID-19,CoviTrem1,Clinical,Presentation,No,Intervention,No,Intervention,1000,1.10.2022,1.04.2023,https://clinicaltrials.gov/show/NCT04544891,No,Results,No,Results,No,Results,21.09.2020,None,
3842,NCT04546776,ClinicalTrials.gov,9.09.2020,8.09.2020,TRUE,Quadram,Institute,Bioscience,Recruiting,Not,Applicable,Observational,United,Kingdom,COVID-19,Persistence,in,Stool,CoPS,Clinical,Presentation,No,Intervention,No,Intervention,200,22.06.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04546776,No,Results,No,Results,No,Results,21.09.2020,None,,
3849,NCT04547283,ClinicalTrials.gov,9.09.2020,14.06.2020,TRUE,Atrium,Health,Recruiting,Not,Applicable,Interventional,United,States,Awake-Prone,Positioning,Strategy,for,Hypoxic,Patients,With,COVID-19,,Procedure,Positioning,Positioning,40,20.09.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04547283,No,Results,No,Results,No,Results,21.09.2020,None,,
3850,NCT04547634,ClinicalTrials.gov,17.08.2020,1.07.2020,TRUE,University,of,Malaga,Recruiting,Not,Applicable,Interventional,Spain,Telerehabilitation,in,Oncology,Patients,,Telehealth,Physio,&,Rehabilitation,Physio,&,Rehabilitation,30,20.11.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04547634,No,Results,No,Results,No,Results,21.09.2020,None,,
3851,NCT04547660,ClinicalTrials.gov,9.09.2020,16.07.2020,TRUE,Hospital,de,Clinicas,de,Porto,Alegre,Recruiting,Phase,3,Interventional,Brazil,Convalescent,Plasma,for,Severe,COVID-19,Patients,PLACOVID,ATMP,Plasma,Plasma,160,21.07.2020,21.10.2020,https://clinicaltrials.gov/show/NCT04547660,No,Results,No,Results,No,Results,21.09.2020,None,
3860,NCT04551274,ClinicalTrials.gov,1.09.2020,1.10.2020,FALSE,Simon,Fraser,University,Not,Recruiting,Not,Applicable,Interventional,Canada,Music,Therapy,in,Frontline,Healthcare,Workers,,Other,(psych),Psychological,Psychological,20,30.11.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04551274,No,Results,No,Results,No,Results,21.09.2020,None,,
3868,ISRCTN59048638,ISRCTN,4.06.2020,15.06.2020,FALSE,CLINEDEM,Recruiting,Not,Applicable,Interventional,Mexico,Sulodexide,in,the,treatment,of,COVID-19,,Drug,Sulodexide,Sulodexide,200,Not,Available,30.11.2020,http://isrctn.com/ISRCTN59048638,No,Results,No,Results,No,Results,21.09.2020,None,,,,,
3878,NCT04331054,ClinicalTrials.gov,29.03.2020,13.04.2020,TRUE,Assistance,Publique,–,Hôpitaux,de,Paris,Recruiting,Phase,3,Interventional,France,Protective,Role,of,Inhaled,Steroids,for,Covid-19,Infection,INHASCO,Drug,Corticosteroids,+,formoterol,Budesonide,,,,,,,,,
3884,NCT04345848,ClinicalTrials.gov,7.04.2020,28.04.2020,FALSE,University,Hospital,,Geneva,Recruiting,Phase,3,Interventional,Switzerland,Preventing,COVID-19,Complications,With,Low-,and,High-dose,Anticoagulation,COVID-HEP,Drug,Heparin,Heparin,200,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04345848,No,Results,No,Results,No,Results,28.09.2020,None,
3885,NCT04350580,ClinicalTrials.gov,8.04.2020,11.04.2020,TRUE,Centre,Hospitalier,St.,Anne,Recruiting,Phase,3,Interventional,France,Polyvalent,Immunoglobulin,in,COVID-19,Related,ARds,ICAR,ATMP,Immunoglobulin,Immunoglobulin,138,21.04.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04350580,No,Results,No,Results,No,Results,28.09.2020,EUCTR2020-001570-30,,,
3886,NCT04353674,ClinicalTrials.gov,7.04.2020,28.04.2020,FALSE,Lawson,Health,Research,Institute,Recruiting,Not,Applicable,Interventional,Canada,Modulation,of,Hyperinflammation,in,COVID-19,,Other,(device),Dialysis,Dialysis,40,20.12.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04353674,No,Results,No,Results,No,Results,28.09.2020,None,,,
3890,NCT04361422,ClinicalTrials.gov,21.04.2020,1.12.2020,FALSE,Tanta,University,Not,Recruiting,Phase,3,Interventional,No,Country,Given,Isotretinoin,in,Treatment,of,COVID-19,Randomized,Drug,Isotretinoin,Isotretinoin,300,21.08.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04361422,No,Results,No,Results,No,Results,28.09.2020,None,,,
3898,NCT04388527,ClinicalTrials.gov,4.05.2020,30.04.2020,TRUE,University,of,Pennsylvania,Recruiting,Phase,1,Interventional,United,States,COVID-19,Convalescent,Plasma,for,Mechanically,Ventilated,Population,,ATMP,Plasma,Plasma,50,31.12.2020,31.03.2021,https://clinicaltrials.gov/show/NCT04388527,No,Results,No,Results,No,Results,28.09.2020,None,,
3899,NCT04393805,ClinicalTrials.gov,16.05.2020,1.06.2020,FALSE,Quovadis,Associazione,Recruiting,Not,Applicable,Observational,Italy,Heparins,for,Thromboprophylaxis,in,COVID-19,Patients:,HETHICO,Study,in,Veneto,HETHICO,Drug,Heparin,Heparin,877,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04393805,No,Results,No,Results,No,Results,28.09.2020,None,
3902,NCT04407273,ClinicalTrials.gov,27.05.2020,14.05.2020,TRUE,Institut,d'Investigació,Sanitària,Pere,Virgili,Not,Recruiting,Not,Applicable,Observational,Spain,STATIN,THERAPY,AND,COVID-19,INFECTION,STACOV,Drug,Statins,Statins,1200,20.08.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04407273,No,Results,No,Results,No,Results,28.09.2020,None,,
3909,NCT04429477,ClinicalTrials.gov,9.06.2020,1.05.2020,TRUE,University,of,São,Paulo,Not,Recruiting,Not,Applicable,Observational,Brazil,Cerebral,Compliance,Impairment,in,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,50,15.07.2020,31.07.2020,https://clinicaltrials.gov/show/NCT04429477,No,Results,No,Results,No,Results,28.09.2020,None
3914,NCT04468087,ClinicalTrials.gov,3.07.2020,7.10.2020,FALSE,Hospital,do,Coração,Not,Recruiting,Phase,2/Phase,3,Interventional,Brazil,Antiviral,Agents,Against,COVID-19,Infection,REVOLUTIOn,Drug,Atazanavir,vs.,Daclatasvir,vs.,Sofusbuvir,vs.,Favipiravir,Atazanavir,,,,,,,,,
3915,NCT04468412,ClinicalTrials.gov,9.07.2020,14.07.2020,FALSE,Radboud,University,Not,Recruiting,Not,Applicable,Observational,Netherlands,Influence,of,COVID-19,on,Vascular,Endothelial,Function,COVAS,Clinical,Presentation,No,Intervention,No,Intervention,203,30.09.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04468412,No,Results,No,Results,No,Results,28.09.2020,None
3916,NCT04471636,ClinicalTrials.gov,9.07.2020,18.09.2020,FALSE,Ludwig,Maximilian,University,of,Munich,Recruiting,Not,Applicable,Interventional,Germany,Telemedicine,in,Outpatient,Covid-19,Patients,MR,SPOC,Telehealth,Telehealth,Telehealth,600,21.02.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04471636,No,Results,No,Results,No,Results,28.09.2020,None,,
3932,NCT04528329,ClinicalTrials.gov,24.08.2020,30.08.2020,FALSE,ClinAmygate,Recruiting,Phase,4,Interventional,Egypt,Anosmia,and,/,or,Ageusia,and,Early,Corticosteroid,Use,,Drug,Corticosteroids,Dexamthasone,300,30.11.2020,15.12.2020,https://clinicaltrials.gov/show/NCT04528329,No,Results,No,Results,No,Results,28.09.2020,None,,,
3934,NCT04530409,ClinicalTrials.gov,24.08.2020,26.08.2020,FALSE,ClinAmygate,Recruiting,Phase,4,Interventional,Egypt,Timing,of,Corticosteroids,in,COVID-19,,Drug,Corticosteroids,Dexamthasone,450,1.12.2020,1.01.2021,https://clinicaltrials.gov/show/NCT04530409,No,Results,No,Results,No,Results,28.09.2020,None,,,,,,,
3947,NCT04549350,ClinicalTrials.gov,8.09.2020,19.05.2020,TRUE,Zagazig,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Sleep,Quality,Among,HCWs,,Other,No,Intervention,No,Intervention,217,18.08.2020,5.09.2020,https://clinicaltrials.gov/show/NCT04549350,No,Results,No,Results,No,Results,28.09.2020,None,,,,
3948,NCT04549831,ClinicalTrials.gov,11.09.2020,8.04.2020,TRUE,University,of,Siena,Recruiting,Not,Applicable,Observational,Italy,Genetic,Bases,of,COVID-19,Clinical,Variability,GEN-COVID,Genomics,No,Intervention,No,Intervention,2000,8.04.2021,8.04.2026,https://clinicaltrials.gov/show/NCT04549831,No,Results,No,Results,No,Results,28.09.2020,None,,
3962,NCT04554251,ClinicalTrials.gov,6.09.2020,1.09.2020,TRUE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Global,Impact,of,COVID-19,on,Pulmonology,Special,Units,,Health,System,No,Intervention,No,Intervention,100,1.12.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04554251,No,Results,No,Results,No,Results,28.09.2020,None
3967,NCT04555109,ClinicalTrials.gov,17.09.2020,30.06.2020,TRUE,The,Hospital,for,Sick,Children,Recruiting,Not,Applicable,Observational,Canada,Convalescent,Plasma,for,COVID-19,Research,Donor,Study,CONCOR-Donor,ATMP,Plasma,Plasma,1000,30.06.2021,31.03.2022,https://clinicaltrials.gov/show/NCT04555109,No,Results,No,Results,No,Results,28.09.2020,None,
3968,NCT04555148,ClinicalTrials.gov,16.09.2020,20.09.2020,FALSE,Green,Cross,Corporation,Recruiting,Phase,2,Interventional,South,Korea,COVIDIG,(COVID-19,Hyper-ImmunoGlobulin),,ATMP,Immunoglobulin,Immunoglobulin,60,30.12.2020,21.08.2020,https://clinicaltrials.gov/show/NCT04555148,No,Results,No,Results,No,Results,28.09.2020,None,,,,,,
3974,NCT04557241,ClinicalTrials.gov,16.09.2020,1.10.2020,FALSE,Indiana,University,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Brief,Informational,Intervention,for,COVID-19,Misinformation,Prophylaxis,,Other,Other,Other,1000,21.01.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04557241,No,Results,No,Results,No,Results,28.09.2020,None,
3977,NCT04558320,ClinicalTrials.gov,19.09.2020,2.07.2020,TRUE,University,of,Rochester,Recruiting,Not,Applicable,Observational,United,States,COVID-19,and,Lactating,Mothers,,Clinical,Presentation,No,Intervention,No,Intervention,100,1.04.2021,1.04.2021,https://clinicaltrials.gov/show/NCT04558320,No,Results,No,Results,No,Results,28.09.2020,None,,
4003,EUCTR2020-001645-40-IT,EU,Clinical,Trials,Register,22.09.2020,6.05.2020,TRUE,Dompe,Farmaceutici,Authorised,Phase,2/Phase,3,Interventional,Italy,Reparixin,in,COVID-19,pneumonia,,Drug,Reparixin,Reparixin,159,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001645-40,No,Results,No,Results,No,Results,28.09.2020,None,
4011,NCT04333472,ClinicalTrials.gov,1.04.2020,6.10.2020,FALSE,Can-Fite,BioPharma,Not,Recruiting,Phase,2,Interventional,Israel,Piclidenoson,for,Treatment,of,COVID-19,,Drug,Piclidenoson,Piclidenoson,40,6.03.2021,6.07.2021,https://clinicaltrials.gov/show/NCT04333472,No,Results,No,Results,No,Results,5.10.2020,None,,,,,
4015,NCT04343261,ClinicalTrials.gov,8.04.2020,10.04.2020,FALSE,Saint,Francis,Care,Not,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,in,the,Treatment,of,COVID,19,,ATMP,Plasma,Plasma,48,23.07.2020,13.08.2020,https://clinicaltrials.gov/show/NCT04343261,Pre-Print,Article,1.09.2020,https://doi.org/10.1101/2020.08.27.20183293,5.10.2020,None,,
4016,NCT04344587,ClinicalTrials.gov,8.04.2020,23.04.2020,FALSE,Boston,University,Recruiting,Not,Applicable,Interventional,United,States,,Spain,Awake,Prone,Position,for,Early,Hypoxemia,in,COVID-19,APPEX-19,Procedure,Positioning,Positioning,560,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04344587,No,Results,No,Results,No,Results,5.10.2020,None
4020,NCT04346342,ClinicalTrials.gov,9.04.2020,6.03.2020,TRUE,UMC,Amsterdam,Not,Recruiting,Not,Applicable,Observational,Netherlands,PRactice,of,VENTilation,in,COVID-19,Patients,(PRoVENT-COVID),,Other,(physical),Mechanical,ventilation,Mechanical,ventilation,1122,1.09.2020,1.09.2020,https://clinicaltrials.gov/show/NCT04346342,No,Results,No,Results,No,Results,5.10.2020,None
4023,NCT04351295,ClinicalTrials.gov,15.04.2020,20.04.2020,FALSE,Tanta,University,Recruiting,Phase,2/Phase,3,Interventional,Egypt,Efficacy,of,Faviprevir,in,COVID-19,Treatment,,Drug,Favipiravir,Favipiravir,90,1.12.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04351295,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4025,NCT04355767,ClinicalTrials.gov,17.04.2020,11.08.2020,FALSE,Stanford,University,Recruiting,Phase,3,Interventional,United,States,Convalescent,Plasma,in,Outpatients,With,COVID-19,C3PO,ATMP,Plasma,Plasma,600,22.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04355767,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4034,NCT04384445,ClinicalTrials.gov,9.05.2020,8.09.2020,FALSE,Organicell,Regenerative,Medicine,Recruiting,Phase,1/Phase,2,Interventional,United,States,Zofin,(Organicell,Flow),for,Patients,With,COVID-19,,ATMP,Exosomes,Exosomes,20,31.10.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04384445,No,Results,No,Results,No,Results,5.10.2020,None,
4035,NCT04390022,ClinicalTrials.gov,7.05.2020,31.07.2020,FALSE,Clínica,Universidad,de,Navarra,Not,Recruiting,Phase,2,Interventional,Spain,Sars-CoV-2/COVID-19,Ivermectin,Navarra-ISGlobal,Trial,SAINT,Drug,Ivermectin,Ivermectin,24,30.11.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04390022,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4043,NCT04420182,ClinicalTrials.gov,29.05.2020,17.08.2020,FALSE,Lawson,Health,Research,Institute,Recruiting,Not,Applicable,Interventional,Canada,COVID-19,Virtual,Care,at,Home,,Other,(software),eHealth,eHealth,2000,30.06.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04420182,No,Results,No,Results,No,Results,5.10.2020,None,,,
4050,NCT04435522,ClinicalTrials.gov,15.06.2020,21.09.2020,FALSE,Rhode,Island,Hospital,Recruiting,Phase,1,Interventional,United,States,Maraviroc,in,Patients,With,Moderate,and,Severe,COVID-19,,Drug,Maraviroc,Maraviroc,16,31.12.2020,21.01.2020,https://clinicaltrials.gov/show/NCT04435522,No,Results,No,Results,No,Results,5.10.2020,None,
4052,NCT04447638,ClinicalTrials.gov,24.06.2020,20.03.2020,TRUE,Çanakkale,Onsekiz,Mart,University,Not,Recruiting,Not,Applicable,Observational,Turkey,Percutaneous,Tracheostomy,With,COVID-19,,Procedure,Tracheostomy,Tracheostomy,24,1.06.2020,1.06.2020,https://clinicaltrials.gov/show/NCT04447638,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4060,NCT04469114,ClinicalTrials.gov,10.07.2020,16.09.2020,FALSE,Hospital,Israelita,Albert,Einstein,Recruiting,Phase,2,Interventional,Brazil,Tofacitinib,in,Hospitalized,Patients,With,COVID-19,Pneumonia,,Drug,Tofacitinib,Tofacitinib,260,7.12.2020,31.01.2021,https://clinicaltrials.gov/show/NCT04469114,No,Results,No,Results,No,Results,5.10.2020,None,,
4065,NCT04477889,ClinicalTrials.gov,17.07.2020,20.06.2020,TRUE,Methodist,Health,System,Recruiting,Not,Applicable,Observational,United,States,Methodist,Health,System,COVID-19,Patient,Registry,,Clinical,Presentation,No,Intervention,No,Intervention,500,25.12.2020,26.12.2020,https://clinicaltrials.gov/show/NCT04477889,No,Results,No,Results,No,Results,5.10.2020,None
4070,NCT04485169,ClinicalTrials.gov,21.07.2020,1.04.2020,TRUE,UNICEF,Not,Recruiting,Not,Applicable,Interventional,Pakistan,Therapeutic,Plasma,Exchange,for,Coronavirus,Disease-2019,Triggered,Cytokine,Release,Storm,,,,,,,,,,,,,,,,,
4078,NCT04508972,ClinicalTrials.gov,10.08.2020,1.07.2020,TRUE,McGill,University,Recruiting,Not,Applicable,Observational,Canada,The,VOICE-COVID-19,,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,200,1.10.2020,1.11.2020,https://clinicaltrials.gov/show/NCT04508972,No,Results,No,Results,No,Results,5.10.2020,None,,,
4084,NCT04527081,ClinicalTrials.gov,24.08.2020,31.08.2020,FALSE,AnGes,,Inc.,Not,Recruiting,Phase,1/Phase,2,Interventional,Japan,Study,of,COVID-19,DNA,Vaccine,(AG0302-COVID19),,ATMP,Vaccine,Vaccine,30,26.11.2020,30.09.2021,https://clinicaltrials.gov/show/NCT04527081,No,Results,No,Results,No,Results,5.10.2020,None,,
4091,NCT04549636,ClinicalTrials.gov,28.08.2020,18.09.2020,FALSE,McMaster,University,Recruiting,Not,Applicable,Observational,Canada,COVID-19,Related,Lung,Ventilation,and,Perfusion,Injury,,Other,(physical),Mechanical,ventilation,Mechanical,ventilation,92,21.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04549636,No,Results,No,Results,No,Results,5.10.2020,None,
4093,NCT04555122,ClinicalTrials.gov,29.04.2020,29.09.2020,FALSE,University,of,California,,Irvine,Not,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,Ad,Intervention,,Other,Other,Other,52500,28.05.2022,28.07.2022,https://clinicaltrials.gov/show/NCT04555122,No,Results,No,Results,No,Results,5.10.2020,None,,,
4097,NCT04558385,ClinicalTrials.gov,20.09.2020,1.07.2020,TRUE,Lahore,General,Hospital,Not,Recruiting,Not,Applicable,Observational,Pakistan,Seroconversion,in,COVID-19,Recovered,Population,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,275,15.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04558385,No,Results,No,Results,No,Results,5.10.2020,None
4104,NCT04559035,ClinicalTrials.gov,21.09.2020,24.09.2020,FALSE,Augusta,University,Recruiting,Not,Applicable,Interventional,United,States,Nasal,Irrigation,to,Reduce,COVID-19,Morbidity,,Procedure,Nasal,Irrigation,Nasal,Irrigation,200,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04559035,No,Results,No,Results,No,Results,5.10.2020,None,,
4105,NCT04559113,ClinicalTrials.gov,15.09.2020,1.05.2020,TRUE,Lahore,General,Hospital,Recruiting,Not,Applicable,Interventional,Pakistan,Methylprednisolone,in,COVID-19,Patients,(Methyl19LGH),Methyl19LGH,Drug,Corticosteroids,Methylprednisolone,200,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04559113,No,Results,No,Results,No,Results,5.10.2020,None,,,,,
4106,NCT04560205,ClinicalTrials.gov,11.07.2020,1.05.2020,TRUE,Lahore,General,Hospital,Recruiting,Phase,1,Interventional,Pakistan,Tocilizumab,in,COVID-19,Lahore,General,Hospital,TC19LGH,Drug,Tocilizumab,Tocilizumab,50,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04560205,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4107,NCT04560231,ClinicalTrials.gov,11.07.2020,1.06.2020,TRUE,Lahore,General,Hospital,Recruiting,Phase,1,Interventional,Pakistan,Remdesivir,in,COVID-19,Lahore,General,Hospital,RC19LGH,Drug,Remdesivir,Remdesivir,30,30.11.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04560231,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4122,NCT04563065,ClinicalTrials.gov,19.09.2020,1.08.2020,TRUE,Universidad,Politécnica,de,Madrid,Recruiting,Not,Applicable,Interventional,Spain,Active,Pregnancy,Against,COVID-19,ACPREGCOV,Other,(exercise),Exercise,Exercise,280,30.11.2020,31.12.2023,https://clinicaltrials.gov/show/NCT04563065,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4126,NCT04563650,ClinicalTrials.gov,18.09.2020,18.09.2020,FALSE,CHU,de,Amiens,Recruiting,Not,Applicable,Interventional,France,COVID-19,Serology,and,Immunosenescence,SERO-CoV-OLD,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,330,21.05.2020,21.11.2020,https://clinicaltrials.gov/show/NCT04563650,No,Results,No,Results,No,Results,5.10.2020,None,,
4127,NCT04563676,ClinicalTrials.gov,23.09.2020,22.09.2020,TRUE,CHU,de,Amiens,Recruiting,Not,Applicable,Interventional,France,Physiopathology,and,Sequelae,of,COVID-19,Infection,SEQ-COV-PHYSIO,Clinical,Presentation,No,Intervention,No,Intervention,400,21.03.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04563676,No,Results,No,Results,No,Results,5.10.2020,None,
4131,NCT04565197,ClinicalTrials.gov,24.09.2020,1.05.2020,TRUE,Lahore,General,Hospital,Not,Recruiting,Phase,1,Interventional,Pakistan,Convalescent,Plasma,Therapy,for,COVID-19,Patients,,ATMP,Plasma,Plasma,20,30.10.2020,30.10.2020,https://clinicaltrials.gov/show/NCT04565197,No,Results,No,Results,No,Results,5.10.2020,None,,,
4136,NCT04565782,ClinicalTrials.gov,22.09.2020,15.09.2020,TRUE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,Corona,Virus,Infection,Among,Liver,Transplant,Recipients,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,150,1.11.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04565782,No,Results,No,Results,No,Results,5.10.2020,None
4144,NCT04568018,ClinicalTrials.gov,18.09.2020,3.07.2020,TRUE,Biosurf,LLC.,Recruiting,Not,Applicable,Observational,Russian,Federation,Surfactant-BL,in,Adult,Acute,Respiratory,Distress,Syndrome,Due,to,COVID-19,,Drug,Surfactant-BL,Surfactant-BL,120,31.12.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04568018,No,Results,No,Results,No,Results,5.10.2020,None
4146,NCT04568148,ClinicalTrials.gov,15.04.2020,15.04.2020,FALSE,University,of,Kansas,Medical,Center,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Biorepository,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,50,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04568148,No,Results,No,Results,No,Results,5.10.2020,None,
4150,NCT04568889,ClinicalTrials.gov,24.09.2020,28.09.2020,FALSE,Harvard,University,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Minnesota,COVID-19,Testing,Project,,Other,Other,Other,1000,2.10.2020,30.06.2021,https://clinicaltrials.gov/show/NCT04568889,No,Results,No,Results,No,Results,5.10.2020,None,,,,
4162,JPRN-jRCT2031200120,JPRN,16.09.2020,16.09.2020,FALSE,Yamaoka,Kunihiro,Recruiting,Phase,2,Interventional,Japan,double-blind,study,in,COvid-19,patients,with,iveRmectin,,Drug,Ivermectin,Ivermectin,240,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,No,Results,No,Results,No,Results,6.10.2020,None,,
4165,JPRN-jRCTs031200124,JPRN,17.09.2020,17.09.2020,FALSE,Kutsuna,Satoshi,Recruiting,Not,Applicable,Interventional,Japan,COVIPLA-R,,ATMP,Plasma,Plasma,59,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,No,Results,No,Results,No,Results,6.10.2020,None,,,,,,,,
4166,JPRN-jRCTs032200131,JPRN,28.09.2020,28.09.2020,FALSE,Izumi,Shinnyuu,Recruiting,Phase,2,Interventional,Japan,PMX-DHP,for,COVID-19,,Procedure,PMX-DHP,PMX-DHP,30,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,No,Results,No,Results,No,Results,6.10.2020,None,,,,,,
4168,JPRN-UMIN000039873,JPRN,19.03.2020,19.03.2020,FALSE,National,Center,for,Global,Health,and,Medicine,Recruiting,Not,Applicable,Observational,Japan,COVID-19,Registry,,Clinical,Presentation,No,Intervention,No,Intervention,99999,Not,Available,31.03.2022,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,No,Results,No,Results,No,Results,6.10.2020,None
4185,IRCT20190717044241N2,IRCT,22.04.2020,20.04.2020,TRUE,Barakat,Pharmaceutical,Group,Recruiting,Phase,1,Interventional,Iran,Cell,therapy,in,patients,with,COVID-19,,ATMP,Cells,(mesenchymal),Cells,(mesenchymal),5,Not,Available,Not,Available,http://en.irct.ir/trial/47110,No,Results,No,Results,No,Results,6.10.2020,None
4192,IRCT20180624040213N2,IRCT,14.09.2020,21.07.2020,TRUE,Babol,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Montelukast,in,COVID-19,,Drug,Montelukast,Montelukast,114,Not,Available,Not,Available,http://en.irct.ir/trial/49420,No,Results,No,Results,No,Results,6.10.2020,None,,,
4193,IRCT20200504047298N3,IRCT,9.09.2020,22.08.2020,TRUE,Karaj,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,Effect,of,Diphenhydramine,Compound,in,Covid-19,,Drug,Diphenhydramine,Diphenhydramine,120,Not,Available,Not,Available,http://en.irct.ir/trial/49696,No,Results,No,Results,No,Results,6.10.2020,None
4205,IRCT20200907048644N1,IRCT,4.10.2020,22.09.2020,TRUE,Zahedan,University,of,Medical,Sciences,Recruiting,Phase,1,Interventional,Iran,Celecoxib,effects,on,,COVID-19,patients,,Drug,Celecoxib,Celecoxib,60,Not,Available,Not,Available,http://en.irct.ir/trial/50932,No,Results,No,Results,No,Results,6.10.2020,None
4216,NCT04346628,ClinicalTrials.gov,10.04.2020,12.07.2020,FALSE,Stanford,University,Recruiting,Phase,2,Interventional,United,States,Oral,Favipiravir,Compared,to,Placebo,in,Subjects,With,Mild,COVID-19,,Drug,Favipiravir,Favipiravir,120,21.07.2020,21.07.2020,https://clinicaltrials.gov/show/NCT04346628,No,Results,No,Results,No,Results,12.10.2020,None
4218,NCT04348929,ClinicalTrials.gov,10.04.2020,16.04.2020,FALSE,CHU,de,Nancy,Recruiting,Not,Applicable,Interventional,France,Birth,Experience,During,COVID-19,Confinement,CONFINE,Clinical,Presentation,No,Intervention,No,Intervention,927,16.08.2021,1.10.2021,https://clinicaltrials.gov/show/NCT04348929,No,Results,No,Results,No,Results,12.10.2020,None,,
4221,NCT04353583,ClinicalTrials.gov,6.04.2020,21.04.2020,FALSE,University,of,Giessen,Recruiting,Not,Applicable,Observational,Germany,Renal,Outcome,in,Patients,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,40,31.12.2020,31.03.2021,https://clinicaltrials.gov/show/NCT04353583,No,Results,No,Results,No,Results,12.10.2020,None,
4223,NCT04354870,ClinicalTrials.gov,16.04.2020,3.04.2020,TRUE,NYU,Langone,Health,Not,Recruiting,Phase,2,Interventional,United,States,COVID-19,PrEP,HCW,HCQ,Study,,Drug,Hydroxychloroquine,Hydroxychloroquine,130,15.09.2020,1.10.2020,https://clinicaltrials.gov/show/NCT04354870,No,Results,No,Results,No,Results,12.10.2020,None,,,
4236,NCT04381884,ClinicalTrials.gov,5.05.2020,18.05.2020,FALSE,Laboratorio,Elea,Not,Recruiting,Phase,2,Interventional,Argentina,Ivermectin,Effect,on,SARS-CoV-2,Replication,in,Patients,With,COVID-19,,Drug,Ivermectin,Ivermectin,45,29.09.2020,29.09.2020,https://clinicaltrials.gov/show/NCT04381884,No,Results,No,Results,No,Results,12.10.2020,None,
4243,NCT04395885,ClinicalTrials.gov,19.05.2020,1.06.2020,FALSE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Sexual,Function,During,COVID,19,Pandemic,,Other,(psych),No,Intervention,No,Intervention,306,31.08.2020,15.09.2020,https://clinicaltrials.gov/show/NCT04395885,No,Results,No,Results,No,Results,12.10.2020,None,
4248,NCT04409509,ClinicalTrials.gov,28.05.2020,1.07.2020,FALSE,CSL,Behring,Recruiting,Phase,2,Interventional,United,States,Treatment,With,CSL312,in,Adults,With,Coronavirus,Disease,2019,(COVID-19),,Drug,Garadacimab,Garadacimab,124,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04409509,No,Results,No,Results,No,Results,12.10.2020,None
4262,NCT04468789,ClinicalTrials.gov,8.07.2020,1.11.2020,FALSE,Boston,University,Not,Recruiting,Not,Applicable,Observational,South,Africa,Evaluation,of,Six-month,HIV,Treatment,Dispensing,in,South,Africa,,Other,Other,Other,150945,21.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04468789,No,Results,No,Results,No,Results,12.10.2020,None
4266,NCT04490278,ClinicalTrials.gov,23.07.2020,29.09.2020,FALSE,Washington,University,in,St.,Louis,Recruiting,Not,Applicable,Interventional,United,States,CoV-PICS:,A,Virtual,Post-ICU,Clinic,,Telehealth,Telehealth,Telehealth,80,30.07.2021,30.07.2021,https://clinicaltrials.gov/show/NCT04490278,No,Results,No,Results,No,Results,12.10.2020,None,,
4267,NCT04492228,ClinicalTrials.gov,25.07.2020,1.09.2020,FALSE,Ospedale,Policlinico,San,Martino,Recruiting,Not,Applicable,Interventional,Italy,Eucaloric,Ketogenic,Diet,in,COVID-19,Cytokine,Storm,Syndrome,ketocovidiet,Other,(nutrition),Nutrition,Nutrition,100,31.12.2020,30.05.2021,https://clinicaltrials.gov/show/NCT04492228,No,Results,No,Results,No,Results,12.10.2020,None
4269,NCT04504734,ClinicalTrials.gov,4.08.2020,30.09.2020,FALSE,Revive,Therapeutics,,Ltd.,Recruiting,Phase,3,Interventional,United,States,Bucillamine,in,Treatment,of,Patients,With,COVID-19,,Drug,Bucillamine,Bucillamine,1000,1.02.2021,1.05.2021,https://clinicaltrials.gov/show/NCT04504734,No,Results,No,Results,No,Results,12.10.2020,None,
4271,NCT04505592,ClinicalTrials.gov,6.08.2020,25.09.2020,FALSE,Hooman,Poor,Recruiting,Phase,2,Interventional,United,States,Tenecteplase,in,Patients,With,COVID-19,,Drug,Tenecteplase,Tenecteplase,60,21.02.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04505592,No,Results,No,Results,No,Results,12.10.2020,None,,,,,
4272,NCT04505774,ClinicalTrials.gov,6.08.2020,4.09.2020,FALSE,Dr.,Matthew,Neal,Recruiting,Phase,4,Interventional,United,States,Anti-thrombotics,for,Adults,Hospitalized,With,COVID-19,(ACTIV-4),,Drug,Heparin,Heparin,2000,21.03.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04505774,No,Results,No,Results,No,Results,12.10.2020,None,,
4273,NCT04509947,ClinicalTrials.gov,11.08.2020,11.08.2020,FALSE,Janssen,Pharmaceutical,Recruiting,Phase,1,Interventional,Japan,A,Study,of,Ad26.COV2.S,in,Adults,(COVID-19),,ATMP,Vaccine,Vaccine,250,8.01.2021,26.10.2021,https://clinicaltrials.gov/show/NCT04509947,No,Results,No,Results,No,Results,12.10.2020,None,,,,
4277,NCT04536376,ClinicalTrials.gov,26.08.2020,1.11.2020,FALSE,Mayo,Clinic,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,First,Responder,Resiliency,Program,During,COVID-19,,Other,No,Intervention,No,Intervention,10,2.08.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04536376,No,Results,No,Results,No,Results,12.10.2020,None
4280,NCT04551339,ClinicalTrials.gov,9.09.2020,28.09.2020,FALSE,Mayo,Clinic,Recruiting,Not,Applicable,Interventional,United,States,Zinc,Versus,Multivitamin,Micronutrient,Supplementation,in,the,Setting,of,COVID-19,ZnCOVID-19,Drug,Zinc,Zinc,4500,14.03.2021,14.05.2021,https://clinicaltrials.gov/show/NCT04551339,No,Results,No,Results,No,Results,12.10.2020,None
4294,NCT04569188,ClinicalTrials.gov,4.09.2020,15.05.2020,TRUE,Azienda,Socio,Sanitaria,Territoriale,di,Mantova,Not,Recruiting,Phase,2,Interventional,Italy,Convalescent,Plasma,in,COVID-19,Elderly,Patients,RESCUE,ATMP,Plasma,Plasma,21,15.08.2020,3.09.2020,https://clinicaltrials.gov/show/NCT04569188,No,Results,No,Results,No,Results,12.10.2020,None
4300,NCT04569877,ClinicalTrials.gov,25.09.2020,24.09.2020,TRUE,University,of,Giessen,Recruiting,Phase,2,Interventional,Germany,GM-CSF,Inhalation,to,Prevent,ARDS,in,COVID-19,Pneumonia,GI-COVID,Drug,Molgramostim,Molgramostim,238,25.12.2022,25.12.2022,https://clinicaltrials.gov/show/NCT04569877,No,Results,No,Results,No,Results,12.10.2020,None,,
4301,NCT04570202,ClinicalTrials.gov,28.09.2020,15.10.2020,FALSE,CHU,de,Tours,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Health,cAre,woRkers,exposeD,to,COVID-19,HARD-COVID19,Other,(psych),Psychological,Psychological,900,15.06.2021,15.07.2022,https://clinicaltrials.gov/show/NCT04570202,No,Results,No,Results,No,Results,12.10.2020,None
4304,NCT04570397,ClinicalTrials.gov,29.09.2020,1.11.2020,FALSE,Brigham,and,Women's,Hospital,Not,Recruiting,Phase,3,Interventional,United,States,Ravulizumab,and,COVID-19,,Drug,Ravulizumab,Ravulizumab,32,21.05.2020,21.11.2020,https://clinicaltrials.gov/show/NCT04570397,No,Results,No,Results,No,Results,12.10.2020,None,,,,
4306,NCT04570462,ClinicalTrials.gov,21.07.2020,18.05.2020,TRUE,Northwell,Health,Recruiting,Not,Applicable,Interventional,United,States,Mild,Hypothermia,for,COVID-19,ARDS,,Other,(device),Cooling,Machine,Cooling,Machine,20,31.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04570462,No,Results,No,Results,No,Results,12.10.2020,None,,
4308,NCT04570982,ClinicalTrials.gov,24.07.2020,30.07.2020,FALSE,Dr.,Pradip,Gyanwali,Recruiting,Not,Applicable,Observational,Nepal,Clinical,Protocol,for,Convalescent,Plasma,and,Remdesivir,Therapy,in,Nepal,CPT-R-Nepal,ATMP,Plasma,Plasma,200,30.10.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04570982,No,Results,No,Results,No,Results,12.10.2020,None
4318,NCT04573868,ClinicalTrials.gov,30.09.2020,1.03.2020,TRUE,Hospitales,Universitarios,Virgen,del,Rocio,Recruiting,Not,Applicable,Observational,Spain,"""National",Study,"""""AEC","COVID-19""""""",,Health,System,No,Intervention,No,Intervention,1000,30.06.2020,30.09.2020,https://clinicaltrials.gov/show/NCT04573868,No,Results,No,Results,No,Results,12.10.2020,None,
4319,NCT04574050,ClinicalTrials.gov,28.09.2020,3.12.2020,FALSE,King's,College,Hospital,NHS,Trust,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,SELF-BREATHE,RCT,for,Chronic,Breathlessness,,Other,Other,Other,40,4.04.2022,30.06.2022,https://clinicaltrials.gov/show/NCT04574050,No,Results,No,Results,No,Results,12.10.2020,None
4323,NCT04575532,ClinicalTrials.gov,1.10.2020,5.10.2020,FALSE,physIQ,,Inc.,Recruiting,Not,Applicable,Observational,United,States,Detection,of,COVID-19,Decompensation,DeCODe,Prognosis,No,Intervention,No,Intervention,400,15.01.2021,22.01.2021,https://clinicaltrials.gov/show/NCT04575532,No,Results,No,Results,No,Results,12.10.2020,None,,,
4325,NCT04575571,ClinicalTrials.gov,24.09.2020,29.04.2020,TRUE,Laval,University,Recruiting,Not,Applicable,Observational,Canada,MAVIPAN:,My,Life,and,the,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,5000,29.04.2025,29.04.2025,https://clinicaltrials.gov/show/NCT04575571,No,Results,No,Results,No,Results,12.10.2020,None,,
4326,NCT04575610,ClinicalTrials.gov,5.08.2020,10.10.2020,FALSE,Yale,University,Not,Recruiting,Phase,2,Interventional,United,States,IRAK4,Inhibition,in,Treatment,of,COVID-19,With,ARDS,(I-RAMIC),,Drug,PF-06650833,PF-06650833,68,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04575610,No,Results,No,Results,No,Results,12.10.2020,None
4333,EUCTR2020-001610-38-DK,EU,Clinical,Trials,Register,7.04.2020,16.09.2020,FALSE,Slagelse,Hospital,Authorised,Phase,4,Interventional,Denmark,Irbesartan,and,Oseltamivir,treatment,of,COVID-19,infection.,,Drug,Irbesartan,+,Oseltamivir,Irbesartan,,,,,,,,,,,
4339,NCT04322773,ClinicalTrials.gov,24.03.2020,5.04.2020,TRUE,Marius,Henriksen,Not,Recruiting,Phase,2,Interventional,Denmark,Anti-il6,Treatment,of,Serious,COVID-19,Disease,With,Threatening,Respiratory,Failure,TOCIVID,Drug,Tocilizumab,vs.,sarilumab,Tocilizumab,,,,,,,,,,
4346,NCT04335305,ClinicalTrials.gov,31.03.2020,9.04.2020,FALSE,MedSIR,Recruiting,Phase,2,Interventional,Spain,Checkpoint,Blockade,in,COVID-19,Pandemic,COPERNICO,Drug,Tocilizumab,+,Pembrolizumab,Tocilizumab,,,,,,,,,,,,,,,,,
4350,NCT04341935,ClinicalTrials.gov,6.04.2020,30.01.2021,FALSE,University,of,Miami,Not,Recruiting,Phase,4,Interventional,United,States,Effects,of,DPP4,Inhibition,on,COVID-19,,Drug,Linagliptin,Linagliptin,20,30.06.2021,30.12.2021,https://clinicaltrials.gov/show/NCT04341935,No,Results,No,Results,No,Results,19.10.2020,None,,
4353,NCT04347226,ClinicalTrials.gov,2.04.2020,16.04.2020,FALSE,Matthew,Dallos,Recruiting,Phase,2,Interventional,United,States,Anti-Interleukin-8,(Anti-IL-8),for,Patients,With,COVID-19,,Drug,Anti-Interleukin-8,Anti-Interleukin-8,138,21.09.2020,22.09.2020,https://clinicaltrials.gov/show/NCT04347226,No,Results,No,Results,No,Results,19.10.2020,None,,,,
4359,NCT04359277,ClinicalTrials.gov,20.04.2020,21.04.2020,FALSE,NYU,Langone,Health,Not,Recruiting,Phase,3,Interventional,United,States,A,Randomized,Trial,of,Anticoagulation,Strategies,in,COVID-19,,Drug,Enoxaparin,,Heparin,Enoxaparin,,,,,,,,,,
4360,NCT04359797,ClinicalTrials.gov,20.04.2020,27.04.2020,FALSE,Vanderbilt,University,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,Patient,Positioning,Pragmatic,Trial,,Procedure,Positioning,Positioning,300,21.04.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04359797,No,Results,No,Results,No,Results,19.10.2020,None,,,,,
4369,NCT04376580,ClinicalTrials.gov,30.04.2020,30.04.2020,FALSE,Tiva,Group,Recruiting,Not,Applicable,Observational,Argentina,Use,of,the,Nasal,Cannula,During,COVID-19,,Other,(device),Nasal,cannula,Nasal,cannula,100,31.10.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04376580,No,Results,No,Results,No,Results,19.10.2020,None,
4374,NCT04384458,ClinicalTrials.gov,8.05.2020,20.07.2020,FALSE,Federal,University,of,Ceara,Recruiting,Not,Applicable,Interventional,Brazil,Comparative,Study,of,Hydroxychloroquine,and,Ivermectin,in,COVID-19,Prophylaxis,,Drug,(Chemoprophylaxis),Hydroxychloroquine,+,Zinc,Hydroxychloroquine,,,,,,,,,
4378,NCT04394377,ClinicalTrials.gov,8.05.2020,21.06.2020,FALSE,Brazilian,Clinical,Research,Institute,Recruiting,Phase,4,Interventional,Brazil,Full,Anticoagulation,Versus,Prophylaxis,in,COVID-19:,COALIZAO,ACTION,Trial,ACTION,Drug,Rivaroxaban,+,Heparin,Rivaroxaban,,,,,,,,,,
4381,NCT04399356,ClinicalTrials.gov,19.05.2020,12.10.2020,FALSE,Tufts,Medical,Center,Not,Recruiting,Phase,2,Interventional,No,Country,Given,Niclosamide,for,Mild,to,Moderate,COVID-19,,Drug,Niclosamide,Niclosamide,100,1.01.2021,12.02.2021,https://clinicaltrials.gov/show/NCT04399356,No,Results,No,Results,No,Results,19.10.2020,None,
4384,NCT04415151,ClinicalTrials.gov,2.06.2020,29.07.2020,FALSE,Yale,University,Recruiting,Phase,2,Interventional,United,States,Tofacitinib,for,Treatment,of,Moderate,COVID-19,I-TOMIC,Drug,Tofacitinib,Tofacitinib,60,31.03.2021,31.03.2021,https://clinicaltrials.gov/show/NCT04415151,No,Results,No,Results,No,Results,19.10.2020,None,,,,
4386,NCT04421612,ClinicalTrials.gov,4.06.2020,2.04.2020,TRUE,Haukeland,University,Hospital,Recruiting,Not,Applicable,Interventional,Norway,Coping,With,2020,-,No,Health,Without,Mental,Health,Co_Coping,Other,(psych),Psychological,Psychological,400,1.01.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04421612,No,Results,No,Results,No,Results,19.10.2020,None
4397,NCT04459286,ClinicalTrials.gov,3.07.2020,9.10.2020,FALSE,Obafemi,Awolowo,University,Recruiting,Phase,2,Interventional,Nigeria,The,Nitazoxanide,Plus,Atazanavir,for,COVID-19,Study,NACOVID,Drug,Nitazoxanide,+,Atazanavir/ritonavir,Nitazoxanide,,,,,,,,,,,,,
4406,NCT04490239,ClinicalTrials.gov,20.07.2020,9.10.2020,FALSE,Joshua,Sharp,Not,Recruiting,Phase,1,Interventional,United,States,Intranasal,Heparin,Tolerability,Study,,Drug,Heparin,Heparin,6,20.11.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04490239,No,Results,No,Results,No,Results,19.10.2020,None,,,,,
4408,NCT04496076,ClinicalTrials.gov,13.07.2020,2.04.2020,TRUE,University,of,Pittsburgh,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Brain,Injury,,Clinical,Presentation,No,Intervention,No,Intervention,300,31.12.2020,31.03.2021,https://clinicaltrials.gov/show/NCT04496076,No,Results,No,Results,No,Results,19.10.2020,None,,,
4409,NCT04496128,ClinicalTrials.gov,13.07.2020,13.04.2020,TRUE,University,of,Pittsburgh,Recruiting,Not,Applicable,Observational,United,States,COVID19,Neurological,Manifestation,,Clinical,Presentation,No,Intervention,No,Intervention,300,31.12.2020,31.03.2021,https://clinicaltrials.gov/show/NCT04496128,No,Results,No,Results,No,Results,19.10.2020,None,,,
4418,NCT04522817,ClinicalTrials.gov,20.08.2020,5.10.2020,FALSE,Caladrius,Biosciences,,Inc.,Recruiting,Phase,1,Interventional,United,States,CLBS119,for,Repair,of,COVID-19,Induced,Pulmonary,Damage,,Drug,CLBS119,CLBS119,12,21.05.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04522817,No,Results,No,Results,No,Results,19.10.2020,None
4435,NCT04566276,ClinicalTrials.gov,15.09.2020,1.01.2021,FALSE,Chulalongkorn,University,Not,Recruiting,Phase,1,Interventional,Thailand,ChulaCov19,mRNA,Vaccine,in,Healthy,Adults,,ATMP,Vaccine,Vaccine,96,21.03.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04566276,No,Results,No,Results,No,Results,19.10.2020,None,,,,
4439,NCT04572399,ClinicalTrials.gov,28.09.2020,1.10.2020,FALSE,Cedars-Sinai,Medical,Center,Recruiting,Not,Applicable,Interventional,United,States,UVA,Light,Device,to,Treat,COVID-19,,Other,Ultraviolet,Therapy,Ultraviolet,Therapy,5,20.12.2020,20.12.2020,https://clinicaltrials.gov/show/NCT04572399,No,Results,No,Results,No,Results,19.10.2020,None,
4446,NCT04577534,ClinicalTrials.gov,3.09.2020,14.08.2020,TRUE,Jarmo,Oksi,Recruiting,Phase,3,Interventional,Finland,COVID-19:,Salvage,TOcilizumab,as,a,Rescue,Measure,COVIDSTORM,Drug,Tocilizumab,Tocilizumab,90,31.12.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04577534,No,Results,No,Results,No,Results,19.10.2020,None,,,,
4453,NCT04579588,ClinicalTrials.gov,6.10.2020,1.12.2020,FALSE,Stanford,University,Not,Recruiting,Not,Applicable,Observational,United,States,Understanding,Immunity,to,the,Flu,Vaccine,in,COVID-19,Patients,,ATMP,Vaccine,Vaccine,80,1.12.2022,1.12.2022,https://clinicaltrials.gov/show/NCT04579588,No,Results,No,Results,No,Results,19.10.2020,None
4455,NCT04581031,ClinicalTrials.gov,4.05.2020,11.07.2020,FALSE,The,Christie,NHS,Foundation,Trust,Recruiting,Not,Applicable,Interventional,United,Kingdom,COntinuous,Signs,Monitoring,In,Covid-19,Patients,COSMIC-19,Other,(device),Biosensors,Biosensors,60,1.02.2021,1.02.2021,https://clinicaltrials.gov/show/NCT04581031,No,Results,No,Results,No,Results,19.10.2020,None
4456,NCT04581044,ClinicalTrials.gov,6.10.2020,17.09.2020,TRUE,Cairo,University,Recruiting,Not,Applicable,Observational,Egypt,Impact,of,COVID-19,on,Psoriasis,Practice,,Health,System,No,Intervention,No,Intervention,150,23.10.2020,23.10.2020,https://clinicaltrials.gov/show/NCT04581044,No,Results,No,Results,No,Results,19.10.2020,None,,
4463,NCT04581200,ClinicalTrials.gov,4.10.2020,1.11.2020,FALSE,Duke,University,Not,Recruiting,Not,Applicable,Interventional,United,States,Lift,Mobile,Mindfulness,for,COVID-19,Distress,Symptoms,LIFTCOVID,Other,(psych),Psychological,Psychological,300,31.05.2021,30.09.2021,https://clinicaltrials.gov/show/NCT04581200,No,Results,No,Results,No,Results,19.10.2020,None,
4469,NCT04581928,ClinicalTrials.gov,6.10.2020,10.10.2020,FALSE,ClinAmygate,Not,Recruiting,Not,Applicable,Observational,Egypt,Patients,Reactions,Towards,Their,Diagnosis,as,Having,COVID-19,,Other,No,Intervention,No,Intervention,300,10.12.2020,15.12.2020,https://clinicaltrials.gov/show/NCT04581928,No,Results,No,Results,No,Results,19.10.2020,None,
4470,NCT04581954,ClinicalTrials.gov,5.10.2020,2.10.2020,TRUE,Imperial,College,London,Recruiting,Phase,1/Phase,2,Interventional,United,Kingdom,Inflammatory,Signal,Inhibitors,for,COVID-19,(MATIS),MATIS,Drug,Fostamatinib,vs.,Ruxolitinib,Fostamatinib,,,,,,,,,,,,
4475,NCT04582344,ClinicalTrials.gov,1.10.2020,14.09.2020,TRUE,Health,Institutes,of,Turkey,Recruiting,Phase,3,Interventional,Turkey,Clinical,Trial,For,SARS-CoV-2,Vaccine,(COVID-19),,ATMP,Vaccine,Vaccine,13000,15.02.2021,15.04.2021,https://clinicaltrials.gov/show/NCT04582344,No,Results,No,Results,No,Results,19.10.2020,None,,,
4476,NCT04583306,ClinicalTrials.gov,9.10.2020,1.06.2020,TRUE,Fondazione,Don,Carlo,Gnocchi,Onlus,Recruiting,Not,Applicable,Observational,Italy,The,Salivary,Raman,COVID-19,Fingerprint,DISCOVER,Clinical,Presentation,No,Intervention,No,Intervention,120,15.12.2020,1.06.2021,https://clinicaltrials.gov/show/NCT04583306,No,Results,No,Results,No,Results,19.10.2020,None
4480,NCT04583865,ClinicalTrials.gov,7.10.2020,7.10.2020,FALSE,University,Hospital,,Toulouse,Not,Recruiting,Not,Applicable,Observational,France,Feasibility,and,Quality,of,TeleConsultation,in,Pediatric,Anesthesia,TéléCCCAP,Telehealth,Telehealth,Telehealth,400,14.09.2021,14.03.2022,https://clinicaltrials.gov/show/NCT04583865,No,Results,No,Results,No,Results,19.10.2020,None
4481,NCT04583982,ClinicalTrials.gov,7.10.2020,9.10.2020,FALSE,Adaptive,Biotechnologies,Not,Recruiting,Not,Applicable,Observational,United,States,ImmuneSense™,COVID-19,Study,,Diagnostics,Diagnostic,Test,or,Assessment,Diagnostic,Test,or,Assessment,125,9.01.2021,9.01.2021,https://clinicaltrials.gov/show/NCT04583982,No,Results,No,Results,No,Results,19.10.2020,None
4523,NCT04388813,ClinicalTrials.gov,4.05.2020,28.05.2020,FALSE,Verily,Life,Sciences,LLC,Recruiting,Not,Applicable,Observational,United,States,Predictors,of,Severe,COVID-19,Outcomes,PRESCO,Prognosis,No,Intervention,No,Intervention,1500,21.02.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04388813,No,Results,No,Results,No,Results,26.10.2020,None,
4525,NCT04400058,ClinicalTrials.gov,21.05.2020,1.06.2020,FALSE,Octapharma,Recruiting,Phase,3,Interventional,United,States,Octagam,10%,Therapy,in,COVID-19,Patients,With,Severe,Disease,Progression,,ATMP,Immunoglobulin,Immunoglobulin,208,30.12.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04400058,No,Results,No,Results,No,Results,26.10.2020,None,
4533,NCT04419610,ClinicalTrials.gov,16.04.2020,9.10.2020,FALSE,Imperial,College,London,Recruiting,Phase,1,Interventional,United,Kingdom,RAS,and,Coagulopathy,in,COVID19,,Drug,TRV027,TRV027,60,20.12.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04419610,No,Results,No,Results,No,Results,26.10.2020,None,,,,
4542,NCT04435184,ClinicalTrials.gov,16.06.2020,9.07.2020,FALSE,Johns,Hopkins,University,Recruiting,Phase,2,Interventional,United,States,Crizanlizumab,for,Treating,COVID-19,Vasculopathy,CRITICAL,Drug,Crizanlizumab,Crizanlizumab,40,31.12.2020,31.01.2021,https://clinicaltrials.gov/show/NCT04435184,No,Results,No,Results,No,Results,26.10.2020,None,,,,
4543,NCT04435795,ClinicalTrials.gov,16.06.2020,14.09.2020,FALSE,McGill,University,Recruiting,Phase,2/Phase,3,Interventional,Canada,Inhaled,Ciclesonide,for,Outpatients,With,COVID19,CONTAIN,Drug,Ciclesonide,Ciclesonide,454,25.02.2021,25.03.2021,https://clinicaltrials.gov/show/NCT04435795,No,Results,No,Results,No,Results,26.10.2020,None,,,,
4544,NCT04436276,ClinicalTrials.gov,15.06.2020,15.07.2020,FALSE,Janssen,Pharmaceutical,Recruiting,Phase,1/Phase,2,Interventional,United,States,,Belgium,A,Study,of,Ad26.COV2.S,in,Adults,(COVID-19),,ATMP,Vaccine,Vaccine,1045,15.09.2021,4.01.2024,https://clinicaltrials.gov/show/NCT04436276,No,Results,No,Results,No,Results,26.10.2020,None
4548,NCT04451174,ClinicalTrials.gov,26.06.2020,23.06.2020,TRUE,University,of,Chile,Recruiting,Phase,3,Interventional,Chile,Early,Use,of,Corticosteroids,in,Non-critical,Patients,With,COVID-19,Pneumonia,PREDCOVID,Drug,Corticosteroids,Prednisone,184,30.11.2020,30.12.2020,https://clinicaltrials.gov/show/NCT04451174,No,Results,No,Results,No,Results,26.10.2020,None
4558,NCT04495907,ClinicalTrials.gov,30.07.2020,6.08.2020,FALSE,Davita,Clinical,Research,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Progression,in,End-Stage,Kidney,Disease,COPE,Clinical,Presentation,No,Intervention,No,Intervention,1000,20.12.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04495907,No,Results,No,Results,No,Results,26.10.2020,None
4562,NCT04512079,ClinicalTrials.gov,11.08.2020,8.09.2020,FALSE,Valentin,Fuster,Recruiting,Phase,4,Interventional,United,States,FREEDOM,COVID-19,Anticoagulation,Strategy,FREEDOM,COVID,Drug,Apixaban,vs.,Enoxaparin,Apixaban,,,,,,,,,,,,,,,
4565,NCT04513470,ClinicalTrials.gov,10.08.2020,1.08.2020,TRUE,Hadassah,Medical,Organization,Not,Recruiting,Phase,1,Interventional,Israel,Allocetra-OTS,in,COVID-19,,ATMP,Cells,(mononuclear),Cells,(mononuclear),5,21.01.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04513470,No,Results,No,Results,No,Results,26.10.2020,None,,,,
4570,NCT04530604,ClinicalTrials.gov,25.08.2020,1.10.2020,FALSE,Gregory,Yanik,Recruiting,Phase,1,Interventional,United,States,Defibrotide,Therapy,for,SARS-CoV2,(COVID-19),Acute,Respiratory,Distress,Syndrome,(ARDS),,Drug,Defibrotide,Defibrotide,12,1.10.2021,1.10.2021,https://clinicaltrials.gov/show/NCT04530604,No,Results,No,Results,No,Results,26.10.2020,None
4578,NCT04557605,ClinicalTrials.gov,9.09.2020,14.09.2020,FALSE,University,of,Saskatchewan,Not,Recruiting,Not,Applicable,Interventional,Canada,Effects,of,a,Face,Mask,on,Oxygenation,During,Exercise,,Other,Other,Other,14,15.10.2020,15.10.2020,https://clinicaltrials.gov/show/NCT04557605,No,Results,No,Results,No,Results,26.10.2020,None
4579,NCT04568031,ClinicalTrials.gov,21.08.2020,23.08.2020,FALSE,AstraZeneca,Recruiting,Phase,1/Phase,2,Interventional,Japan,Study,of,AZD1222,for,the,Prevention,of,COVID-19,in,Japan,,Drug,(Chemoprophylaxis),AZD1222,AZD1222,256,10.11.2021,10.11.2021,https://clinicaltrials.gov/show/NCT04568031,No,Results,No,Results,No,Results,26.10.2020,None
4583,NCT04570488,ClinicalTrials.gov,25.09.2020,15.05.2020,TRUE,NYU,Langone,Health,Recruiting,Not,Applicable,Interventional,United,States,Predicting,Favorable,Outcomes,in,Hospitalized,Covid-19,Patients,,Prognosis,No,Intervention,No,Intervention,1200,30.12.2020,15.05.2021,https://clinicaltrials.gov/show/NCT04570488,No,Results,No,Results,No,Results,26.10.2020,None
4608,NCT04588792,ClinicalTrials.gov,14.10.2020,19.10.2020,FALSE,Queen's,University,Not,Recruiting,Phase,2/Phase,3,Interventional,Canada,Furosemide,as,Supportive,Therapy,for,COVID-19,Respiratory,Failure,FaST-1,Drug,Furosemide,Furosemide,640,1.10.2021,1.10.2021,https://clinicaltrials.gov/show/NCT04588792,No,Results,No,Results,No,Results,26.10.2020,None,
4610,NCT04589104,ClinicalTrials.gov,12.10.2020,26.05.2020,TRUE,Duke,University,Not,Recruiting,Not,Applicable,Interventional,United,States,Expressive,Writing,for,COVID-19,Resilience,,Other,(psych),Psychological,Psychological,63,17.08.2020,17.08.2020,https://clinicaltrials.gov/show/NCT04589104,No,Results,No,Results,No,Results,26.10.2020,None,,,
4611,NCT04589117,ClinicalTrials.gov,12.10.2020,27.05.2020,TRUE,Duke,University,Not,Recruiting,Not,Applicable,Interventional,United,States,Expressive,Writing,for,COVID-19,Resilience,for,Parents,,Other,(psych),Psychological,Psychological,11,2.08.2020,2.08.2020,https://clinicaltrials.gov/show/NCT04589117,No,Results,No,Results,No,Results,26.10.2020,None,
4621,NCT04590378,ClinicalTrials.gov,14.10.2020,1.03.2020,TRUE,Usak,University,Recruiting,Not,Applicable,Observational,Turkey,Pulmonary,Embolism,and,COVID-19,COVID-19-PE,Clinical,Presentation,No,Intervention,No,Intervention,600,1.11.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04590378,No,Results,No,Results,No,Results,26.10.2020,None,,,,
4626,NCT04591158,ClinicalTrials.gov,15.09.2020,15.09.2020,FALSE,Bridge,to,Health,Medical,and,Dental,USA,Recruiting,Not,Applicable,Interventional,Canada,COVID-19,and,Lung,Ultrasound,Utility,,Telehealth,Telehealth,Telehealth,100,21.09.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04591158,No,Results,No,Results,No,Results,26.10.2020,None,
4628,NCT04591210,ClinicalTrials.gov,6.10.2020,30.10.2020,FALSE,Ottawa,Heart,Institute,Research,Corporation,Not,Recruiting,Phase,3,Interventional,Canada,The,COVID-RASi,Trial,(COVID-19),,Drug,ACE,inhibitors,or,ARBs,ACE,inhibitors,,,,,,,,,,,
4629,NCT04591600,ClinicalTrials.gov,15.10.2020,1.07.2020,TRUE,Alkarkh,Health,Directorate-Baghdad,Not,Recruiting,Phase,1/Phase,2,Interventional,Iraq,Effectiveness,of,Ivermectin,and,Doxycycline,on,COVID-19,Patients,,Drug,Ivermectin,+,Doxycyline,Ivermectin,,,,,,,,,,
4633,NCT04592055,ClinicalTrials.gov,16.10.2020,20.03.2020,TRUE,Usak,University,Recruiting,Not,Applicable,Observational,Turkey,The,Effect,of,COVID-19,on,Diabetes,Mellitus,COVID-19-DM,Clinical,Presentation,No,Intervention,No,Intervention,500,15.10.2020,1.11.2020,https://clinicaltrials.gov/show/NCT04592055,No,Results,No,Results,No,Results,26.10.2020,None,
4634,NCT04592354,ClinicalTrials.gov,15.10.2020,15.10.2020,FALSE,Terra,Biological,LLC,Recruiting,Not,Applicable,Interventional,United,States,Anhydrous,Enol-Oxaloacetate,(AEO),on,Improving,Fatigue,in,Post-COVID-19,Survivors,AEO,Supplement,Oxaloacetate,Oxaloacetate,40,15.04.2021,15.06.2021,https://clinicaltrials.gov/show/NCT04592354,No,Results,No,Results,No,Results,26.10.2020,None
4640,NCT04593654,ClinicalTrials.gov,16.10.2020,1.03.2020,TRUE,Karolinska,Institutet,Not,Recruiting,Not,Applicable,Observational,Sweden,Dosing,of,Thromboprophylaxis,and,Mortality,in,Critically,Ill,COVID-19,Patients,,Drug,Tinzaparin,,dalteparin,tinzaparin,,,,,,,,,,
4643,ISRCTN12107048,ISRCTN,28.05.2020,8.06.2020,FALSE,University,of,Cambridge,Recruiting,Not,Applicable,Interventional,United,Kingdom,Supporting,weight,management,during,COVID-19,,Other,(exercise),Exercise,Exercise,360,Not,Available,30.04.2021,http://isrctn.com/ISRCTN12107048,No,Results,No,Results,No,Results,26.10.2020,None,,
4664,NCT04317092,ClinicalTrials.gov,19.03.2020,19.03.2020,TRUE,National,Cancer,Institute,Not,Recruiting,Phase,2,Interventional,Italy,Tocilizumab,in,COVID-19,Pneumonia,(TOCIVID-19),TOCIVID-19,Drug,Tocilizumab,Tocilizumab,400,19.12.2020,19.12.2022,https://clinicaltrials.gov/show/NCT04317092,Pre-Print,Article,5.06.2020,https://doi.org/10.1101/2020.06.01.20119149,2.11.2020,EUCTR2020-001110-38,,,,,,
4666,NCT04323800,ClinicalTrials.gov,24.03.2020,10.06.2020,FALSE,Johns,Hopkins,University,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,to,Stem,Coronavirus,(CSSC-001),CSSC-001,ATMP,Plasma,Plasma,500,31.12.2022,23.01.2020,https://clinicaltrials.gov/show/NCT04323800,No,Results,No,Results,No,Results,2.11.2020,None,,,
4669,NCT04334629,ClinicalTrials.gov,2.04.2020,26.05.2020,FALSE,King's,College,London,Recruiting,Phase,4,Interventional,United,Kingdom,LIBERATE,Trial,in,COVID-19,LIBERATE,Drug,Ibuprofen,Ibuprofen,230,25.05.2021,25.09.2021,https://clinicaltrials.gov/show/NCT04334629,No,Results,No,Results,No,Results,2.11.2020,None,,,,,
4687,NCT04372602,ClinicalTrials.gov,30.04.2020,12.10.2020,FALSE,Washington,University,in,St.,Louis,Recruiting,Phase,2,Interventional,United,States,Duvelisib,to,Combat,COVID-19,,Drug,Duvelisib,Duvelisib,28,30.11.2021,30.04.2022,https://clinicaltrials.gov/show/NCT04372602,No,Results,No,Results,No,Results,2.11.2020,None,,,
4689,NCT04373109,ClinicalTrials.gov,16.04.2020,16.04.2020,FALSE,Jeremia,Held,Not,Recruiting,Not,Applicable,Observational,Switzerland,Stroke,Rehabilitation,Outcome,During,COVID-19,Lockdown,SROCL,Clinical,Presentation,No,Intervention,No,Intervention,36,12.10.2020,12.10.2020,https://clinicaltrials.gov/show/NCT04373109,No,Results,No,Results,No,Results,2.11.2020,None,
4690,NCT04373460,ClinicalTrials.gov,30.04.2020,3.06.2020,FALSE,Johns,Hopkins,University,Recruiting,Phase,2,Interventional,United,States,Convalescent,Plasma,to,Limit,SARS-CoV-2,Associated,Complications,CSSC-004,ATMP,Plasma,Plasma,1344,21.12.2022,31.01.2023,https://clinicaltrials.gov/show/NCT04373460,No,Results,No,Results,No,Results,2.11.2020,None,,
4694,NCT04386265,ClinicalTrials.gov,11.05.2020,15.04.2020,TRUE,SerenaGroup,,Inc.,Recruiting,Not,Applicable,Observational,United,States,,Poland,Compassionate,Use,of,Hyperbaric,Oxygen,Therapy,,Drug,Oxygen,Oxygen,100,11.05.2022,11.05.2022,https://clinicaltrials.gov/show/NCT04386265,No,Results,No,Results,No,Results,2.11.2020,None,
4700,NCT04402944,ClinicalTrials.gov,12.05.2020,5.07.2020,FALSE,Boston,Children's,Hospital,Recruiting,Phase,2,Interventional,United,States,Pulmozyme,to,Improve,COVID-19,ARDS,Outcomes,,Drug,Dornase,alfa,Dornase,alfa,60,31.05.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04402944,No,Results,No,Results,No,Results,2.11.2020,None,
4706,NCT04410328,ClinicalTrials.gov,28.05.2020,21.10.2020,FALSE,Rutgers,University,Recruiting,Phase,3,Interventional,United,States,Aggrenox,To,Treat,Acute,Covid-19,ATTAC-19,Drug,Dipyridamole,Dipyridamole,132,15.03.2021,15.12.2021,https://clinicaltrials.gov/show/NCT04410328,No,Results,No,Results,No,Results,2.11.2020,None,,,,,
4707,NCT04412785,ClinicalTrials.gov,1.06.2020,30.06.2020,FALSE,University,of,Pennsylvania,Recruiting,Phase,1,Interventional,United,States,Cyclosporine,in,Patients,With,Moderate,COVID-19,,Drug,Cyclosporine,Cyclosporine,20,21.04.2020,21.12.2020,https://clinicaltrials.gov/show/NCT04412785,No,Results,No,Results,No,Results,2.11.2020,None,,,
4711,NCT04418284,ClinicalTrials.gov,3.06.2020,5.06.2020,FALSE,South,Valley,University,Recruiting,Not,Applicable,Observational,Egypt,Online,Learning,of,Veterinary,Anatomy,During,COVID-19,Pandemic,,Other,No,Intervention,No,Intervention,400,5.11.2020,5.11.2020,https://clinicaltrials.gov/show/NCT04418284,No,Results,No,Results,No,Results,2.11.2020,None
4713,NCT04420676,ClinicalTrials.gov,4.06.2020,24.09.2020,FALSE,Medical,University,of,Graz,Recruiting,Not,Applicable,Interventional,Austria,Synbiotic,Therapy,of,Gastrointestinal,Symptoms,During,Covid-19,Infection,SynCov,Supplement,Probiotics,Probiotics,108,21.12.2020,22.12.2020,https://clinicaltrials.gov/show/NCT04420676,No,Results,No,Results,No,Results,2.11.2020,None,
4722,NCT04448119,ClinicalTrials.gov,24.06.2020,16.10.2020,FALSE,Appili,Therapeutics,Inc.,Recruiting,Phase,2,Interventional,Canada,Control,of,COVID-19,Outbreaks,in,Long,Term,Care,,Drug,Favipiravir,Favipiravir,760,21.03.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04448119,No,Results,No,Results,No,Results,2.11.2020,None,,
4734,NCT04462757,ClinicalTrials.gov,12.06.2020,28.05.2020,TRUE,University,of,Manchester,Not,Recruiting,Phase,2,Interventional,United,Kingdom,SCIL-1Ra,in,COVID-19,Feasibility,&,PK/PD,SCIL_COV19,Drug,Anakinra,Anakinra,5,31.08.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04462757,No,Results,No,Results,No,Results,2.11.2020,None,,
4737,NCT04482699,ClinicalTrials.gov,20.07.2020,30.11.2020,FALSE,Rapa,Therapeutics,LLC,Not,Recruiting,Phase,1/Phase,2,Interventional,United,States,RAPA-501-Allo,Off-the-Shelf,Therapy,of,COVID-19,,ATMP,Cells,(Allogeneic),Cells,(Allogeneic),88,30.12.2021,1.06.2022,https://clinicaltrials.gov/show/NCT04482699,No,Results,No,Results,No,Results,2.11.2020,None
4742,NCT04501458,ClinicalTrials.gov,5.08.2020,18.05.2020,TRUE,Surgical,Systems,Research,Group,Recruiting,Not,Applicable,Interventional,Kenya,Western,Kenya,Integrated,COVID-19,Response,,Health,System,Health,System,Health,System,200000,19.12.2020,19.12.2020,https://clinicaltrials.gov/show/NCT04501458,No,Results,No,Results,No,Results,2.11.2020,None,
4744,NCT04507230,ClinicalTrials.gov,7.08.2020,7.08.2020,FALSE,Assiut,University,Recruiting,Not,Applicable,Observational,Egypt,COVID-19,Associated,Coagulopathy,in,Egypt,,Clinical,Presentation,No,Intervention,No,Intervention,150,31.10.2020,31.10.2020,https://clinicaltrials.gov/show/NCT04507230,No,Results,No,Results,No,Results,2.11.2020,None,,,
4746,NCT04508712,ClinicalTrials.gov,8.08.2020,10.08.2020,FALSE,RenJi,Hospital,Recruiting,Not,Applicable,Observational,China,Long-term,Outcomes,in,Patients,With,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,900,31.08.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04508712,No,Results,No,Results,No,Results,2.11.2020,None,,
4754,NCT04535674,ClinicalTrials.gov,31.08.2020,9.10.2020,FALSE,Apogenix,AG,Recruiting,Phase,2,Interventional,Spain,,Russian,Federation,Asunercept,in,Patients,With,Severe,COVID-19,ASUNCTIS,Drug,Asunercept,Asunercept,400,21.02.2020,21.05.2020,https://clinicaltrials.gov/show/NCT04535674,No,Results,No,Results,No,Results,2.11.2020,None,,
4760,NCT04558125,ClinicalTrials.gov,19.09.2020,8.09.2020,TRUE,Cedars-Sinai,Medical,Center,Not,Recruiting,Phase,4,Interventional,United,States,Low-Dose,Tenecteplase,in,Covid-19,Diagnosed,With,Pulmonary,Embolism,,Drug,Tenecteplase,Tenecteplase,45,31.12.2021,30.06.2022,https://clinicaltrials.gov/show/NCT04558125,No,Results,No,Results,No,Results,2.11.2020,None
4770,NCT04590053,ClinicalTrials.gov,15.10.2020,20.10.2020,FALSE,Hadassah,Medical,Organization,Recruiting,Phase,2,Interventional,Israel,Allocetra-OTS,in,COVID-19,,Phase,II,,Drug,Allocetra-OTS,Allocetra-OTS,24,21.02.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04590053,No,Results,No,Results,No,Results,2.11.2020,None,,,,
4773,NCT04593069,ClinicalTrials.gov,12.10.2020,7.10.2020,TRUE,East,Limburg,Hospital,Recruiting,Not,Applicable,Interventional,Belgium,The,COGCOV,Study,in,ICU,Patients,COGCOV,Clinical,Presentation,No,Intervention,No,Intervention,60,28.02.2021,28.02.2021,https://clinicaltrials.gov/show/NCT04593069,No,Results,No,Results,No,Results,2.11.2020,None,
4781,NCT04594668,ClinicalTrials.gov,7.10.2020,24.04.2020,TRUE,Aarhus,University,Recruiting,Phase,2,Interventional,Denmark,Senicapoc,in,COVID-19,Patients,With,Severe,Respiratory,Insufficiency,COVIPOC,Drug,Senicapoc,Senicapoc,46,24.04.2021,31.12.2021,https://clinicaltrials.gov/show/NCT04594668,No,Results,No,Results,No,Results,2.11.2020,None,,,
4784,NCT04595110,ClinicalTrials.gov,14.09.2020,25.03.2020,TRUE,Anna,Falanga,Recruiting,Not,Applicable,Observational,Italy,Hemostatic,Profile,in,Patients,Affected,by,COVID-19,EMO-COVID,Clinical,Presentation,No,Intervention,No,Intervention,400,25.04.2021,10.05.2021,https://clinicaltrials.gov/show/NCT04595110,No,Results,No,Results,No,Results,2.11.2020,None,
4787,NCT04595240,ClinicalTrials.gov,14.10.2020,1.05.2020,TRUE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,Egypt,Semen,Analysis,Changes,in,Covid-19,Positivepatients,,Clinical,Presentation,No,Intervention,No,Intervention,100,15.10.2020,15.10.2020,https://clinicaltrials.gov/show/NCT04595240,No,Results,No,Results,No,Results,2.11.2020,None,
4788,NCT04596098,ClinicalTrials.gov,30.07.2020,30.04.2020,TRUE,University,Hospital,,Grenoble,Recruiting,Not,Applicable,Observational,France,Immune,Responses,to,COVID-19,,,,,,,,,,,,,,,,,,,,,
4803,NCT04600440,ClinicalTrials.gov,20.10.2020,25.04.2020,TRUE,Skåne,University,Hospital,Recruiting,Not,Applicable,Interventional,Sweden,Convalescent,Plasma,in,the,Treatment,of,Covid-19,COP20,ATMP,Plasma,Plasma,100,31.12.2021,28.02.2022,https://clinicaltrials.gov/show/NCT04600440,No,Results,No,Results,No,Results,2.11.2020,None,,,
4805,NCT04600895,ClinicalTrials.gov,15.09.2020,1.11.2020,FALSE,Appili,Therapeutics,Inc.,Not,Recruiting,Phase,3,Interventional,No,Country,Given,The,Prevent,Severe,COVID-19,(PRESECO),Study,PRESECO,Drug,Favipiravir,Favipiravir,826,21.08.2020,21.10.2020,https://clinicaltrials.gov/show/NCT04600895,No,Results,No,Results,No,Results,2.11.2020,None,
4806,NCT04600999,ClinicalTrials.gov,8.10.2020,7.10.2020,TRUE,University,of,Pecs,Recruiting,Phase,3,Interventional,Hungary,Clinical,Trial,of,Favipiravir,Treatment,of,Patients,With,COVID-19,,Drug,Favipiravir,Favipiravir,150,21.06.2020,21.06.2020,https://clinicaltrials.gov/show/NCT04600999,No,Results,No,Results,No,Results,2.11.2020,None,
4809,NCT04601090,ClinicalTrials.gov,15.10.2020,16.09.2020,TRUE,Oslo,University,Hospital,Recruiting,Not,Applicable,Observational,Norway,Survival,Rates,and,Longterm,Outcomes,After,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,250,22.09.2020,22.09.2020,https://clinicaltrials.gov/show/NCT04601090,No,Results,No,Results,No,Results,2.11.2020,None
4815,NCT04602351,ClinicalTrials.gov,21.10.2020,1.11.2020,FALSE,NMC,Specialty,Hospital,Not,Recruiting,Not,Applicable,Observational,United,Arab,Emirates,Communication,in,ICU,During,COVID-19,,Other,No,Intervention,No,Intervention,200,30.11.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04602351,No,Results,No,Results,No,Results,2.11.2020,None
4817,NCT04602481,ClinicalTrials.gov,23.10.2020,31.05.2020,TRUE,University,of,Bern,Recruiting,Not,Applicable,Observational,Switzerland,COVID-19,in,People,With,Primary,Ciliary,Dyskinesia,,Clinical,Presentation,No,Intervention,No,Intervention,1000,31.05.2022,31.05.2025,https://clinicaltrials.gov/show/NCT04602481,No,Results,No,Results,No,Results,2.11.2020,None
4818,NCT04602507,ClinicalTrials.gov,22.10.2020,1.10.2020,TRUE,CES,University,Not,Recruiting,Phase,2,Interventional,Colombia,Ivermectin,in,Adults,With,Severe,COVID-19.,,Drug,Ivermectin,Ivermectin,100,21.02.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04602507,No,Results,No,Results,No,Results,2.11.2020,None,,,,
4823,NCT04603079,ClinicalTrials.gov,19.10.2020,1.11.2020,FALSE,Forman,Christian,College,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Nurse,Leadership,for,Hospital,Infection,Control,,Health,System,Other,Other,200,1.02.2021,1.03.2021,https://clinicaltrials.gov/show/NCT04603079,No,Results,No,Results,No,Results,2.11.2020,None
4916,DRKS00021306,German,Clinical,Trials,Register,14.04.2020,31.03.2020,TRUE,University,Hospital,,Bonn,Not,Recruiting,Not,Applicable,Observational,Germany,Covid-19,Case-Cluster-Study,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1400,Not,Available,9.04.2020,http://www.drks.de/DRKS00021306,Pre-Print,Article,2.06.2020,https://doi.org/10.1101/2020.05.04.20090076,2.11.2020,None
4979,DRKS00023171,German,Clinical,Trials,Register,26.10.2020,2.11.2020,FALSE,BKK,Verkehrsbau,Union,GmbH,Not,Recruiting,Not,Applicable,Interventional,Germany,Virtual,Assisted,Living,,Other,Other,Other,207,Not,Available,Not,Available,http://www.drks.de/DRKS00023171,No,Results,No,Results,No,Results,2.11.2020,None
5044,CTRI/2020/04/024697,CTRI,17.04.2020,17.04.2020,FALSE,Caring,Mahajan,Imaging,Not,Recruiting,Not,Applicable,Observational,India,COVID-19,Data-bank,Project,,Clinical,Presentation,No,Intervention,No,Intervention,100000,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42835,No,Results,No,Results,No,Results,4.11.2020,None,
5051,CTRI/2020/04/024806,CTRI,22.04.2020,26.04.2020,FALSE,All,India,Institute,of,Medical,Sciences,Recruiting,Phase,2,Interventional,India,Imatinib,in,COVID-19,infection,,Drug,Imatinib,Imatinib,100,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,No,Results,No,Results,No,Results,4.11.2020,None,
5056,CTRI/2020/04/024833,CTRI,24.04.2020,1.05.2020,FALSE,Dr.,Narayanan,Parameswaran,Not,Recruiting,Not,Applicable,Interventional,India,BCG-Denmark,versus,no-BCG,for,COVID,19,prevention,,ATMP,Vaccine,Vaccine,1826,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,No,Results,No,Results,No,Results,4.11.2020,None
5070,CTRI/2020/05/024959,CTRI,1.05.2020,1.05.2020,FALSE,Biocon,Limited,Not,Recruiting,Phase,2,Interventional,India,Efficacy,and,Safety,of,Itolizumab,in,COVID-19,Complications,,Drug,Itolizumab,Itolizumab,30,Not,Available,7.07.2020,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,No,Results,No,Results,No,Results,4.11.2020,None,
5113,CTRI/2020/05/025216,CTRI,16.05.2020,26.05.2020,FALSE,Rohit,Walia,Not,Recruiting,Not,Applicable,Observational,India,HCQ,POCKET,ECG,Ambulatory,Telemetry,,Study,,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,30,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43755,No,Results,No,Results,No,Results,4.11.2020,None
5115,CTRI/2020/05/025217,CTRI,17.05.2020,29.05.2020,FALSE,Dr.,Bhawna,Sirohi,Recruiting,Not,Applicable,Observational,India,COVID-19,and,cancer,chemotherapy,,Clinical,Presentation,No,Intervention,No,Intervention,200,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43015,No,Results,No,Results,No,Results,4.11.2020,None,
5139,CTRI/2020/05/025299,CTRI,21.05.2020,1.06.2020,FALSE,Wockhardt,Ltd,Not,Recruiting,Phase,2,Interventional,India,Convalescent,Plasma,treatment,trial,in,COVID,19,patients,,ATMP,Plasma,Plasma,20,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,No,Results,No,Results,No,Results,4.11.2020,None
5197,CTRI/2020/06/025613,CTRI,4.06.2020,15.06.2020,FALSE,Rohit,Walia,Not,Recruiting,Phase,4,Interventional,India,Melatonin,Immune,Boost,COVID,19,Study,,Drug,Melatonin,Melatonin,200,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,No,Results,No,Results,No,Results,4.11.2020,None,,
5231,CTRI/2020/06/025852,CTRI,12.06.2020,14.06.2020,FALSE,Intramural,Not,Recruiting,Phase,1/Phase,2,Interventional,India,RNB,in,UPUMS,SAIFAI,,Traditional,Medicine,(Drug),Traditional,Medicine,Traditional,Medicine,20,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,No,Results,No,Results,No,Results,4.11.2020,None
5234,CTRI/2020/06/025854,CTRI,13.06.2020,25.06.2020,FALSE,Indian,Council,of,Medical,Research,Not,Recruiting,Not,Applicable,Interventional,India,BCG,vaccination,against,COVID-19,,ATMP,Vaccine,Vaccine,1450,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,No,Results,No,Results,No,Results,4.11.2020,None,
5240,CTRI/2020/06/025862,CTRI,14.06.2020,13.06.2020,TRUE,No,Sponsor,Name,Given,Recruiting,Phase,1,Interventional,India,Low,Dose,Radiation,Therapy,for,COVID-19,,Other,Radiation,Radiation,10,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,No,Results,No,Results,No,Results,4.11.2020,None,
5248,CTRI/2020/06/026000,CTRI,21.06.2020,26.06.2020,FALSE,Seth,GS,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5249,CTRI/2020/06/026001,CTRI,21.06.2020,25.06.2020,FALSE,All,India,Institute,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,India,Ivermectin,in,COVID,,Drug,Ivermectin,Ivermectin,120,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,No,Results,No,Results,No,Results,4.11.2020,None,
5258,CTRI/2020/06/026047,CTRI,23.06.2020,1.07.2020,FALSE,Swet,Nisha,Not,Recruiting,Not,Applicable,Observational,India,Dental,education,and,coronavirus,,Other,No,Intervention,No,Intervention,25,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44913,No,Results,No,Results,No,Results,4.11.2020,None,,
5261,CTRI/2020/06/026123,CTRI,24.06.2020,25.06.2020,FALSE,Dr.,Sushant,Meshram,Not,Recruiting,Phase,2,Interventional,India,Plasma,therapy,in,corona,patients(Severe,COVID-19).,,ATMP,Plasma,Plasma,472,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,No,Results,No,Results,No,Results,4.11.2020,None,
5268,CTRI/2020/06/026152,CTRI,26.06.2020,26.06.2020,FALSE,Seth,GS,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5286,CTRI/2020/06/026232,CTRI,29.06.2020,10.07.2020,FALSE,DVFM,Not,Recruiting,Phase,3,Interventional,India,Ivermectin,in,the,prevention,of,covid-19,,Drug,Ivermectin,Ivermectin,50,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,No,Results,No,Results,No,Results,4.11.2020,None,,,
5290,CTRI/2020/06/026256,CTRI,30.06.2020,10.07.2020,FALSE,Topiwala,National,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5298,CTRI/2020/07/026339,CTRI,2.07.2020,15.07.2020,FALSE,Tata,Memorial,Centre,Recruiting,Not,Applicable,Observational,India,Understanding,COVID,and,cancer,,Clinical,Presentation,No,Intervention,No,Intervention,1000,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44951,No,Results,No,Results,No,Results,4.11.2020,None,
5366,CTRI/2020/07/026671,CTRI,18.07.2020,27.07.2020,FALSE,Bisleri,Charitable,Trust,Not,Recruiting,Not,Applicable,Interventional,India,Ozone,Therapy,for,Covid,19,patients,,Drug,Ozone,Ozone,10,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,No,Results,No,Results,No,Results,4.11.2020,None,
5375,CTRI/2020/07/026700,CTRI,20.07.2020,27.07.2020,FALSE,Ayurved,Rasayani,Not,Recruiting,Not,Applicable,Interventional,India,Ayurvedic,Rasayana,therapies,,Traditional,Medicine,(Drug),Traditional,Medicine,Traditional,Medicine,200,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,No,Results,No,Results,No,Results,4.11.2020,None,
5386,CTRI/2020/07/026791,CTRI,25.07.2020,1.08.2020,FALSE,Dr.,Deepti,Siddharthan,Recruiting,Phase,2/Phase,3,Interventional,India,Statin,and,Aspirin,in,SARS-CoV-2,infection,,Drug,Atorvostatin,,Aspirin,Atorvostatin,,,,,,,,,,,,,
5401,CTRI/2020/07/026834,CTRI,27.07.2020,7.08.2020,FALSE,Director,Not,Recruiting,Not,Applicable,Interventional,India,REaCHing,to,you,with,listening,ears,,,,,,,,,,,,,,,,,,,,,
5419,CTRI/2020/08/026956,CTRI,1.08.2020,10.08.2020,FALSE,Principal,Investigator,Not,Recruiting,Not,Applicable,Observational,India,Telemedicine,effectiveness,during,COVID-19,,Telehealth,Telehealth,Telehealth,463,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46136,No,Results,No,Results,No,Results,4.11.2020,None,,,,
5465,CTRI/2020/08/027109,CTRI,13.08.2020,21.08.2020,FALSE,Staidson,(Beijing),Biopharmaceuticals,Co.,,Ltd,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5468,CTRI/2020/08/027110,CTRI,13.08.2020,22.08.2020,FALSE,Vardhman,Mahavir,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5488,CTRI/2020/08/027226,CTRI,18.08.2020,28.08.2020,FALSE,Jai,Prakash,Agarwal,Recruiting,Not,Applicable,Observational,India,Study,of,Radiotherapy,practice,during,Corona,Pandemic,,Other,Radiation,Radiation,2500,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46685,No,Results,No,Results,No,Results,4.11.2020,None,
5514,CTRI/2020/08/027403,CTRI,26.08.2020,7.09.2020,FALSE,Maulana,Azad,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5534,CTRI/2020/08/027490,CTRI,31.08.2020,10.09.2020,FALSE,University,of,Liverpool,Not,Recruiting,Not,Applicable,Observational,India,Neurological,manifestations,of,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,200,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47009,No,Results,No,Results,No,Results,4.11.2020,None
5544,CTRI/2020/09/027560,CTRI,2.09.2020,15.09.2020,FALSE,Dr.,Kalyan,Banerjee,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5547,CTRI/2020/09/027562,CTRI,3.09.2020,1.10.2020,FALSE,Maulana,Azad,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5572,CTRI/2020/09/027782,CTRI,14.09.2020,23.09.2020,FALSE,Dr.,Aalap,Prajapati,Not,Recruiting,Not,Applicable,Observational,India,Dental,practices,in,COVID-19,,Health,System,No,Intervention,No,Intervention,1600,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47085,No,Results,No,Results,No,Results,4.11.2020,None
5646,CTRI/2020/10/028360,CTRI,12.10.2020,19.10.2020,FALSE,Seth,GS,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5669,CTRI/2020/10/028523,CTRI,21.10.2020,30.10.2020,FALSE,Parumkhswami,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5678,CTRI/2020/10/028567,CTRI,22.10.2020,1.11.2020,FALSE,Seth,GS,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5679,CTRI/2020/10/028539,CTRI,22.10.2020,28.10.2020,FALSE,Maulana,Azad,Medical,College,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5691,CTRI/2020/10/028657,CTRI,27.10.2020,30.10.2020,FALSE,Department,of,pharmacology,Not,Recruiting,Not,Applicable,Observational,India,Remdesivir,effect,in,the,treatment,of,corona,,Drug,Remdesivir,Remdesivir,275,Not,Available,Not,Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47817,No,Results,No,Results,No,Results,4.11.2020,None
5703,JPRN-jRCTs051200049,JPRN,26.08.2020,1.09.2020,FALSE,Iwahori,Kota,Recruiting,Phase,2,Interventional,Japan,Therapeutic,drug,development,program,for,COVID-19,,Drug,Demethylchlortetracycline,+,Favipiravir,Demethylchlortetracycline,,,,,,,,,,,,,,,
5705,JPRN-jRCTs061200002,JPRN,20.05.2020,20.05.2020,FALSE,Eiki,Ichihara,Recruiting,Phase,2,Interventional,Japan,Teprenone,for,preventing,aggravation,of,COVID-19,,Drug,Teprenone,Teprenone,100,Not,Available,Not,Available,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,No,Results,No,Results,No,Results,4.11.2020,None,,,
5723,PACTR202004801273802,PACTR,2.04.2020,20.04.2020,FALSE,Lagos,State,Government,Recruiting,Phase,3,Interventional,Nigeria,Lagos,COVID-19,Chloroquine,Treatment,Trial,(LACCTT),,Drug,Chloroquine,vs.,Hydroxychloroquine,Chloroquine,,,,,,,,,,,,,,
5729,PACTR202009786901147,PACTR,7.05.2020,1.10.2020,FALSE,Dr.,William,Schilling,Not,Recruiting,Phase,3,Interventional,Kenya,Hydroxychloroquine,for,prevention,of,COVID-19,,Drug,(Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,Not,Available,30.04.2022,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,No,Results,No,Results,No,Results,4.11.2020,None,,
5734,PACTR202006899597082,PACTR,29.05.2020,29.04.2020,TRUE,Malagasy,Government,Not,Recruiting,Phase,2,Interventional,Madagascar,Efficacy,of,a,new,COVID-19,treatment,,Drug,Artesunate,vs.,Artesunate,+,Vitamin,C,Artesunate,,,,,,,,,,,
5740,PACTR202006760881890,PACTR,23.06.2020,1.08.2020,FALSE,Lagos,State,Government,Recruiting,Phase,2,Interventional,Nigeria,Lagos,Covid-19,Convalescent,Plasma,Trial,(LACCPT),,ATMP,Plasma,Plasma,100,Not,Available,30.09.2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,No,Results,No,Results,No,Results,4.11.2020,None,,,
5744,PACTR202007700757139,PACTR,7.07.2020,13.07.2020,FALSE,Cytel,Inc,Not,Recruiting,Phase,2,Interventional,South,Africa,TOGETHER,3,Trial.,COVID-19,,Drug,Lopinavir/ritonavir,vs.,Vitamin,C,Lopinavir/ritonavir,,,,,,,,,,,,,,
5746,PACTR202008855701534,PACTR,5.08.2020,21.09.2020,FALSE,Obafemi,Awolowo,University,Not,Recruiting,Phase,2,Interventional,Nigeria,The,Nitazoxanide,Plus,Atazanavir,for,COVID-19,Study,,Drug,Nitazoxanide,and,Atazanavir/ritonavir,Nitazoxanide,,,,,,,,,,,,
5750,PACTR202010537777617,PACTR,13.09.2020,1.11.2020,FALSE,EMSKE,Phytochem,Not,Recruiting,Phase,2,Interventional,Kenya,FLAVOCOV,Distributed,Clinical,Trial.,COVID-19,,Drug,Diosmin,+,hesperidin,Diosmin,,,,,,,,,,,,,,,
5752,PACTR202010729372570,PACTR,25.09.2020,5.10.2020,FALSE,Government,of,Uganda,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ancillary,Study,of,the,ANTICOV,Study:,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5760,RBR-8969zg,REBEC,13.04.2020,14.04.2020,FALSE,University,de,São,Paulo,Not,Recruiting,Not,Applicable,Interventional,Brazil,Treatment,of,2019-nCoV,Pneumonia,with,N-acetylcysteine,,Drug,N-acetylcysteine,N-acetylcysteine,200,Not,Available,14.10.2020,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,No,Results,No,Results,No,Results,4.11.2020,None,
5761,RBR-658khm,REBEC,22.04.2020,1.04.2020,TRUE,Centro,Medico,Mazzei,Recruiting,Not,Applicable,Interventional,Brazil,Telemedicine,in,the,Covid-19,pandemic,in,Brazil,,,,,,,,,,,,,,,,,,,
5763,RBR-3k4wxb,REBEC,5.05.2020,1.05.2020,TRUE,Hospital,Santo,António,Not,Recruiting,Phase,2,Interventional,Brazil,Evaluation,of,the,use,of,Hydroxychlorochine,in,Chinese,flu,,Drug,Hydroxychloroquine,+,Azithromycin,Hydroxychloroquine,,,,,,,,,,
5789,RBR-35734p,REBEC,5.08.2020,5.08.2020,FALSE,Angitec,Recruiting,Phase,1/Phase,2,Interventional,Brazil,Treatment,of,severe,COVID-19,with,angiotensin-(1-7),,Drug,Angiotensin,Angiotensin,130,Not,Available,30.10.2020,http://www.ensaiosclinicos.gov.br/rg/RBR-35734p/,No,Results,No,Results,No,Results,4.11.2020,None,,,,
"""",during,COVID-19,pandemic,in,"Brazil""""""",,Other,(psych),Psychological,Psychological,44,Not,Available,30.09.2020,http://www.ensaiosclinicos.gov.br/rg/RBR-2w7ghc/,No,Results,No,Results,No,Results,4.11.2020,None,,,,,,,,,,,,,,,,
5821,RBR-4kjqtg,REBEC,5.08.2020,5.08.2020,FALSE,Universidade,Federal,de,Goias,Recruiting,Phase,2,Interventional,Brazil,Testing,of,BCG,vaccine,against,COVID-19,,ATMP,Vaccine,Vaccine,400,Not,Available,31.12.2020,http://www.ensaiosclinicos.gov.br/rg/RBR-4kjqtg/,No,Results,No,Results,No,Results,4.11.2020,None,,
5825,RPCEC00000307,RPCEC,14.04.2020,10.04.2020,TRUE,Center,for,Genetic,Engineering,and,Biotechnology,(CIGB),,Havana,Recruiting,Phase,2,Interventional,Cuba,ESPERANZA,study,,Drug,Interferon,alpha,Interferon,alpha,120,Not,Available,30.07.2020,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,Pre-Print,Article,1.08.2020,https://doi.org/10.1101/2020.07.29.20164251,3.11.2020,None,
5827,RPCEC00000309,RPCEC,5.05.2020,20.05.2020,FALSE,Colima,State,Health,Service,Recruiting,Phase,1/Phase,2,Interventional,Mexico,Therapy,for,COVID-19-Phase,I-II,,Drug,Homeostec,+,Paracetamol,Homeostec,,,,,,,,,,,,,,
5830,RPCEC00000312,RPCEC,13.05.2020,29.04.2020,TRUE,Cuban,Ministry,of,Public,Health,Recruiting,Not,Applicable,Observational,Cuba,PrevengHo-Vir,Homeoprohylaxis,COVID-2019,,Other,Homeopathy,Homeopathy,180,Not,Available,31.12.2020,https://rpcec.sld.cu/en/trials/RPCEC00000312-En,No,Results,No,Results,No,Results,3.11.2020,None,,,,
5831,RPCEC00000313,RPCEC,14.05.2020,31.03.2020,TRUE,Center,for,Genetic,Engineering,and,Biotechnology,(CIGB),,Havana,Not,Recruiting,Not,Applicable,Interventional,Cuba,CIGB-258,at,COVID-19,,Drug,CIGB-258,CIGB-258,16,Not,Available,30.04.2020,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,Pre-Print,Article,2.06.2020,https://doi.org/10.1101/2020.05.27.20110601,3.11.2020,None,
5832,RPCEC00000314,RPCEC,22.05.2020,24.04.2020,TRUE,Finlay,Vaccine,Institute,(IFV),Recruiting,Not,Applicable,Interventional,Cuba,VA-MENGOC-BC,to,stimulate,the,innate,response,against,SARS-CoV-2,,ATMP,Vaccine,Vaccine,115000,Not,Available,30.06.2020,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,No,Results,No,Results,No,Results,3.11.2020,None
5843,RPCEC00000332,RPCEC,13.08.2020,24.08.2020,FALSE,Finlay,Vaccine,Institute,(IFV),Recruiting,Phase,1/Phase,2,Interventional,Cuba,SOBERANA,01,,ATMP,Vaccine,Vaccine,676,Not,Available,11.01.2021,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,No,Results,No,Results,No,Results,3.11.2020,None,,,,,
5847,RPCEC00000338,RPCEC,17.10.2020,19.10.2020,FALSE,Finlay,Vaccine,Institute,(IFV),Not,Recruiting,Phase,1,Interventional,Cuba,SOBERANA,01A,,ATMP,Vaccine,Vaccine,60,Not,Available,31.01.2021,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,No,Results,No,Results,No,Results,3.11.2020,None,,,,,
5848,RPCEC00000340,RPCEC,27.10.2020,2.11.2020,FALSE,Finlay,Vaccine,Institute,(IFV),Not,Recruiting,Phase,1,Interventional,Cuba,SOBERANA,02,,ATMP,Vaccine,Vaccine,40,Not,Available,6.01.2021,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,No,Results,No,Results,No,Results,3.11.2020,None,,,,,
5855,TCTR20200820006,TCTR,20.08.2020,20.08.2020,FALSE,Faculty,of,Medicine,Recruiting,Not,Applicable,Observational,Thailand,Response,time,of,motorlance,in,COVID-19,pandemic,,Health,System,No,Intervention,No,Intervention,871,21.10.2020,21.10.2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6682,No,Results,No,Results,No,Results,4.11.2020,None
5857,TCTR20200709002,TCTR,2.07.2020,21.06.2020,TRUE,Mahidol,University,Recruiting,Not,Applicable,Observational,Thailand,Impact,of,the,COVID-19,lockdown,on,dry,eye,,Other,No,Intervention,No,Intervention,144,21.06.2021,21.06.2021,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6466,No,Results,No,Results,No,Results,4.11.2020,None,
5870,PER-013-20,REPEC,25.06.2020,1.06.2020,TRUE,Seguro,Social,de,Salud,Recruiting,Phase,2,Interventional,Peru,CONVALESCENT,PLASMA,AS,TREATMENT,FOR,COVID-19,,ATMP,Plasma,Plasma,192,Not,Available,Not,Available,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,No,Results,No,Results,No,Results,4.11.2020,None,
"""","""""""""""""""",,ATMP,Plasma,Plasma,100,Not,Available,Not,Available,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,No,Results,No,Results,No,Results,4.11.2020,None,,,,,,,,,,,,,,,,,,,,
5885,NCT04324736,ClinicalTrials.gov,25.03.2020,10.03.2020,TRUE,Nantes,University,Hospital,Not,Recruiting,Not,Applicable,Observational,France,"""""""COVID-19",and,Diabetes,"Outcomes""""""",CORONADO,Clinical,Presentation,No,Intervention,No,Intervention,5309,10.04.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04324736,Journal,Article,29.05.2020,https://doi.org/10.1007/s00125-020-05180-x,9.11.2020,None,,,,
5886,NCT04328961,ClinicalTrials.gov,23.03.2020,31.03.2020,FALSE,University,of,Washington,Not,Recruiting,Phase,2/Phase,3,Interventional,United,States,Hydroxychloroquine,for,COVID-19,Post-exposure,Prophylaxis,(PEP),,Drug,(Chemoprophylaxis),Hydroxychloroquine,vs.,Vitamin,C,Hydroxychloroquine,,,,,,,,,
5890,NCT04332107,ClinicalTrials.gov,30.03.2020,22.05.2020,FALSE,Thomas,M.,Lietman,Recruiting,Phase,3,Interventional,United,States,Azithromycin,for,COVID-19,Treatment,in,Outpatients,Nationwide,ACTION,Drug,Azithromycin,Azithromycin,2271,30.09.2021,30.12.2021,https://clinicaltrials.gov/show/NCT04332107,No,Results,No,Results,No,Results,9.11.2020,None,,
5903,NCT04348422,ClinicalTrials.gov,13.04.2020,1.05.2020,FALSE,Assaf-Harofeh,Medical,Center,Recruiting,Not,Applicable,Observational,Israel,Evaluating,the,Immune,Response,for,COVID-19,COVIDIMMUNE,Clinical,Presentation,No,Intervention,No,Intervention,1000,1.12.2020,31.12.2020,https://clinicaltrials.gov/show/NCT04348422,No,Results,No,Results,No,Results,9.11.2020,None,
5907,NCT04351516,ClinicalTrials.gov,15.04.2020,21.04.2020,TRUE,University,Hospital,,Tübingen,Not,Recruiting,Phase,2/Phase,3,Interventional,Germany,Test,and,Treat,COVID,65plus+,COVID65plus,Drug,Hydroxychloroquine,Hydroxychloroquine,350,31.12.2020,1.05.2021,https://clinicaltrials.gov/show/NCT04351516,No,Results,No,Results,No,Results,9.11.2020,EUCTR2020-001482-37,,
5913,NCT04358926,ClinicalTrials.gov,21.04.2020,30.04.2020,FALSE,Assaf-Harofeh,Medical,Center,Not,Recruiting,Not,Applicable,Interventional,Israel,Hyperbaric,Oxygen,Therapy,Effect,in,COVID-19,RCT,(HBOTCOVID19),HBOTCOVID19,Drug,Oxygen,Oxygen,30,15.10.2020,1.11.2020,https://clinicaltrials.gov/show/NCT04358926,No,Results,No,Results,No,Results,9.11.2020,None,
5919,NCT04361214,ClinicalTrials.gov,22.04.2020,5.05.2020,FALSE,University,of,Chicago,Recruiting,Phase,1,Interventional,United,States,Leflunomide,in,Mild,COVID-19,Patients,,Drug,Leflunomide,Leflunomide,20,21.02.2020,21.02.2020,https://clinicaltrials.gov/show/NCT04361214,No,Results,No,Results,No,Results,9.11.2020,None,,,,
5924,NCT04364009,ClinicalTrials.gov,17.04.2020,27.04.2020,TRUE,CHU,de,Tours,Not,Recruiting,Phase,3,Interventional,France,Anakinra,for,COVID-19,Respiratory,Symptoms,ANACONDA,Drug,Anakinra,Anakinra,71,20.10.2020,3.11.2020,https://clinicaltrials.gov/show/NCT04364009,No,Results,No,Results,No,Results,9.11.2020,EUCTR2020-001734-36,,,,
5932,NCT04372693,ClinicalTrials.gov,27.04.2020,1.09.2020,FALSE,Cairo,University,Recruiting,Not,Applicable,Interventional,Egypt,Unplanned,Shifting,to,Online,Distance,Learning:,Nursing,Students',Perception,and,Achievement,(COVID-19),Other,Other,Other,180,30.01.2021,28.02.2021,https://clinicaltrials.gov/show/NCT04372693,No,Results,No,Results,No,Results,9.11.2020,None
5935,NCT04373889,ClinicalTrials.gov,13.04.2020,22.04.2020,FALSE,Sciensano,Not,Recruiting,Not,Applicable,Observational,Belgium,COVID-19,Among,Healthcare,Workers,in,Belgian,Hospitals,COVHECBEHO,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,850,30.04.2021,30.04.2021,https://clinicaltrials.gov/show/NCT04373889,No,Results,No,Results,No,Results,9.11.2020,None
5938,NCT04375202,ClinicalTrials.gov,29.04.2020,18.04.2020,FALSE,University,of,Perugia,Recruiting,Phase,2,Interventional,Italy,Colchicine,in,COVID-19:,a,Pilot,Study,COLVID-19,Drug,Colchicine,Colchicine,308,30.06.2021,31.10.2021,https://clinicaltrials.gov/show/NCT04375202,No,Results,No,Results,No,Results,9.11.2020,EUCTR2020-001475-33,,,,
5952,NCT04388826,ClinicalTrials.gov,13.05.2020,18.06.2020,FALSE,Veru,Inc.,Recruiting,Phase,2,Interventional,United,States,COVID-19,Treatment,of,Severe,Acute,Respiratory,Syndrome,With,Veru-111,,Drug,Veru-111,Veru-111,40,30.11.2020,18.12.2020,https://clinicaltrials.gov/show/NCT04388826,No,Results,No,Results,No,Results,9.11.2020,None,
5956,NCT04392141,ClinicalTrials.gov,15.05.2020,1.04.2020,TRUE,Kermanshah,University,of,Medical,Sciences,Recruiting,Phase,1/Phase,2,Interventional,Iran,Colchicine,Plus,Phenolic,Monoterpenes,to,Treat,COVID-19,,Drug,Colchicine,+,Phenolic,Monoterpenes,Colchicine,,,,,,,,,
5977,NCT04411680,ClinicalTrials.gov,29.05.2020,18.08.2020,FALSE,Partner,Therapeutics,,Inc.,Recruiting,Phase,2,Interventional,United,States,Study,of,Sargramostim,in,Patients,With,COVID-19,iLeukPulm,Drug,Sargramostim,Sargramostim,60,20.11.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04411680,No,Results,No,Results,No,Results,9.11.2020,None,
5978,NCT04412343,ClinicalTrials.gov,29.05.2020,23.05.2020,TRUE,University,of,British,Columbia,Not,Recruiting,Not,Applicable,Interventional,Canada,The,Seniors,COvid-19,Pandemic,and,Exercise,Study,SCOPE,Other,(exercise),Exercise,Exercise,241,5.10.2020,5.10.2020,https://clinicaltrials.gov/show/NCT04412343,No,Results,No,Results,No,Results,9.11.2020,None
5996,NCT04447131,ClinicalTrials.gov,17.06.2020,29.04.2020,TRUE,University,of,São,Paulo,Recruiting,Not,Applicable,Observational,Brazil,Effect,of,COVID-19,on,Platelet,Aggregation,,Clinical,Presentation,No,Intervention,No,Intervention,200,30.06.2021,30.07.2021,https://clinicaltrials.gov/show/NCT04447131,No,Results,No,Results,No,Results,9.11.2020,None
6002,NCT04455308,ClinicalTrials.gov,30.06.2020,21.07.2020,FALSE,Rennes,University,Hospital,Not,Recruiting,Not,Applicable,Interventional,France,COVID-19,and,Chilblains,ECCES,Clinical,Presentation,No,Intervention,No,Intervention,269,19.10.2020,19.10.2020,https://clinicaltrials.gov/show/NCT04455308,No,Results,No,Results,No,Results,9.11.2020,None,,,
6004,NCT04462783,ClinicalTrials.gov,7.07.2020,1.12.2020,FALSE,University,of,Michigan,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Emergency,Department,(ED),Self-Monitoring,Pilot,COVID-19,,Other,Other,Other,200,21.04.2020,21.04.2020,https://clinicaltrials.gov/show/NCT04462783,No,Results,No,Results,No,Results,9.11.2020,None,
6017,NCT04482634,ClinicalTrials.gov,21.07.2020,1.09.2020,FALSE,Koç,University,Recruiting,Not,Applicable,Interventional,Turkey,Tele-rehabilitation,Versus,Home,Exercise,Program,in,COVID-19,,Telehealth,Physio,&,Rehabilitation,Physio,&,Rehabilitation,122,22.08.2020,22.08.2020,https://clinicaltrials.gov/show/NCT04482634,No,Results,No,Results,No,Results,9.11.2020,None
6022,NCT04489446,ClinicalTrials.gov,25.07.2020,19.08.2020,FALSE,Andrés,Bello,National,University,Recruiting,Phase,1/Phase,2,Interventional,Chile,Sildenafil,in,COVID-19,,Drug,Sildenafil,Sildenafil,40,20.12.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04489446,No,Results,No,Results,No,Results,9.11.2020,None,,,,,
6030,NCT04498273,ClinicalTrials.gov,3.08.2020,7.09.2020,FALSE,Frank,C,Sciurba,Recruiting,Phase,3,Interventional,United,States,COVID-19,Positive,Outpatient,Thrombosis,Prevention,in,Adults,Aged,40-80,,Drug,Apixaban,Apixaban,7000,21.09.2020,21.09.2020,https://clinicaltrials.gov/show/NCT04498273,No,Results,No,Results,No,Results,9.11.2020,None
6038,NCT04506268,ClinicalTrials.gov,7.08.2020,9.09.2020,FALSE,University,of,Pennsylvania,Not,Recruiting,Not,Applicable,Interventional,United,States,COVID-19,SAFE,Enrollment,COVID,SAFE,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1200,13.10.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04506268,No,Results,No,Results,No,Results,9.11.2020,None
6039,NCT04507893,ClinicalTrials.gov,5.08.2020,15.03.2020,TRUE,University,of,Palermo,Recruiting,Not,Applicable,Observational,Italy,Comparison,Between,Positive,and,Negative,COVID-19,Pneumonia,,Clinical,Presentation,No,Intervention,No,Intervention,80,30.09.2020,1.12.2020,https://clinicaltrials.gov/show/NCT04507893,No,Results,No,Results,No,Results,9.11.2020,None
6040,NCT04509999,ClinicalTrials.gov,7.08.2020,26.10.2020,FALSE,University,of,Florida,Recruiting,Phase,3,Interventional,United,States,Bicalutamide,to,Block,TMPRSS2,in,Males,With,COVID-19,Infection,,Drug,Bicalutamide,Bicalutamide,100,22.09.2020,22.09.2020,https://clinicaltrials.gov/show/NCT04509999,No,Results,No,Results,No,Results,9.11.2020,None
6043,NCT04510493,ClinicalTrials.gov,11.08.2020,23.10.2020,FALSE,University,Hospital,,Basel,Recruiting,Phase,3,Interventional,Switzerland,Canakinumab,in,Patients,With,COVID-19,and,Type,2,Diabetes,CanCovDia,Drug,Canakinumab,Canakinumab,116,23.09.2020,23.09.2020,https://clinicaltrials.gov/show/NCT04510493,No,Results,No,Results,No,Results,9.11.2020,None
6045,NCT04511819,ClinicalTrials.gov,8.08.2020,28.08.2020,FALSE,Fulcrum,Therapeutics,Recruiting,Phase,3,Interventional,Brazil,,United,States,,Mexico,Losmapimod,Safety,and,Efficacy,in,COVID-19,LOSVID,Drug,Losmapimod,Losmapimod,410,20.11.2020,20.11.2020,https://clinicaltrials.gov/show/NCT04511819,No,Results,No,Results,No,Results,9.11.2020,None
6055,NCT04534725,ClinicalTrials.gov,30.08.2020,1.11.2020,FALSE,Peter,MacCallum,Cancer,Centre,Not,Recruiting,Phase,3,Interventional,No,Country,Given,COVID-19,Prevention,and,Treatment,in,Cancer,,,,,,,,,,,,,,,,
6058,NCT04539275,ClinicalTrials.gov,27.08.2020,16.11.2020,FALSE,VA,Office,of,Research,and,Development,Not,Recruiting,Phase,3,Interventional,United,States,COVID-19,(VA,CURES-1),VA,CURES-1,ATMP,Plasma,Plasma,702,20.06.2022,18.07.2022,https://clinicaltrials.gov/show/NCT04539275,No,Results,No,Results,No,Results,9.11.2020,None,
6059,NCT04539821,ClinicalTrials.gov,3.09.2020,1.10.2020,FALSE,VA,Office,of,Research,and,Development,Recruiting,Not,Applicable,Interventional,United,States,Virtual,Pain,Care,Management,(COVID-19),VCPM,Telehealth,Telehealth,Telehealth,60,31.03.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04539821,No,Results,No,Results,No,Results,9.11.2020,None,
6061,NCT04542408,ClinicalTrials.gov,6.09.2020,6.11.2020,FALSE,University,Hospital,,Hamburg-Eppendorf,Not,Recruiting,Phase,3,Interventional,Germany,Hamburg,Edoxaban,for,Anticoagulation,in,COVID-19,Study,HERO-19,Drug,Edoxaban,or,Heparin,Edoxaban,,,,,,,,,,,
6066,NCT04554433,ClinicalTrials.gov,17.09.2020,1.12.2020,FALSE,Mansoura,University,Not,Recruiting,Phase,3,Interventional,No,Country,Given,New,Treatment,for,COVID-19,Using,Ethanol,Vapor,Inhalation,.,,Drug,Ethanol,+,Aspirin,Ethanol,,,,,,,,,
6068,NCT04559009,ClinicalTrials.gov,21.09.2020,15.10.2020,FALSE,Atrium,Health,Recruiting,Not,Applicable,Observational,United,States,COVID-19,Amyotrophic,Lateral,Sclerosis,(ALS),Registry,,Clinical,Presentation,No,Intervention,No,Intervention,100,31.12.2023,30.04.2024,https://clinicaltrials.gov/show/NCT04559009,No,Results,No,Results,No,Results,9.11.2020,None,
6076,NCT04568876,ClinicalTrials.gov,24.09.2020,23.10.2020,FALSE,Epitech,Group,SpA,Recruiting,Phase,4,Interventional,Italy,Micronized,and,Ultramicronized,Palmitoylethanolamide,in,COVID-19,Patients,,Drug,Palmitoylethanolamide,Palmitoylethanolamide,40,21.11.2020,21.11.2020,https://clinicaltrials.gov/show/NCT04568876,No,Results,No,Results,No,Results,9.11.2020,None,,,
6084,NCT04576728,ClinicalTrials.gov,24.09.2020,6.10.2020,FALSE,Biotest,Recruiting,Phase,2,Interventional,Spain,Efficacy,and,Safety,of,Trimodulin,in,Subjects,With,Severe,COVID-19,ESsCOVID,Drug,Trimodulin,Trimodulin,164,21.03.2020,21.03.2020,https://clinicaltrials.gov/show/NCT04576728,No,Results,No,Results,No,Results,9.11.2020,None,,
6088,NCT04579458,ClinicalTrials.gov,6.10.2020,16.11.2020,FALSE,Vanderbilt,University,Recruiting,Not,Applicable,Observational,United,States,Assessment,of,COVID-19,in,Tearfilm,,Clinical,Presentation,No,Intervention,No,Intervention,500,9.05.2021,9.05.2021,https://clinicaltrials.gov/show/NCT04579458,No,Results,No,Results,No,Results,9.11.2020,None,,
6091,NCT04581863,ClinicalTrials.gov,7.10.2020,21.10.2020,FALSE,University,of,Pennsylvania,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,COVID-19,Watch,+,COVID-19,Pulse,,Other,(device),Biosensors,Biosensors,850,21.02.2021,31.10.2021,https://clinicaltrials.gov/show/NCT04581863,No,Results,No,Results,No,Results,9.11.2020,None,
6103,NCT04594278,ClinicalTrials.gov,18.10.2020,1.11.2020,FALSE,University,Health,Network,,Toronto,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,COVID-19,Burnout,Study,,Other,(psych),Psychological,Psychological,100,1.04.2021,1.07.2021,https://clinicaltrials.gov/show/NCT04594278,No,Results,No,Results,No,Results,9.11.2020,None,
6112,NCT04598581,ClinicalTrials.gov,20.10.2020,2.11.2020,FALSE,University,Hospital,,Basel,Recruiting,Not,Applicable,Interventional,Switzerland,Low,Dose,Radiation,Therapy,for,Severe-Acute-Respiratory-Syndrome-Coronavirus-2,(SARS-CoV-2),,COVID-19,COVID-RT-01,Other,Radiation,Radiation,22,21.10.2020,21.11.2020,https://clinicaltrials.gov/show/NCT04598581,No,Results,No,Results,No,Results,9.11.2020,None
6117,NCT04603677,ClinicalTrials.gov,25.10.2020,8.07.2020,TRUE,Colorado,State,University,Recruiting,Not,Applicable,Observational,United,States,Northern,Colorado,COVID-19,Biobank,NoCo-CoBio,Clinical,Presentation,No,Intervention,No,Intervention,200,30.07.2022,30.07.2022,https://clinicaltrials.gov/show/NCT04603677,No,Results,No,Results,No,Results,9.11.2020,None,,
6121,NCT04603924,ClinicalTrials.gov,20.10.2020,7.10.2020,TRUE,ANA,Therapeutics,Recruiting,Phase,2/Phase,3,Interventional,United,States,Study,of,Niclosamide,in,Moderate,Hospitalized,Coronavirus-19,(COVID-19),Patients,,Drug,Niclosamide,Niclosamide,436,21.06.2020,22.06.2020,https://clinicaltrials.gov/show/NCT04603924,No,Results,No,Results,No,Results,9.11.2020,None
6128,NCT04604327,ClinicalTrials.gov,23.10.2020,26.10.2020,FALSE,Clínica,Universidad,de,Navarra,Recruiting,Phase,3,Interventional,Spain,Comparison,of,Two,Different,Doses,of,Bemiparin,in,COVID-19,BEMICOP,Drug,Bemiparin,Bemiparin,164,31.05.2021,31.07.2021,https://clinicaltrials.gov/show/NCT04604327,No,Results,No,Results,No,Results,9.11.2020,None
6133,NCT04605588,ClinicalTrials.gov,26.10.2020,1.11.2020,FALSE,Rutgers,University,Recruiting,Phase,2,Interventional,United,States,A,Triple,Combination,Antiviral,Coronavirus,Therapy,(TriACT),for,COVID-19,TriACT,Drug,Nitazoxanide,+,Ribavirin,+,Hydroxychloroquine,itazoxanide,,,,,,,,,
6140,NCT04606069,ClinicalTrials.gov,26.10.2020,1.11.2020,FALSE,University,of,Maryland,,Baltimore,Not,Recruiting,Phase,1/Phase,2,Interventional,United,States,Treat,COVID-19,Patients,With,Regadenoson,,Drug,Regadenoson,Regadenoson,40,30.11.2021,31.01.2022,https://clinicaltrials.gov/show/NCT04606069,No,Results,No,Results,No,Results,9.11.2020,None
6144,NCT04606732,ClinicalTrials.gov,27.10.2020,20.09.2020,TRUE,University,of,Bologna,Recruiting,Not,Applicable,Observational,Italy,CardioVascular,Disease,Progression,and,Prognosis,in,COVID-19,CVP-Covid19,Clinical,Presentation,No,Intervention,No,Intervention,2000,31.12.2020,31.12.2021,https://clinicaltrials.gov/show/NCT04606732,No,Results,No,Results,No,Results,9.11.2020,None
6149,NCT04608097,ClinicalTrials.gov,28.10.2020,28.10.2020,FALSE,Uppsala,University,Recruiting,Not,Applicable,Interventional,Sweden,Understanding,Reactions,to,Emotional,Material,in,the,Media,During,COVID-19,,Other,Other,Other,66,15.01.2021,15.01.2021,https://clinicaltrials.gov/show/NCT04608097,No,Results,No,Results,No,Results,9.11.2020,None,
6154,NCT04608383,ClinicalTrials.gov,23.10.2020,1.11.2020,FALSE,Assistance,Publique,–,Hôpitaux,de,Paris,Not,Recruiting,Not,Applicable,Observational,France,Laparoscopy,and,COVID-19,Contamination,LAPCOV,Other,No,Intervention,No,Intervention,20,1.01.2022,1.01.2022,https://clinicaltrials.gov/show/NCT04608383,No,Results,No,Results,No,Results,9.11.2020,None
6162,NCT04609839,ClinicalTrials.gov,26.10.2020,27.10.2020,FALSE,University,Hospital,,Strasbourg,Recruiting,Not,Applicable,Observational,France,FOLLOW-UP,OF,PATIENTS,WITH,COVID-19.,TeleRea'nCo,Clinical,Presentation,No,Intervention,No,Intervention,200,27.04.2023,27.04.2023,https://clinicaltrials.gov/show/NCT04609839,No,Results,No,Results,No,Results,9.11.2020,None,
6169,NCT04610541,ClinicalTrials.gov,11.10.2020,12.10.2020,FALSE,University,of,Pecs,Recruiting,Phase,3,Interventional,Hungary,REMdesivir-HU,Clinical,Study,and,Severe,Covid-19,Patients,,Drug,Remdesivir,Remdesivir,2000,30.10.2021,30.11.2021,https://clinicaltrials.gov/show/NCT04610541,No,Results,No,Results,No,Results,9.11.2020,None,,,
6183,NCT04613271,ClinicalTrials.gov,25.10.2020,15.10.2020,TRUE,Ina-Respond,Recruiting,Phase,3,Interventional,Indonesia,Efficacy,and,Safety,of,Favipiravir,in,Covid-19,Patients,in,Indonesia,FVR,Drug,Favipiravir,vs.,Favipiravir,+,Azithromycin,Favipiravir,,,,,,,,,,
6187,NCT04613817,ClinicalTrials.gov,30.10.2020,20.11.2020,FALSE,Sciensano,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,Sero-prevalence,COVID-19,Among,Belgian,Children,SeCoBelChild,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,1640,30.06.2021,31.08.2021,https://clinicaltrials.gov/show/NCT04613817,No,Results,No,Results,No,Results,9.11.2020,None
6189,NCT04614012,ClinicalTrials.gov,2.11.2020,2.07.2020,TRUE,Anna,Falanga,Recruiting,Not,Applicable,Interventional,Italy,Hyperimmune,Plasma,for,Patients,With,COVID-19,IMMUNO-COVID19,ATMP,Plasma,Plasma,100,2.07.2022,2.07.2022,https://clinicaltrials.gov/show/NCT04614012,No,Results,No,Results,No,Results,9.11.2020,None,,,,,
6195,NCT04615026,ClinicalTrials.gov,3.11.2020,4.11.2020,FALSE,University,Hospital,,Augsburg,Recruiting,Not,Applicable,Observational,Germany,Prevalence,of,Thrombosis,in,COVID-Patients,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,400,30.06.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04615026,No,Results,No,Results,No,Results,9.11.2020,None
6197,NCT04615195,ClinicalTrials.gov,3.11.2020,10.06.2020,TRUE,University,Hospital,,Toulouse,Recruiting,Not,Applicable,Observational,France,Effect,of,COVID19-related,COntainment,in,ChildreN,E-COCCON,Other,(psych),No,Intervention,No,Intervention,1000,2.07.2020,30.11.2020,https://clinicaltrials.gov/show/NCT04615195,No,Results,No,Results,No,Results,9.11.2020,None
6200,NCT04615416,ClinicalTrials.gov,26.10.2020,1.05.2020,TRUE,Columbia,University,Recruiting,Not,Applicable,Interventional,United,States,Emotion,Regulation,Training,Via,Telehealth,During,the,COVID-19,Pandemic,ERT-P,Other,(psych),Psychological,Psychological,100,21.01.2020,23.01.2020,https://clinicaltrials.gov/show/NCT04615416,No,Results,No,Results,No,Results,9.11.2020,None
6203,NCT04615741,ClinicalTrials.gov,29.10.2020,1.11.2020,FALSE,University,of,Lethbridge,Not,Recruiting,Not,Applicable,Interventional,No,Country,Given,Finding,Wellness,in,the,Pandemic,,Other,(psych),Psychological,Psychological,200,28.02.2021,30.04.2021,https://clinicaltrials.gov/show/NCT04615741,No,Results,No,Results,No,Results,9.11.2020,None,
6205,NCT04615936,ClinicalTrials.gov,2.11.2020,10.07.2020,TRUE,Sunnybrook,Health,Sciences,Centre,Recruiting,Not,Applicable,Interventional,Canada,Nasal,Photodisinfection,COVID,Proof,of,Concept,Study,,Drug,Methylene,Blue,Methylene,Blue,100,31.05.2021,31.05.2021,https://clinicaltrials.gov/show/NCT04615936,No,Results,No,Results,No,Results,9.11.2020,None
6207,NCT04615975,ClinicalTrials.gov,31.10.2020,1.11.2020,FALSE,University,of,Padova,Recruiting,Not,Applicable,Interventional,Italy,Ketogenic,Diet,as,Protective,Factor,During,COVID-19,,Other,(nutrition),Nutrition,Nutrition,28,30.07.2021,30.08.2021,https://clinicaltrials.gov/show/NCT04615975,No,Results,No,Results,No,Results,9.11.2020,None,,
6208,NCT04616001,ClinicalTrials.gov,2.11.2020,1.11.2020,TRUE,Sharp,HealthCare,Not,Recruiting,Phase,4,Interventional,United,States,IVIG,in,Patients,With,Severe,COVID-19,Requiring,Mechanical,Ventilation,,ATMP,Immunoglobulin,Immunoglobulin,10,30.06.2021,30.06.2021,https://clinicaltrials.gov/show/NCT04616001,No,Results,No,Results,No,Results,9.11.2020,None
6211,NCT04616976,ClinicalTrials.gov,1.11.2020,1.01.2020,TRUE,Southeast,University,,China,Not,Recruiting,Not,Applicable,Observational,China,COVID-19,With,Convalescent,Plasma,,ATMP,Plasma,Plasma,78,29.02.2020,1.11.2020,https://clinicaltrials.gov/show/NCT04616976,No,Results,No,Results,No,Results,9.11.2020,None,,,,
6216,NCT04617535,ClinicalTrials.gov,2.11.2020,1.01.2021,FALSE,Regeneron,Pharmaceuticals,Not,Recruiting,Not,Applicable,Expanded,Access,No,Country,Given,Compassionate,Use,of,REGN-COV2,for,the,Treatment,of,COVID-19,,Drug,REGN10933+REGN10987,REGN10933,,,,,,,,,,
6219,NCT04618796,ClinicalTrials.gov,2.11.2020,1.04.2021,FALSE,Assiut,University,Not,Recruiting,Not,Applicable,Observational,No,Country,Given,Effect,of,COVID-19,Pandemic,on,Vaccination,Compliance,,ATMP,Vaccine,Vaccine,100,1.04.2022,1.05.2022,https://clinicaltrials.gov/show/NCT04618796,No,Results,No,Results,No,Results,9.11.2020,None,
6276,ChiCTR2000036849,ChiCTR,25.08.2020,1.10.2020,FALSE,Huashan,Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6305,IRCT20100228003449N31,IRCT,8.10.2020,26.09.2020,TRUE,Tehran,University,of,Medical,Sciences,Recruiting,Phase,2/Phase,3,Interventional,Iran,Corticosteroids,in,COVID-19,,Drug,Corticosteroids,Dexamethasone,119,Not,Available,Not,Available,http://en.irct.ir/trial/51163,No,Results,No,Results,No,Results,9.11.2020,None,,
6307,IRCT20200922048804N1,IRCT,6.10.2020,5.08.2020,TRUE,Tehran,University,of,Medical,Sciences,Not,Recruiting,Not,Applicable,Interventional,Iran,Melatonin,in,COVID-19,,Drug,Melatonin,Melatonin,20,Not,Available,Not,Available,http://en.irct.ir/trial/51177,No,Results,No,Results,No,Results,9.11.2020,None,,
6314,IRCT20181208041886N1,IRCT,18.10.2020,22.10.2020,FALSE,Esfahan,University,of,Medical,Sciences,Recruiting,Not,Applicable,Interventional,Iran,Levamizole,in,treatment,of,COVID19.,,Drug,Levamizole,Levamizole,60,Not,Available,Not,Available,http://en.irct.ir/trial/51501,No,Results,No,Results,No,Results,9.11.2020,None,
6323,IRCT20200927048848N2,IRCT,4.11.2020,31.10.2020,TRUE,Mashhad,University,of,Medical,Sciences,Recruiting,Phase,3,Interventional,Iran,squalene,and,COVID-19,,Drug,Squalene,vs.,Hydroxychloroquine,+,Lopinavir/ritonavir,Squalene,,,,,,,,,,,,,
6326,EUCTR2020-002502-75-DE,EU,Clinical,Trials,Register,26.06.2020,5.10.2020,FALSE,University,Hospital,,Tübingen,Authorised,Phase,2,Interventional,Germany,Covid-19,Vaccination,Trial,,ATMP,Vaccine,Vaccine,32,Not,Available,Not,Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002502-75,No,Results,No,Results,No,Results,9.11.2020,None,
6334,NL8551,Netherlands,Trial,Register,23.04.2020,23.04.2020,FALSE,Zuyderland,Medical,Centre,Recruiting,Not,Applicable,Observational,Netherlands,Covid,High-intensity,Immunosuppression,in,Cytokine,release,syndrome,,Drug,Corticosteroids,+,Tocilizumab,Methylprednisolone,,,,,,,,,,,
6348,NL8587,Netherlands,Trial,Register,6.05.2020,7.05.2020,FALSE,CIRO,Recruiting,Not,Applicable,Observational,Netherlands,Quality,of,life,in,COVID-19,survivors,,Other,(psych),No,Intervention,No,Intervention,500,Not,Available,1.06.2021,https://trialregister.nl/trial/8587,No,Results,No,Results,No,Results,9.11.2020,None
6361,NL8645,Netherlands,Trial,Register,19.05.2020,23.03.2020,TRUE,UMC,Amsterdam,Recruiting,Not,Applicable,Observational,Netherlands,Sero-surveillance,SARS-CoV-2,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,800,Not,Available,31.12.2020,https://trialregister.nl/trial/8645,No,Results,No,Results,No,Results,9.11.2020,None,,
6364,NL8526,Netherlands,Trial,Register,14.04.2020,26.04.2020,FALSE,Zuyderland,Medical,Centre,Not,Recruiting,Not,Applicable,Observational,Netherlands,Neuroinvasion,in,COVID-19,,Clinical,Presentation,No,Intervention,No,Intervention,10,Not,Available,26.06.2020,https://trialregister.nl/trial/8526,No,Results,No,Results,No,Results,9.11.2020,None
6369,NL8726,Netherlands,Trial,Register,23.06.2020,1.06.2020,TRUE,CHDR,Recruiting,Not,Applicable,Interventional,Netherlands,Effect,of,hydroxychloroquine,treatment,on,the,general,immunocompetence,,Drug,Hydroxychloroquine,Hydroxychloroquine,40,Not,Available,9.09.2020,https://trialregister.nl/trial/8726,No,Results,No,Results,No,Results,9.11.2020,None,
6375,NL8787,Netherlands,Trial,Register,21.07.2020,1.06.2020,TRUE,Leiden,University,Medical,Center,Recruiting,Not,Applicable,Interventional,Netherlands,COVID-VTE,follow-up,study,,Clinical,Presentation,No,Intervention,No,Intervention,400,Not,Available,31.12.2020,https://trialregister.nl/trial/8787,No,Results,No,Results,No,Results,9.11.2020,None
6382,NL8842,Netherlands,Trial,Register,18.08.2020,9.04.2020,TRUE,Drs.,Sasja,Duijff,&,Eva,Potharst,Recruiting,Not,Applicable,Interventional,Netherlands,Online,Communities,,Other,(psych),Psychological,Psychological,50,Not,Available,9.04.2021,https://trialregister.nl/trial/8842,No,Results,No,Results,No,Results,9.11.2020,None,
6389,NL8947,Netherlands,Trial,Register,4.10.2020,5.10.2020,FALSE,UMC,Amsterdam,Recruiting,Not,Applicable,Interventional,Netherlands,ReCOVer:,Cognitive,Behavioural,Therapy,for,post-COVID-19,fatigue,,Other,(psych),Psychological,Psychological,114,Not,Available,5.10.2022,https://trialregister.nl/trial/8947,No,Results,No,Results,No,Results,9.11.2020,None
6394,NL8483,Netherlands,Trial,Register,26.03.2020,16.03.2020,TRUE,Fred,Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6396,NL8491,Netherlands,Trial,Register,31.03.2020,31.03.2020,FALSE,UMC,Amsterdam,Recruiting,Not,Applicable,Interventional,Netherlands,Countering,Lung,Damage,in,COVID-19,infection,(CounterCovid),study,,Drug,Imatinib,Imatinib,386,Not,Available,30.06.2020,https://trialregister.nl/trial/8491,No,Results,No,Results,No,Results,9.11.2020,None
6405,NCT04370067,ClinicalTrials.gov,28.04.2020,1.05.2020,FALSE,Semmelweis,University,Recruiting,Not,Applicable,Observational,Hungary,HUNgarian,COronaVirus,Disease-19,Epidemiological,Research,,Clinical,Presentation,(Epidemiology),No,Intervention,No,Intervention,11200,1.05.2021,1.08.2021,https://clinicaltrials.gov/ct2/show/NCT04370067,No,Results,No,Results,No,Results,16.06.2020,None,,
6409,NCT04342221,ClinicalTrials.gov,8.04.2020,29.03.2020,TRUE,University,Hospital,,Tübingen,Recruiting,Phase,3,Interventional,Germany,Hydroxychloroquine,for,COVID-19,,Drug,Hydroxychloroquine,Hydroxychloroquine,220,21.03.2020,22.02.2020,https://clinicaltrials.gov/ct2/show/NCT04342221,No,Results,No,Results,No,Results,2.07.2020,EUCTR2020-001224-33,,,,,,
6413,NCT04405739,ClinicalTrials.gov,26.05.2020,16.06.2020,FALSE,Ridgeback,Biotherapeutics,Recruiting,Phase,2,Interventional,United,States,The,Effect,of,EIDD-2801,on,Viral,Shedding,of,SARS-CoV-2,(COVID-19),,Drug,EIDD-2801,EIDD-2801,60,28.10.2020,25.11.2020,https://clinicaltrials.gov/ct2/show/NCT04405739,No,Results,No,Results,No,Results,7.07.2020,None
6414,NCT04414267,ClinicalTrials.gov,1.06.2020,26.05.2020,TRUE,Hellenic,Institute,for,the,Study,of,Sepsis,Recruiting,Phase,4,Interventional,Greece,Bacillus,Calmette-gu‚àö¬©rin,Vaccination,to,Prevent,COVID-19,,ATMP,Vaccine,Vaccine,900,25.05.2021,25.05.2021,https://clinicaltrials.gov/ct2/show/NCT04414267,No,Results,No,Results,No,Results,14.07.2020,EUCTR2020-002448-21
6418,NCT04400838,ClinicalTrials.gov,12.05.2020,28.05.2020,FALSE,University,of,Oxford,Recruiting,Phase,2/Phase,3,Interventional,United,Kingdom,Investigating,a,Vaccine,Against,COVID-19,COV002,ATMP,Vaccine,Vaccine,12330,21.09.2020,21.09.2020,https://clinicaltrials.gov/ct2/show/NCT04400838,No,Results,No,Results,No,Results,24.08.2020,EUCTR2020-001228-32,,,
6419,NCT04425031,ClinicalTrials.gov,5.06.2020,25.08.2020,FALSE,Aalborg,University,Hospital,Recruiting,Phase,4,Interventional,Denmark,Handling,Oxygenation,Targets,in,COVID-19,(HOT-COVID),HOT-COVID,Drug,Oxygen,Oxygen,780,1.12.2022,1.03.2024,https://clinicaltrials.gov/ct2/show/NCT04425031,No,Results,No,Results,No,Results,14.09.2020,EUCTR2017-000632-34,,,,
